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Abstract 
Introduction 
Histological chorioamnionitis (HCA) is inflammation of the fetal membranes. Understanding 
the fetal membrane microbiota linked to inflammation and bacterial infection is incomplete. 
This research aimed to increase current knowledge of the fetal membrane microbiota in 
HCA, including bacterial profile, bacterial load and correlation to inflammatory response. In 
addition, to investigate the application of Formalin-Fixed Paraffin-Embedded (FFPE) tissues 
to microbiota research. Finally, to optimise Raman spectroscopy on low biomass cultures 
for future application to HCA detection. 
Methods 
A retrospective cohort study was employed on fetal membranes from patients with preterm 
spontaneous labour and HCA (n=12), or preterm (n=6) and term labour without HCA (n=6), 
plus low risk term patients (n=58). To investigate bacterial profiles, 16S rRNA Illumina 
sequencing was performed. Bacterial loads were assessed by 16S rRNA BactQuant qPCR, 
with bacterial loads also correlated to inflammatory marker data. The spectral fingerprint 
and biochemical composition of three bacteria were analysed using Raman spectroscopy.  
Results 
Bacterial loads were significantly greater from HCA patients (5013.066 copies/µl) compared 
to preterm (288.873 copies/µl) and term without HCA (254.819 copies/µl). Increased 
bacterial load was positively correlated with maternal inflammatory staging, and the 
expression of five inflammatory markers. Non-HCA patients, low risk term patients and 
negative controls did not display distinct bacterial loads (200-300 copies/µl). A trend for 
increased Prevotella with increased inflammation was detected. Over half of sequences 
from FFPE fetal membranes were identified as contaminants. Bacteria were identified by 
one Raman spectral peak (1003 cm-1). 
Discussion 
Inflammatory HCA involves bacterial infection and increased bacterial load in a dose 
response relationship, with an association to increased Prevotella. Bacteria is not acquired 
in utero on fetal membranes without an inflammatory condition. Frozen tissues remain the 
gold standard for microbiota research. Optimisation of Raman microspectroscopy for 
bacterial detection on clinical tissues is required to improve diagnosis. 
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Chapter One: Introduction. 
 
1.1 The placenta and fetal environment 
The maternal-fetal interface composed of the maternal decidua and placental disk 
(Edmonds, 2008); plus the fetal components of the fetal membranes, amniotic fluid 
and umbilical cord, are essential for optimum fetal development (Edmonds, 
2008)(Figure 1.1). 
The placenta is a large transient organ acting as a key communicator between the 
maternal and fetal environment, which is vital for maintenance of pregnancy 
(Donnelly and Campling, 2019; Menon, Richardson and Lappas, 2018). Functions 
include gaseous exchange, vitamin and mineral transportation via a concentration 
gradient (Jones and Jansson, 2007), elimination of waste metabolites (Serrano et 
al, 2002) and secretion of human chorionic gonadotrophin (Donnelly and Campling, 
2019). The maternal decidua which adheres to the fetal membranes contains 
differentiated stromal cells, maternal blood vessels and immune cells (Pansky, 
1982)(Figure 1.1). Placental and chorionic villi act as an anchor for stability and to 
give increased maternal-fetal contact area (Pansky, 1982). The umbilical cord is 
also a maternal-fetal communication pathway (Di Naro et al, 2001)(Figure 1.1). 
The fetal membranes overlay the placenta and decidua to create an internal capsule 
of the amniotic cavity (Pansky, 1982)(Figure 1.1). The contained amniotic fluid 
provides mechanical cushioning, plus growth factors and antimicrobial effectors to 
protect and aid development of the fetus (Underwood, Gilbert and Sherman, 2005). 
Amniotic fluid is also used as a diagnostic media during amniocentesis for prenatal 
assessment (Underwood, Gilbert and Sherman, 2005). 
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Figure 1.1 Schematic diagram of the fetal environment. A cross section of the fetal 
environment during gestation required for maintenance of pregnancy, displaying the fused 
amnion and chorion of the fetal membranes, in close contact with the maternal decidua. 
Invasion of the chorionic villi into the placenta creates maternal-fetal communication. 
Diagram not to scale. 
 
1.1.1 Fetal membrane morphology  
The fetal membranes which encapsulate the developing fetus are formed from the 
outer chorion and the deeper amnion, which overlay the placental disk (Sood et al, 
2006)(Figure 1.2). 
 
1.1.1.1 Amnion 
The amnion is up to 500 µm thick and is composed of an epithelium layer, basement 
membrane, compact layer, avascular reticular tissue and sponge layer 
interconnecting to the chorion (Mamede et al, 2012)(Figure 1.2). The single cuboidal 
epithelial cell layer is the initial layer in contact with the amniotic cavity and amniotic 
fluid (Canzoneri et al, 2013). The basement membrane functions as a permeable 
barrier and aids with structural integrity (Mamede et al, 2012)(Figure 1.3). The dense 
outer collagen-rich layers have high tensile strength and flexibility to withstand 
movement and growth (Verbruggen et al, 2017).  
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1.1.1.2 Chorion 
The outer chorion is formed from a fibrous reticular layer, basement membrane, and 
deeper trophoblast layer (Bourne, 1962)(Figure 1.2). The chorion acts as an 
immunological barrier of protection between the fetus and the maternal or external 
environment (Verbruggen et al, 2017). The chorionic villi interlock with the maternal 
decidua to allow nutrient transfer and stabilise the membranes (Sood et al, 
2006)(Figure 1.3).  
 
Figure 1.2 Schematic diagram of the fetal membrane structure. A schematic 
representation of a cross section of the multiple layered and multiple functioning fetal 
membranes, consisting of the amnion and chorion, plus the fused maternal decidua during 
gestation. For this diagram the uterine cavity would be superior to the fetal membranes, 
with the placental disk inferior to this diagram. Diagram not to scale. 
4 
 
 
Figure 1.3 Histological image of the fetal membrane structure. A histological cross 
section of the fetal membranes and maternal decidua stained with haematoxylin and eosin. 
Image displays the amnion composed of the epithelial cells (E), basement membrane (BM), 
mesenchymal layer (M) and intermediate spongy layer (IZ). Chorion composed of the 
chorionic basement membrane (CM) and trophoblast cells (T). Prelabelled figure from 
Elfayomy and Almasry (2014). 
 
1.1.2 Characteristics of the fetal membranes 
The fetal membranes maintain structural integrity throughout gestation for continual 
survival of the fetus (Edmonds, 2008), with nutrients supplied via diffusion from 
amniotic fluid and the maternal decidua (Mamede et al, 2012). The fetal membranes 
express few class II HLAs to suppress immunological response and avoid immune 
rejection throughout gestation (Murphy et al, 2014). Alongside vital in utero 
functioning, fetal membranes possess anti-angiogenic and pro-apoptotic 
characteristics (Mamede et al, 2012), which have been exploited in regenerative 
medicine, superficial wounds and tissue engineering research (Lei et al, 2017; 
Mamede et al, 2012; Mi et al, 2012). 
During development the amnion originates from the amniotic ectoderm, with the 
chorion from the somatic mesoderm (Edmonds, 2008). At 14-16 weeks gestation, 
the amnion and chorion fuse into an individual entity (Edmonds, 2008). At term, the 
morphology of the fetal membranes alter to create a specific zone of weakness, 
leading to membrane rupture and consequential parturition (Verbruggen et al, 
2017). If the membranes are prematurely weakened, premature rupture of the 
membranes (PROM), preterm PROM (PPROM) and preterm birth (PTB) may occur 
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(Richardson et al, 2017; Verbruggen et al, 2017). PROM is defined as rupture of the 
fetal membranes prior to the onset of contractions and active labour (Goldenberg et 
al, 2008), with PPROM specific to occurrence at <37 weeks gestation (Fortner et al, 
2014).  
 
1.1.3 Immunology of the fetal membranes  
The fetal membranes and placenta possess unique immunological characteristics, 
with versatile protective mechanisms and immune modulation to prevent invasion 
and allow fetal development. 
Toll-like receptor (TLR) expression on the fetal membranes begins at 25 weeks 
gestation and matures throughout gestation (Mor, Aldo and Alvero, 2017). TLRs are 
the first line of immune defence to recognise pathogen associated molecular 
patterns, with TLR4 and TLR2 the greatest expressed (Mor, Aldo and Alvero, 2017; 
Waring et al, 2015). TLR4-MD2 complex recognises bacterial lipopolysaccharides 
(LPS) leading to TLR4 dimerisation and the recruitment of adaptor proteins, 
including MyD88 or TIRAP (Kawai and Akira, 2010). These factors recruit IRAK for 
rapid activation of the NF-Κβ transcription factor and proinflammatory cytokine 
response (Kawai and Akira, 2010). Alternatively, internalisation of TLR4-MD2 leads 
to TRIF and TRAM activation to promote interferons (IFN) and further NF-Κβ 
activation (Kawai and Akira, 2010). Alternatively, TLR2/TLR1 homo/heterodimers 
recognise Gram negative triacyl lipopeptides to activate TIRAP and MyD88 
dependent pathway for NF-Κβ expression (Kawai and Akira, 2010). 
Further to this, the immunomodulated pregnancy state is characterised by 
suppression of type 1 T helper (Th1) proinflammatory cytokine and activation of type 
2 T helper (Th2) anti-inflammatory profile at the maternal-fetal interface (Morelli et 
al, 2015). The amnion and decidua have a role in inhibiting Th1 activation due to the 
production of interleukin-13 (IL-13) and IL-4, with a reverse back to Th1 activity, 
including increased TNFα and IFNγ from the fetal membranes during active labour 
(Morelli et al, 2015). Negative regulation of T helper cells can lead to pregnancy 
related conditions including PTB and pre-eclampsia (Hsu and Nanan, 2014). In 
alternate body sites, a Th1/Th2 balance is optimum, with imbalance in the 
respiratory tract epithelia linked to allergies and asthma (Mazzarella et al, 2002). 
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The fetal membranes also possess atypical human leukocyte antigen (HLA) 
expression, with absence of HLA-A and HLA-B (Hori et al, 2006; Huddleston and 
Schust, 2004). This may increase vulnerability to natural killer (NK) cell mediated 
attack as HLAs are antigen presenting for NK cells, but chorionic extravillous 
cytotrophoblasts present HLA-C, HLA-G and HLA-E (Aagaard-Tillery, Silver and 
Dalton, 2006; Huddleston and Schust, 2004), leading to an immunosuppressive 
effect and preventing NK attack (Hsu and Nanan, 2014). The decidua constitutes 
mainly of NK cells, accounting for 50-90% of leukocytes (Aagaard-Tillery, Silver and 
Dalton, 2006; Mor, Aldo and Alvero, 2017). However, decidual NK cells differ to 
peripheral blood NK cells due to increased CD56 expression required for 
remodelling of spiral placental and decidual arteries (Hsu and Nanan, 2014; Mor, 
Aldo and Alvero, 2017), and lack of CD16 reducing cytotoxicity (Morelli et al, 2015). 
The characteristic HLA presentation is also seen in other immunomodulated 
locations including the retina, iris, and cornea (Aagaard-Tillery, Silver and Dalton, 
2006; Hori et al, 2006; Hsu and Nanan, 2014). 
 
1.2 Preterm birth: Epidemiology, risk factors, complications and treatments 
Parturition (action of giving birth) is a physiological process controlled by endocrine, 
paracrine and autocrine mechanisms from placental, fetal and maternal 
components, including oxytocin and prostaglandin feedback loops (Kota et al, 
2013). Term birth is defined as parturition at 37-42 weeks gestation and is the 
normal gestational length in human pregnancy (Pansky, 1982). PTB is classified as 
parturition <37 weeks, with this further categorised into late preterm (34-36 weeks; 
Shapiro-Mendoza and Lackritz, 2012), early preterm (28-34 weeks; Goldenberg et 
al, 2008; Tucker, 2004) and extreme preterm birth (<28 weeks; Morgan et al, 2016). 
PTB occurs in 15 million births worldwide per year (NICE, 2019; WHO, 2015). The 
global burden of PTB is 11%, varying from 5% occurrence and 90% survival rates 
in European countries, compared to 18% occurrence and 10% survival in African 
countries (Blencowe et al, 2012; Vogel et al, 2018).  
The occurrence of PTB is spontaneous in 70% of cases (Goldenberg et al, 2008). 
In the remaining cases medical interventions and invasive procedures (Kemp, 
2014), or maternal complication, including placenta previa or fetal distress may 
initiate PTB (Vogel et al, 2018). Regardless of spontaneity, PPROM is a significant 
risk factor, occurring prior to PTB in 30% of cases (Brown et al, 2018). PTB has 
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been associated with other risk factors, including maternal age (Londero et al, 
2019), smoking (Varga et al, 2017), vaginal dysbiosis (Brown et al, 2018), multiple 
pregnancies, diabetes, high blood pressure (WHO, 2015) and infection, such as 
chorioamnionitis (Friese, 2003; Jones et al, 2009).  
Preterm birth is a leading cause of mortality, accounting for 35% of mortality in 
newborns and 16% of mortality in children under five (UNIGME, 2017). 
Complications include necrotising enterocolitis (NEC), maternal and fetal sepsis, 
plus respiratory and neurological conditions (Tomlinson et al, 2019; Vogel et al, 
2018).  
The current World Health Organisation (WHO) and National Institute for Health and 
Care Excellence (NICE) guidelines for intervention of PTB include administering 
prophylactic corticosteroids and antibiotics to supress labour, plus supporting the 
neonate after birth with oxygen therapy, feeding support and thermal care (NICE, 
2019; WHO, 2015).  
 
1.3 Chorioamnionitis 
Chorioamnionitis is an inflammatory condition of the fetal membranes, and is a 
causal factor of PTB (Redline et al, 2003). Two subcategories of chorioamnionitis 
exist (clinical and histological chorioamnionitis) and are defined by maternal and 
fetal clinical characteristics or morphological presentation of the placenta and fetal 
membranes.  
Chorioamnionitis impacts 5% of pregnancies, with occurrence inversely related to 
gestational age as incident rates are greater in PTB, occurring at 11%, 35% and 40-
94% in late, early and extreme PTB, respectively (Kim et al, 2015). Whilst 
occurrence is 2-4% at term (Kim et al, 2015). The prevalence of histological 
chorioamnionitis (HCA) varies worldwide due to environmental, maternal and 
healthcare factors (Chan et al, 2016; Malloy, 2014). The prevalence is higher in non-
western countries, with 66% in Bangladesh (Chan et al, 2016), compared to 1-5% 
in developed countries, including the UK and USA (Malloy, 2014). This is due to 
increased occurrence of home births, absence of skilled midwives, plus reduced 
diagnostic and preventative care in non-western countries (Johnson, Adami and 
Farzin, 2017).  
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1.3.1 Clinical chorioamnionitis (CCA) 
Clinical chorioamnionitis occurs in 10-30% of chorioamnionitis cases (Jessop and 
Sebire, 2011) and is diagnosed prior to and during parturition according to routinely 
monitored maternal and fetal clinical characteristics. Indicators include maternal 
fever (>38 °C), uterine tenderness, tachycardia (>100 bpm maternal, >160 bpm 
fetal), vaginal discharge and elevated maternal white blood cell count (WBC; Tita 
and Andrews, 2010). Maternal fever is the most sensitive method of diagnosis (95-
100%; Tita and Andrews, 2010). But each characteristic is non-specific to 
chorioamnionitis when investigated individually (Tita and Andrews, 2010). Thus, 
maternal fever, plus two of the remaining characteristics are to be present for a 
definitive diagnosis (Sahni, Franco-Fuenmayor and Shattuck, 2019). 
 
1.3.2 Histological chorioamnionitis (HCA) 
Only one third of patients with chorioamnionitis present with clinical symptoms 
(CCA), with two thirds asymptomatic or subclinical (Redline et al, 2003; Smulian et 
al, 1999). HCA occurs more frequently in PTB (30-50%) than CCA (Jessop and 
Sebire, 2011). HCA is diagnosed following routine placental collection and 
assessment of tissue morphology for maternal and fetal inflammatory response 
factors (Redline et al, 2003). The placenta, fetal membranes and umbilical cord are 
collected following parturition and processed via fixative and embedding procedures 
to give Formalin-Fixed Paraffin-Embedded (FFPE) samples, before staining with 
haematoxylin and eosin (H&E; Holzman et al, 2007). Diagnosis is then performed 
by two independent clinicians, based on the abundance of macrophages and 
neutrophils within the fetal membranes, plus necrosis and thickening of the fetal 
membranes (Redline et al, 2003). The severity, progression and intensity of the 
condition is then categorised using Redline staging and grading criteria (Redline et 
al, 2003)(Table 1.1). Redline criteria is the combination of two historical diagnostic 
methods (Blanc, 1980; Salafia, Weigl and Silberman, 1989), and is the most 
universal method applied to current diagnostic research (Catano Sabogal, Fonseca 
and Garcia-Perdomo, 2018), due to the combination of staging and grading to 
increase specificity of detection (Redline et al, 2003). Inflammatory staging refers to 
the progression of the condition, whereas inflammatory grading measures intensity 
(Redline et al, 2003)(Table 1.1). Severity of HCA increases as more neutrophils 
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penetrate deeper across the membranes and into the amnion, eliciting a greater 
inflammatory response (Becroft, Thompson and Mitchell, 2012; Redline et al, 2003). 
The inflammatory response in chorioamnionitis may not be isolated to the fetal 
membranes. Further inflammation involving the amniotic fluid or umbilical cord is 
defined as intra-amniotic infection (Han et al, 2009). Fetal involvement following 
inflammatory stimuli can lead to; fetal inflammatory response syndrome, with 
funisitis, involving outer umbilical cord neutrophil presence, plus umbilical artery and 
venous involvement (Redline et al, 2003; Redline, 2006); or fetal vasculitis, with 
neutrophil influx in the chorionic plate fetal vessels or umbilical cord (Hecht et al, 
2009). Thus, specific identification and classification of each neonatal condition is 
important to tailor individual treatment.  
The fixed and processed fetal membrane rolls used for HCA diagnosis are archived, 
but rarely utilised beyond immunological and pathological diagnosis. FFPE fetal 
membrane samples could be valuable when there is a shortage of biological sample, 
or biobank storage limitations (Janecka, Adamczyk and Gasinska, 2015). The 
beneficial application of FFPE fetal membranes to HCA microbiota research 
requires investigation. 
 
 
Stage  Characteristic 
One <5 neutrophils within the chorionic plate or chorionic connective tissues 
Two >5 scattered neutrophils in the chorionic plate or amnion 
Three Degenerating neutrophils in the amniotic basement membrane 
Grade Characteristic 
One  Small clusters of maternal neutrophils within the amnion or chorionic plate 
Two Multiple large clusters of neutrophils or leukocytes between the chorion and 
decidua or chorionic plate 
 
Table 1.1 Redline criteria for the detection of inflammatory response in the placenta 
and fetal membranes. Histological chorioamnionitis is diagnosed by assessment of the 
placenta and fetal membranes postpartum following fixing and embedding the tissues and 
histological staining. Criteria displayed as stage or grade to detect inflammatory response 
on the fetal membranes, categorised by abundance of macrophages and neutrophils within 
the fetal membranes (Redline et al, 2003). Severity of inflammation increases numerically. 
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1.3.3 Maternal risk factors for chorioamnionitis  
Multiple risk factors for developing chorioamnionitis have been suggested (Ategeka 
et al, 2019; Jung et al, 2010; Kim et al, 2015; Konwar et al, 2018). PPROM is a 
significant risk factor to chorioamnionitis, with 88% of PPROM also displaying 
chorioamnionitis (Steel et al, 2005), this is due to early rupture of membranes 
leading to extended time to labour, increasing the opportunity of ascending bacterial 
infection and early PTB (Czikk, McCarthy and Murphy, 2011; Jessop and Sebire, 
2011; Jung et al, 2010). Further investigated risk factors for chorioamnionitis in PTB 
include large cervical dilation (Kim et al, 2015), multiple examinations, invasive fetal 
procedures (Czikk, McCarthy and Murphy, 2011) and short cervical length (Jung et 
al, 2010). These factors are also linked to increased opportunistic bacterial 
translocation. In term patients, ethnicity and extended delivery duration were risk 
factors for HCA (Becroft, Thompson and Mitchell, 2012). Maternal inflammation and 
infection are significantly associated with chorioamnionitis in term and PTB patients 
(Doyle et al, 2017; Sweeney et al, 2016) and will be discussed in detail in future 
sections.  
 
1.3.4 Complications in chorioamnionitis  
Chorioamnionitis is a leading cause of global PTB and the cases of PTB are rising 
(Tambor et al, 2015), thus research investigating HCA is increasingly important to 
understand development of the condition. Although incident rates vary across HCA 
and CCA, maternal and fetal complications are similar. If undiagnosed, 
chorioamnionitis may lead to further complication for the mother and neonate 
immediately and throughout life. In addition to PTB, HCA has been linked to adverse 
maternal and neonatal outcomes including, low birth weight (Ategeka et al, 2019), 
early onset sepsis (Sahni, Franco-Fuenmayor and Shattuck, 2019), cerebral palsy, 
structural brain lesions and developmental deficiency, due to persistent exposure to 
inflammation and immune activation (Becroft, Thompson and Mitchell, 2012; 
Galinsky et al, 2013). NEC, which is intestinal inflammation in the neonate, occurs 
more frequently in the presence of chorioamnionitis (Been et al, 2013; Taft et al, 
2015), with NEC diagnosed in 10% of chorioamnionitis cases (Lu and Claud, 2018). 
Improving current knowledge and diagnosis aims to reduce negative outcomes 
associated with chorioamnionitis. Along with affecting the individual, treatment, 
management and neonatal intensive care costs create collateral impact to the 
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economy and health care services (Kim et al, 2015). To improve the diagnosis and 
treatment of chorioamnionitis, first a greater understanding of the condition, 
including bacterial presence and inflammatory biomarkers is required.  
 
1.3.5 Diagnosis, prevention and treatment of HCA 
Early diagnosis and intervention of HCA is difficult due to the absence of clinical 
signs (Redline et al, 2003), thus it is increasingly important to continue research into 
diagnostic biomarkers. Although retrospective histological analysis is beneficial for 
management of the condition, informing of antibiotic treatment targeting potential 
causative microorganisms (Johnson, Adami and Farzin, 2017), alternate ways to 
diagnose HCA earlier are being studied (Catano Sabogal, Fonseca and Garcia-
Perdomo, 2018; Jung et al, 2010). The inflammatory response to microorganisms 
within placental membranes creates a biomarker for predicting chorioamnionitis. 
Chemokines and cytokines, including interleukin-6 (IL-6) and IL-8 are routinely used 
for CCA severity diagnosis (Jung et al, 2010; Tita and Andrews, 2010), but are yet 
to be applied to asymptomatic HCA. Multiple biochemical markers have been 
suggested for maternal inflammatory detection; including IL-6, IL-8 and MMP-9 
(Musilova et al, 2015; Roberts et al, 2012), with these increased in umbilical cord 
(Roberts et al, 2012) or amniotic fluid with inflammation and chorioamnionitis 
(Musilova et al, 2015). Current research relates a specific IL-6 gene allele 
characteristic to HCA (Konwar et al, 2019), yet this was limited to East Asian 
populations and not related to European, African or South Asian populations. A 
recent Cochrane systematic review and meta-analysis observed that inflammatory 
marker C-reactive protein (CRP) in maternal serum was the most beneficial 
measurement for HCA detection; with 69% sensitivity and 77% specificity to HCA 
(Catano Sabogal, Fonseca and Garcia-Perdomo, 2018). NICE also recommends 
further research into CRP for the prediction of HCA following PPROM (NICE, 2019). 
CRP is suggested to be lower in healthy preterm compared to healthy term (Tita 
and Andrews, 2010) indicating levels are gestational age dependent, limiting 
specificity to HCA. Alternatively, monitoring WBCs provided 67% sensitivity and 
72% specificity to HCA (Jung et al, 2010).  
Many biochemical diagnostic methods aim to detect maternal inflammation or 
infection rather than chorioamnionitis specifically. This can lead to false positive 
results and decrease the specificity of diagnosis to HCA as it is impacted by 
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inflammation elsewhere in the body (Cobo, Kacerovsky and Jacobsson, 2017). The 
inflammatory profile of maternal blood or plasma may not be reflective of the fetal 
membranes (Seong et al, 2014), with amniotic fluid samples a better predictor of 
infection and inflammation (Park et al, 2018). The combination of multiple 
biochemical and morphological diagnostic tests may be required to definitively 
diagnose the condition. 
The absence of symptoms and delayed diagnosis creates difficulties for treatment 
interventions. Currently, there are no clear NICE guidelines for the treatment of 
chorioamnionitis (NICE, 2019). The main priority is to reduce time from membrane 
rupture until delivery, preventing exposure to external microorganisms (Doyle et al, 
2014; Doyle et al, 2017). Treating the potential causative bacteria, including 
Ureaplasma and Mycoplasma by aminopenicillin and gentamicin is beneficial to 
reduce infection (Johnson, Adami and Farzin, 2017). Yet, antibiotic treatment should 
only be administered if chorioamnionitis is confirmed histologically (Higgins et al, 
2016). 
 
1.4 Microbiology and the microbiota 
The microbiome is all of the genetic material of all the microorganisms in one 
environment or location at one specific time (Proctor, 2011), with the microbiota 
focussing specifically on bacterial gene elements (Proctor, 2011). Microbiomes are 
detected in diverse locations, from the human gut (Stewart et al, 2016; Young et al, 
2017), lungs and sputum (Purcell et al, 2014), oral cavity (Fardini et al, 2010) and 
vaginal mucosal surface (Romero et al, 2014a), to environmental locations including 
hospital wards (Shin et al, 2015) and ultrapure water (Kulakov et al, 2002). The 
microbiota for each location varies in type, abundance and diversity of bacteria. The 
microbiota is the unique fingerprint of a sample, providing distinct characteristics 
and functions (Lloyd-Price, Abu-Ali and Huttenhower, 2016). The microbiota is also 
temporally dynamic, for example, Lactobacillus within the vaginal microbiota 
increases throughout gestation, decreasing again postpartum (MacIntyre et al, 
2015).  
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1.4.1 Microbiology of the fetal environment and HCA 
The microbiota of the placenta and fetal membranes is inconclusive (Aagaard et al, 
2014; Jones et al, 2009; Leiby et al, 2018). The assumption that the placenta, fetal 
membranes and developing fetus remain sterile throughout a healthy pregnancy 
were originally accepted. However, in the 1980s bacteria were detected for the first 
time by culture methods from 16% of healthy chorion tissues (Kovalovski et al, 
1982). This pioneering study questioned previously assumed theories and led to 
ongoing placental microbiota research and debates (Aagaard et al, 2014; Jones et 
al, 2009; Leiby et al, 2018). The three debated theories of the placental and fetal 
membrane microbiota are; the sterile placenta theory, sterile inflammation theory 
and the theory of a genuine placental microbiota.  
 
1.4.1.1 Sterile placenta theory 
The constant sterile placenta theory suggests that the placenta and fetal 
membranes are sterile and do not contain a genuine and unique microbiota (de 
Goffau et al, 2019; Kuperman et al, 2020; Perez-Munoz et al, 2017; Theis et al, 
2019). Multiple microbiological and molecular methods (bacterial culture, Gram 
staining, immunohistochemistry (IHC), electron microscopy, quantitative 
polymerase chain reaction (qPCR) and next generation sequencing (NGS)) failed 
to detect any bacteria on healthy or pre-eclampsia placental tissues (Kuperman et 
al, 2020). With all samples and negative controls beyond the quantification and limit 
of detection in the qPCR methodology. Any bacterial detection in these tissues is 
attributed to exposure to the external maternal environment of the skin and vaginal 
cavity (Jones et al, 2009), linked to mode of delivery. This confirmed by vaginal 
originating bacteria including Lactobacillus present in vaginal births, and caesarean 
section births containing skin surface bacteria such as Staphylococcus (Dominguez-
Bello et al, 2010). Contrasting evidence suggests low contribution from bacteria of 
vaginal origin, as Onderdonk et al (2008a; 2008b) discovered only 12% of placental 
membranes from vaginal delivery included vaginal originating Lactobacillus, with 
Staphylococcus and Corynebacterium detected in 42%, possibly originating from 
the maternal skin microbiota (Onderdonk et al, 2008a). Detection may be attributed 
to gestational age rather than mode of delivery, with diverse polymicrobial detection 
in PTB, including Ureaplasma, Fusobacterium, Streptococcus and Mycoplasma 
compared to a dominance of Lactobacillus at term (Jones et al, 2009; Onderdonk et 
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al, 2008b). Alternatively, bacteria detected in these tissues may arise from 
environmental contamination. Lauder et al (2016) and Shin et al (2015) suggested 
that fetal membrane bacteria originated from environmental sources, with 
sequencing methods unable to differentiate between negative technical controls of 
hospital environment, biological safety cabinets or DNA extraction kit negatives and 
healthy placenta (Theis et al, 2019), suggesting contribution during sample 
processing (Weiss et al, 2014).  
 
1.4.1.2 Sterile inflammation theory 
A second theory is the sterile inflammation theory, suggesting that the placenta is 
sterile without complication and bacteria are only detected if an infection, disease or 
pregnancy related condition is present (Fichorova et al, 2011; McCuaig et al, 2018; 
Seferovic et al, 2016). Sterile inflammation has been related to tissue trauma, 
hypoxic stress and danger signalling of damage associated molecular patterns 
(DAMPs; Rock et al, 2010). Bacterial detection has been correlated to the location 
of initial infection or inflammation, as oral pathogens, mainly Fusobacterium have 
been detected in the placenta following periodontal disease (McCuaig et al, 2018; 
Seferovic et al, 2016). This suggests haematogenous transfer of bacteria to the fetal 
membranes, with translocation from the oral environment explored in other 
conditions including, chronic kidney disease (Hickey et al, 2020). This supported by 
bacteria characteristic to bacterial vaginosis (Gardnerella vaginalis and Prevotella) 
detected only when bacterial vaginosis was confirmed (Fichorova et al, 2011).  
 
1.4.1.3 Genuine microbiota theory 
A third theory suggests that a constant, non-pathogenic, low abundance placental 
microbiota exists, consisting of Escherichia, Proteobacteria and Tenericutes 
(Aagaard et al, 2014). This profile was detected across 320 placentas compared to 
five alternate body sites taken from non-pregnant patients via whole genome 
sequencing. This study was one of the first to raise such controversial aspects, 
generating response from the scientific community and raising questions on the lack 
of contamination controls from identical patients and external environments (Kilman, 
2014). Due to the low biomass of the placenta and fetal membranes, increased 
contamination from DNA extraction kits and laboratory reagents is apparent (Salter 
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et al, 2014). Escherichia is the suggested main component of the placental 
microbiota, yet also the primary bacterium identified as a contaminant in low 
biomass microbiota research (Eisenhofer et al, 2019; Glassing et al, 2016; Salter et 
al, 2014; Stinson, Keelan and Payne, 2018b). Previous studies have detected 
genera in fetal membranes that originate from kit negative controls, including Dorea 
and Pseudomonas (Glassing et al, 2016; Salter et al, 2014). Careful consideration 
is required when interpreting findings and elucidating the microbiota of fetal 
membranes, with requirements to include negative controls, to detect and 
investigate the potential contaminating kit reagent microbiota or ‘kitome’ within each 
study.  
 
1.4.2 Placental and fetal membrane microbiota with chorioamnionitis 
Although the existence of a unique healthy fetal membrane microbiota remains 
debated (Aagaard et al, 2014; Jones et al, 2009; Leiby et al, 2018), research has 
expanded into investigating the placental and fetal membrane microbiota when a 
maternal condition is present, relating to the sterile inflammation theory. Findings 
suggest differences in bacterial profiles and diversity in patients diagnosed with 
chorioamnionitis, compared to patients without chorioamnionitis (Prince et al, 2016; 
Sweeney et al, 2016). The bacterial profile in PTB patients with HCA has shown to 
contain greater urogenital and oral bacteria (Prince et al, 2016), including greater 
Fusobacterium and Ureaplasma in HCA, yet increased Lactobacillus in term 
placenta, independent of HCA status (Prince et al, 2016). Yet, fetal membrane 
swabs were utilised rather than extracted tissue samples, with all patient 
demographics displaying consistently high levels of Escherichia (Prince et al, 2016). 
Ureaplasma is the most frequently isolated bacteria from patients with HCA, 
occurring in 59% and 60% of preterm and term membranes with chorioamnionitis, 
respectively (Sweeney et al, 2016), proposing involvement in chorioamnionitis 
regardless of gestational age. However, only late preterm births were included in 
the cohort limiting generalisation to this research focussing on early preterm, which 
display the greatest risk of chorioamnionitis (Decembrino et al, 2014). This Gram-
negative commensal vaginal bacterium was the only bacteria significantly correlated 
to chorioamnionitis in placental samples via species-specific multiplex qPCR, 
detected in 33% compared to 9% without chorioamnionitis (Cox et al, 2016). Other 
bacteria measured but not linked were Mycoplasma, Gardnerella and Streptococcus 
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(Cox et al, 2016). Prevotella is a Gram-negative commensal oral bacteria, which 
has been detected in 47% of HCA placenta with bacterial vaginosis via culture 
techniques (Fichorova et al, 2011). Prevotella has been strongly linked to vaginal 
pathologies and dysbiosis including bacterial vaginosis (Aroutcheva, Ling and Faro, 
2008; Si et al, 2017), also to additional negative neonatal outcomes of spontaneous 
PTB (sPTB; Kim et al, 2015) and small gestational size (Doyle et al, 2017). 
It may not be the type of bacteria or bacterial profile in the fetal membranes that 
impact chorioamnionitis, but the abundance of bacteria. Previous research has 
linked bacterial load to HCA (Doyle et al, 2017; Jones et al, 2009; Kim et al, 2009). 
Bacterial loads of up to 5.2 log10 copies/µl have been detected in fetal membranes 
with HCA (Doyle et al, 2017). Studies have linked bacterial loads and specific genera 
as combined factors in HCA, including a two-fold increase in Prevotella from 
cultured membranes (Hecht et al, 2009). 
The inflammatory response in HCA displays high variation which may be bacterium 
dependent. Fetal membranes react to bacterial presence by increasing IL-1β, TNF-
α and IL-6 cytokines (Maddipati et al, 2016), creating an inflammatory cascade to 
increase neutrophil influx and host defence response (Kim et al, 2015). Fichorova 
et al (2011) suggested bacterial dependent levels, with Ureaplasma generating an 
increase in MIP-1β and ITAC, yet Mycoplasma creating an increase in MMP-9.  
Novel biomarkers have been studied to improve HCA detection and diagnosis, plus 
understand the inflammatory pathway response in HCA. The study initiating this 
research project investigated the gene expression of TLR signalling pathways in 
HCA via qPCR (Waring et al, 2015). Findings displayed increased TLR1, TLR2 and 
LY96 in HCA chorion, or increased IL-8 and IRAK2 within HCA amnion, with 
correlation between increased gene expression of these inflammatory factors and 
maternal inflammatory stage and grade (Waring et al, 2015). This suggests the 
involvement of bacteria as inflammatory agents, activating inflammation via the 
common IRAK and NF-Κβ pathway (Waring et al, 2015). Yet further investigation 
into the amount and type of bacteria required to activate the inflammatory response 
in HCA is required. 
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1.4.3 Pathway of initiation in chorioamnionitis 
To support the detection of bacterial communities in the placenta and fetal 
membranes, investigating the route of transportation and pathway of initiation is 
important. One theory states that bacteria ascend from the lower female 
reproductive tract (Park et al, 2009), with bacteria detected in the placenta from 
vaginal or lower reproductive tract origin, such as Mycoplasma and Ureaplasma 
supporting the theory (Prince et al, 2016). Contrasting research highlights that 
ascending bacteria are detected in a minority of chorioamnionitis cases, with active 
uterine contractions during parturition the initiating factor rather than a passive 
process occurring prior to, and therefore causing preterm labour (Jones et al, 2009). 
This route would require bacteria to possess the characteristics to transverse and 
survive through multiple immunologically active tissues and diverse environments 
within the reproductive system (Hyde and Schust, 2016), including the mucosal 
interface serving as an additional immunological and physical barrier to colonisation 
(Hyde and Schust, 2016). In vitro studies have demonstrated this capability, with 
Prevotella able to invade human cervical endothelial cells (Strombeck et al, 2007). 
A further theory generating increased support is the haematogenous and systemic 
transport of bacteria. Animal studies support this pathway, as oral or intravenous 
inoculation with the intestinal originating Lactobacillus reuteri led to detection of this 
bacterium in 20% of placentas, where it would not otherwise naturally reside 
(Seferovic et al, 2016). As one of the most diverse body sites, the likelihood of 
isolating comparable bacteria from oral origin is high (Gomez-Arango et al, 2017), 
yet human studies reveal conflicting research, suggesting no bacterial correlation 
exists between amnion and oral samples (Bearfield et al, 2002). Bacteria may also 
reach the fetal membranes following invasive procedures during gestation, including 
amniocentesis (Jackel and Lai, 2013; Rode et al, 2000). By disrupting the protective 
multiple membrane barrier and exposing the fetal environment to external sources, 
pathogenic bacterium may be introduced to the fetal membranes (Jackel and Lai, 
2013). The collection of multiple body site and environmental samples would 
support research to determine the origin of bacteria in the fetal membranes. 
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1.5 Microbiota research and evolving techniques  
Originally the universal method for bacterial detection was microbiological culturing, 
as this is a low cost, low time commitment technique, which remains useful for 
medical microbiological diagnostics (Bilen et al, 2018). Yet, methodological 
detection limits prevent the investigation of uncultivable and low-density bacterium 
(Han et al, 2009; Prosser et al, 2007). The 16S rRNA gene now used in qPCR allows 
sensitive and reliable detection of uncultivable bacterium, including Fusobacterium 
(Han et al, 2009; Nadkarni et al, 2002). The universal 16S rRNA gene is ubiquitous 
to all bacteria, with specific variable regions allowing detection and differentiation 
across bacterial genera and species (Fuks et al, 2018). Molecular and 
microbiological techniques are highly beneficial for quantitative research of the 
microbiota, with focus on abundance and bacterial loads or quantitative changes in 
biomarkers. However, minimal qualitative information can be derived from these 
methods. The requirement for high sample processing within sequencing and qPCR 
increases the occurrence of contamination, especially in low biomass samples (de 
Goffau et al, 2018; de Goffau et al, 2019; Eisenhofer et al, 2019).  
Microbiological sequencing of the fetal membranes will improve current knowledge, 
but spatial location and visual identification of bacteria would be beneficial to confirm 
bacterial presence. Integration of analytical methods is increasing, with various 
spectroscopy techniques used in reproductive related research studying cervical 
remodelling (O’Brien et al, 2014) and pre-eclampsia (Chen et al, 2014). However, is 
yet to be used for investigating biochemical profiles in fetal membranes with 
chorioamnionitis or combined with sequencing technologies. Novel techniques, 
including Raman spectroscopy monitor independent biochemical properties of 
bacteria or tissues to differentiate between conditions (Chen et al, 2014). Detection 
of a spectral fingerprint specific to HCA by a timely, non-destructive and label free 
method would improve point of care diagnosis, plus confirm bacterial location in a 
biochemical context. Raman spectroscopy is beneficial to HCA and fetal membrane 
analysis due to a reduction in sample processing, plus decreased impact of external 
bacterial contribution and contamination of these low biomass tissues (Pahlow et al, 
2015). Current placental research has focussed on biochemical structures, including 
detection of differentiated α-helix and β-pleated sheet structure in pre-eclampsia 
patients (Chen et al, 2014). Intrauterine growth restriction has been linked to Raman 
shifts in amide functional groups (I, II and III; Pielesz et al, 2019), plus differential 
haemoglobin Raman shifts in hypoxic placental samples (Schlabritz-Loutsevitch et 
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al, 2017). Previous research highlights the potential beneficial application to HCA, 
but due to the low biomass characteristics of the fetal membranes, the ability for 
Raman spectroscopy to accurately detect low concentrations of bacteria must 
initially be determined prior to clinical application. 
 
1.6 Thesis relevance 
Knowledge of the fetal membrane microbiota with HCA is incomplete. Further 
research is required to identify associated microorganisms and inflammatory 
biomarkers of HCA in fetal membranes. Initial experiments aim to inform subsequent 
studies, enhance current knowledge on the pathological process behind HCA, plus 
aid in future development of novel diagnostic targets. With a combined aim to detect 
HCA, plus reduce associated negative maternal and neonatal outcomes, including 
PTB. Current literature highlights the difficulty of achieving a firm explanation of the 
fetal membrane microbiota in HCA, with involvement of a complex interactive 
polymicrobial pathway. 
 
1.7 Overview of thesis aims 
The overarching theme of this thesis was to increase current knowledge and 
understanding of the fetal membrane microbiota in HCA.  
- The first results chapter aims to investigate the microbiota of frozen fetal 
membranes with HCA and compare this to non-HCA fetal membranes from 
preterm and term patients via Illumina sequencing (Chapter three). This also 
investigates the relationship between the microbiota, abundance, bacterial 
profile and individual bacteria to HCA inflammation levels.  
- Chapter four aims to compare matched paired FFPE and frozen fetal 
membranes to determine if routinely collected and analysed FFPE samples 
could be utilised in microbiota research. 
- Chapter five aims to determine if bacterial loads can be detected on low risk 
term fetal membranes, plus to further clarify and confirm bacterial load levels 
on fetal membranes with HCA compared to preterm and term patients via 
16S rRNA gene qPCR. In addition to investigate the link between bacterial 
load and HCA inflammation levels or inflammatory marker expression. 
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- Chapter six aims to investigate if the novel non-invasive, non-destructive 
Raman spectroscopy method can identify and differentiate bacteria in low 
biomass cultures. This aims to understand the potential application to 
bacterial detection on fetal membranes. 
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Chapter Two: Research methodology.  
 
To investigate the fetal membrane microbiota multiple methodologies were 
explored. Firstly, fetal membrane tissues were collected, DNA was extracted with 
commercial DNA extraction kits, then quantified via NanoDrop spectrophotometer, 
agarose gel electrophoresis and Bioanalyzer chip-based electrophoresis. Illumina 
sequencing was performed for microbiota analysis and 16S rRNA gene qPCR for 
bacterial load investigations. The theory of each method is explained followed by 
specific methodological processes.  
A list of reagents, chemicals, commercial kits and equipment used throughout this 
research can be found in the appendix (A.1).  
 
2.1 Sample and tissue selection  
Fetal membrane samples utilised for this retrospective cohort study are a subset of 
samples included in a previous study investigating inflammatory signalling of the 
Toll-like receptor (TLR) pathway in chorioamnionitis (Waring et al, 2015). This 
research project expands on previous findings by focussing on the bacterial 
involvement of the inflammatory response in HCA. Samples were utilised for current 
research via a transfer agreement, with prior approval from Newcastle and North 
Tyneside 1 Research Ethics Committee (10/H0906/71).  
Women were recruited for the original prospective study following admission to 
Newcastle Upon Tyne NHS Foundation Trust Hospitals with spontaneous labour. 
Over 12-months, 24 women gave written consent to collect and store their placental 
and fetal membrane samples and use outcome data for research purposes. 
Samples were categorised into three groups; preterm spontaneous labour with 
histological chorioamnionitis (HCA; n=12), preterm spontaneous labour without 
HCA (PTB; n=6) and term spontaneous labour without HCA (Term; n=6). 
Spontaneous labour was defined as the presence of regular spontaneous uterine 
contractions with progressive cervical dilation leading to delivery. Inclusion criteria 
for preterm patients were; singleton pregnancy, spontaneous labour, and 
gestational age <34 weeks covering early PTB. Alternatively for the term cohort; 
singleton pregnancy, spontaneous labour, and ≥37 weeks gestation. Term patients 
were excluded if displaying histologically confirmed chorioamnionitis. 
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2.2 Fetal membrane preparation  
Placental tissue and amniochorionic membranes were collected immediately 
following delivery. Amniochorionic membranes were sterile dissected from the 
placental edge and stored in sterile ice cold phosphate buffered saline (1X PBS), 
before being washed thoroughly in 1X PBS to remove blood and debris. The amnion 
and chorion were separated, with the maternal decidua scraped from the chorion. 
Individual membranes were then divided into 4-5 cm segments and stored at -80 
°C, until required. These samples form the fresh-frozen fetal membrane subset used 
in this study. 
To detect and diagnose HCA, two amniochorionic membrane rolls were assessed. 
Combined unseparated membranes were fixed in 10% neutral buffered formalin, 
embedded in paraffin wax, sectioned to 3 µm slices, stained with haematoxylin and 
eosin (H&E) and histologically examined. Maternal and fetal inflammatory response 
was assessed by a consultant gynaecologist and histopathologist (Dr Judith 
Bulmer). HCA was defined by standardised Redline criteria at maternal 
inflammatory response stage two or above, with subchorionitis classified as stage 
one maternal inflammatory response (Redline et al, 2003). Amniochorionic 
membrane rolls were stored within a sealed cassette case at room temperature 
(RT), creating the Formalin-Fixed Paraffin-Embedded (FFPE) fetal membrane 
subset analysed in this study.  
 
2.3 Sample selection demographics 
Samples available for analysis included 24 FFPE and frozen fetal membranes 
(Table 2.1). Frozen samples consisted of HCA (n=12), PTB (n=6) and Term (n=6). 
With both amnion and chorion processed (HCA=8, PTB=5, Term=0), amnion only 
(HCA=1, PTB=0, Term=0), or chorion only (HCA=3, PTB=1, Term=6). FFPE fetal 
membrane rolls consisted of HCA (n=12), PTB (n=6) and Term (n=6). Multiple 
locations on the fetal membranes were processed for chorioamnionitis and PTB 
samples giving biological replicates from frozen (n=78) and FFPE tissues (n=111).  
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 HCA (n=12) PTB (n=6) Term (n=6) 
Maternal age (mean (SD)) 29.3 (8.0) 27.0 (5.5) 32.2 (6.0) 
Maternal BMI (mean (SD)) 22.0 (9.2) 22.5 (4.5) 22.3 (2.1) 
Smoker                               Yes 4.0 (33.3) 2.0 (33.3) 0.0 (0.0) 
                                         No 6.0 (50.0) 4.0 (66.7) 6.0 (100.0) 
                                         NA 2.0 (16.7) 0.0 (0.0) 0.0 (0.0) 
Parity (mean (SD)) 1.6 (2.2) 1.5 (1.8) 0.7 (1.2) 
Antibiotics                          Yes 7.0 (58.3) 4.0 (66.6) - 
                                         No 5.0 (41.7) 1.0 (16.7) - 
                                         NA 0.0 (0.0) 1.0 (16.7) - 
Antenatal corticosteroids Yes 11.0 (91.7) 5.0 (83.3) - 
                                         No 1.0 (8.3) 1.0 (16.7) - 
Maternal stage (mean (SD)) 2.2 (0.4) 1.0 (0.0) - 
Maternal grade (mean (SD)) 1.6 (0.5) 1.0 (0.0) - 
Number of clinical CA signs 
(mean (SD)) 
0.9 (1.2) 0.2 (0.4) - 
C-reactive protein (mean 
(SD)) 
55.6 (54.9) 6.4 (2.6) - 
White blood cell count (mean 
(SD)) 
19.1 (6.9) 12.9 (5.2) - 
Previous PTB                   Yes 5.0 (41.7) 1.0 (16.7) - 
                                         No 7.0 (58.3) 5.0 (83.3) - 
Previous early PTB          Yes 2.0 (16.7) 1.0 (16.7) - 
                                         No 10.0 (83.3) 5.0 (83.3) - 
 
Table 2.1 Maternal patient demographics. Maternal characteristics from all patients 
providing fetal membrane samples for the study, including preterm birth with histological 
chorioamnionitis (HCA), plus preterm (PTB) and term without HCA (Term). Values 
displayed as n (%) unless stated. 
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2.4 Genomic DNA extraction 
Commercially available DNA extraction kits have improved the speed, cost and 
efficiency of extracting DNA from complex sources (Demeka and Jenkins, 2009), 
but have received criticism due to increased contamination (de Goffau et al, 2019; 
Laurence, Hatzis and Brash, 2014; Salter et al, 2014). Commercial kits aim to 
extract DNA via chemical, enzymatic, mechanical and thermal methods, plus 
selective binding of silica-based membranes (Lauder et al, 2016). The alternative to 
commercial DNA extraction kits is phenol-chloroform isolation (Senguven et al, 
2014). However, optimised commercial kits increase DNA concentration, improving 
PCR amplification and sequencing (Senguven et al, 2014). The lowest 
contamination levels in kit comparison research was from MoBio (Salter et al, 2014), 
with Qiagen also recommended due to high quality and quantity DNA extracts 
(Janecka, Adamczyk and Gasinska, 2015).  
Throughout the study, methodology and reagents were kept consistent wherever 
possible. However, FFPE and frozen samples were extracted using different 
commercial kits, due to independent tissue characteristics and preparation 
methods. Kit negative controls were included and analysed from both extraction kits 
to monitor variability. Fixative methods increase the complexity of DNA retrieval from 
FFPE tissues. FFPE tissues were fixed in paraffin, thus they require additional 
processing steps. A commercially available FFPE specific DNA extraction kit has 
improved the yield and purity of DNA extracts, plus decreased inhibition in 
downstream analysis (Dietrich et al, 2013). This is due to the deparaffinisation steps 
involving combined use of specific chaotropic salt-based lysis and enzymatic 
buffers, plus high temperature incubations to melt the paraffin wax and reverse 
crosslinkages (Al-Attas et al, 2016; Senguven et al, 2014). These intense 
processing steps decrease the ability to transfer this method to frozen samples. 
These kits also utilise silica membrane columns or magnetic beads to reverse DNA 
binding from fixative processes (Arreaza et al, 2016; Senguven et al, 2014). 
Although fragmentation is universal in FFPE samples, the silica membranes in 
commercial kits will bind only DNA fragments ≥100 bp, improving DNA quality 
(Dietrich et al, 2013). Comparison between commercially available kits has 
suggested optimum use of the Qiagen or MoBio FFPE specific kit (Biesbroek et al, 
2012), with these generating the highest yield, concentration and purity (Huijsmans 
et al, 2010; Janecka, Adamczyk and Gasinska, 2015; Patel et al, 2017; Senguven 
et al, 2014). The MoBio BiOstic FFPE tissue DNA isolation kit was utilised in this 
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research, with previous positive application to placental, umbilical and uterine 
samples (Ernst et al, 2015; Zhao et al, 2016). Whereas the QIAamp Fast DNA tissue 
kit (Qiagen) was selected for frozen tissue DNA extraction due to optimum outcomes 
from kit comparison studies, plus use in current placental and reproductive tract 
microbiota research (Jones et al, 2009; Stewart et al, 2019; Sweeney et al, 2016; 
Weiss et al, 2014). 
 
2.4.1 Genomic DNA extraction: Frozen membranes 
Total genomic DNA was extracted from 25 mg frozen membranes on ice under 
sterile conditions via QIAamp Fast DNA tissue kit (Qiagen). Sectioned and weighed 
fetal membrane tissues were added into individual QIAamp tissue disruption tubes 
containing a metal bead for mechanical lysis, alongside enzymatic and chemical 
lysis provided by the reagents. 265 µl of freshly prepared mastermix was added to 
all tubes, consisting of 200 µl AVE (0.04% NoN3 sodium azide), 40 µL VXL 
(guanidinium chloride and Triton X-100), 1 µl DX reagent (antifoaming buffer), 20 µl 
Proteinase K and 4 µl RNase A (100 mg/ml). Tubes were vortexed for five minutes 
in a Vortex-Genie (Scientific Industries) before transferring to a thermal mixer 
(ThermoMixer, Eppendorf) for ten minutes at 56 °C and 1000 rpm to homogenise 
samples. To all tubes, 265 µl MVL (guanidine and isopropanol) was added and 
vortexed for ten seconds, before transferring the solution to QIAamp mini spin 
columns, with a silica membrane to isolate DNA. Tubes were centrifuged at 13,000 
xg for one minute (Microfuge, Sigma), before transferring the spin column into a 
sterile tube. AW1 buffer (500 µl) was added to all tubes and centrifuged as previous, 
before transferring the spin column into a sterile tube and repeating with 500 µl AW2 
buffer. AW buffers are wash buffers to improve the purity of the eluted DNA without 
affecting DNA quantity. Once transferred to sterile collection tubes, 50 µl elution 
buffer (ATE) was added to the membranes to elute nucleic acids. Tubes were 
incubated for two minutes at RT before centrifuging at 13,000 xg for one minute. 
Silica membranes were discarded, and the eluted nucleic acids were stored at -20 
°C until required for analysis (maximum duration: 18 months). Genomic DNA was 
extracted from all amnion and chorion tissues (n=78). Kit negative controls were 
also processed identical to samples, with dH2O replacing tissue samples (n=9).  
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2.4.2 Genomic DNA extraction: FFPE membranes 
Nucleic acid extraction from FFPE samples were performed via BiOstic FFPE 
Tissue DNA isolation kit (MoBio) at RT under sterile conditions. Samples were 
sectioned to 10 µm in triplicate using a manual rotary microtome (Leica, RM2125). 
External slices were discarded to minimise the impact of environmental 
contamination. Processed slices were weighed and trimmed to 15 mg and added to 
collection tubes. 180 µl FP1 and 20 µl FP2 deparaffinisation solutions were 
immediately added to each tube to chemically and enzymatically dissolve the wax. 
Tubes were vortexed on a Vortex-Genie for 20 seconds and centrifuged (Microfuge, 
Sigma) at 13,000 xg for 30 seconds to bring the wax into contact with the buffers. 
20 µl FP3 was added to the solution and vortexed for ten seconds before incubating 
in a heat block at 55 °C for two-hours. This was followed by a one-hour incubation 
at 90 °C. FP3 contains Proteinase K which enhances the breakdown of DNA-protein 
crosslinkage, with optimum performance at 55 °C. Following incubation, tubes were 
centrifuged at 13,000 xg for one minute and the digested solutions were transferred 
to new collection tubes, avoiding the transfer of remaining wax segments. 200 µl of 
FP4 was added to tubes and vortexed for ten seconds. This chaotropic salt buffer 
aids DNA binding to silica membranes. 200 µl 100% ethanol (FP5) was added to 
the tubes and vortexed for ten seconds to improve binding conditions. Extracts (650 
µl) were transferred onto silica membrane spin columns used to purify and isolate 
DNA. Spin columns were centrifuged at 10,000 xg for one minute and excess 
solution discarded. 500 µl wash buffer (FP6) was added directly onto the membrane 
and centrifuged at 10,000 xg for one minute to remove excess proteins and 
contaminants. The filter column was transferred to a new sterile tube before adding 
500 µl of ethanol wash solution (FP7) and centrifuging as previously. Excess 
solution was discarded, and tubes were centrifuged at 13,000 xg for two minutes 
before transferring the silica membrane to a new sterile tube. To the dried filter 
membrane, 50 µl elution buffer (FP8) was added and incubated at RT for five 
minutes. Tubes were centrifuged at 10,000 xg for one minute. The spin column was 
discarded, and eluted DNA stored at -20 °C until required for downstream 
processing (maximum duration: three months). Wax negative controls formed of 
excess paraffin wax which surround corresponding FFPE fetal membrane tissues 
(n=37) were analysed alongside samples (n=111) to identify the contribution of 
microorganisms within the wax. DNA extraction kit negative controls (n=18) were 
processed alongside with identical techniques. 
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Extracted DNA from FFPE and frozen tissues, plus wax and kit negative controls 
were loaded onto 96-well plates for use during sequencing.  
 
2.5 Theory of DNA quantification 
Analysing DNA extract quality and quantity is important prior to downstream 
processing. Determining DNA fragment size is especially crucial for FFPE samples, 
as fixing and embedding processes creates shorter targets for primer annealing in 
sequencing and qPCR (Nagahashi et al, 2017; Patel et al, 2017). NanoDrop 
spectrophotometer is an ultraviolet light absorption spectroscopy method (Ivarsson 
and Carlson, 2010), which determines the quantity (ng/µl) and quality of DNA 
extracts (purity ratios). Purity ratios of A260:A280 compare DNA purity to protein 
contamination, including residual phenol, with A260:A230 detecting organic 
molecules and contamination originating from guanidine, phenol and chaotropic 
salts (Desjardins and Conklin, 2010). Optimum ratios are ~1.8 and >2.0 for 
A260:280 and A260:230, respectively (Desjardins and Conklin, 2010). Values below 
the optimum indicate low DNA purity, issues with extraction methodology or 
contamination, which may impact downstream applications (Desjardins and 
Conklin, 2010). The NanoDrop is rapid and relies on small micro-volumes of liquid 
(1 µl), preventing sample wastage (Ivarsson and Carlson, 2010). However, has been 
criticised as overestimating sample DNA quantity, with low reproducibility between 
replicates (Simbolo et al, 2013).  
Additionally, agarose gel electrophoresis analyses the size and molecular weight of 
DNA fragments when comparing to a reference HyperLadder. Analysis is based on 
separation via molecular size and structural conformation by use of an electric 
charge (Lee et al, 2012). Understanding DNA fragment size is crucial to determine 
if the assigned target sequence will amplify. However, reliance on reference 
HyperLadder quality and visual analysis from the investigator limits specificity (Lee 
et al, 2012). The Qubit has been suggested as an alternate measurement tool, with 
increased application for low biomass samples, accurately detecting DNA yield at 
0.5 ng/µl (Seiler et al, 2016; Simbolo et al, 2013). 
 
2.5.1 NanoDrop spectrophotometer method 
To confirm successful DNA extraction and monitor yield and purity of DNA, 
NanoDrop spectrophotometer (1000, V3.8.1; Thermo Fisher) was performed on 
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extracted DNA from FFPE and frozen fetal membrane tissues, plus wax and kit 
negative controls. The system was cleaned using1 µl dH2O and calibrated using 1 
µl of respective elution buffer which the DNA is stored in, before measuring samples 
(1 µl) in triplicate. DNA concentration (ng/µl), and purity (A260:280 and A260:230) 
were assessed. Average concentration values were calculated and used for 
sequencing preparation. Low yield samples (<50 ng/μl for frozen and <20 ng/μl for 
FFPE) were concentrated using a vacuum centrifuge concentrator (Christ RVC2-18, 
Vacubrand) at 60 °C to evaporate and decrease the solvent and increase solute 
concentration. Samples were then reassessed via NanoDrop spectrophotometer, 
with all samples then displaying optimum concentrations. 
 
2.5.2 Agarose gel electrophoresis method 
A 1% (w/v) agarose gel electrophoresis was performed to further assess DNA 
quality. Agarose was dissolved in 1X TBE with 0.1 µl/ml SYBR Safe DNA gel stain 
(Invitrogen) and set in agarose gel tanks. 10 µl of DNA product of interest was 
combined with 4 µl DNA loading dye (Bioline, 5X) and 6 µl of this loaded into 
corresponding wells of the agarose gel. 5 µl HyperLadder 1KB (Bioline) was loaded 
into the first and last lanes of the gel to determine DNA molecular weight. Agarose 
gel electrophoresis conditions were 150 v for a maximum of one hour, before 
imaging on a Bio-Rad Gel Doc EZ Gel Imager (Image Lab 3.0). 
 
2.5.3 Bioanalyzer chip-based electrophoresis method 
Chip-based electrophoresis (Bioanalyzer) was applied to FFPE samples due to 
difficult detection from agarose gel electrophoresis, plus the inability to accurately 
detect fragmentation and molecular damage (Sah et al, 2013). NanoDrop may 
overestimate DNA concentration in FFPE samples by 17 fold (Heydt et al, 2014), 
possibly due to the combined detection of both single and double stranded DNA 
(Heydt et al, 2014). Overestimating DNA concentration can lead to underestimating 
the volume required in downstream analysis, plus utilising highly fragmented and 
degraded DNA (Heydt et al, 2014). The highly sensitive DNA chip system is 
optimum for the analysis of fragmented DNA from FFPE samples, due to a low 
detection limit (Wimmer et al, 2018). Chip-based gel electrophoresis aimed to further 
investigate the quality and quantity of extracted DNA and increase reliability of 
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findings, as this method measures DNA molecular weight and fragmentation. This 
method applies a similar theory to the classical agarose gel; however, samples 
travel through a charged capillary network before analysing via a detector. 
Numerical values are automatically applied to DNA fragment sizes alongside digital 
gel images for visual analysis (Agilent Technologies, 2014). This method improves 
the accuracy and precision of low abundant DNA detection, removes observer 
variation and requires low sample volumes (Agilent Technologies, 2014). 
 
Firstly, the Bioanalyzer (Agilent 2100) was cleaned with 350 µl dH2O using an 
electrode cleaner. The DNA chip was added to the chip priming station and 9 µl of 
gel dye mix (DNA dye concentrate and DNA gel matrix) was dispensed into wells. 1 
µl sample or reference ladder was pipetted into respective wells. DNA marker (5 µl) 
was also added into all sample wells, plus one ladder only well as a reference. The 
loaded DNA chip was vortexed (IKA Vortex mixer) at 2400 rpm for one minute and 
loaded into the Bioanalyzer receptacle for 40 minutes. Sample concentrations 
(pg/µl) and molecular size (bp) were analysed by peak tables and electropherogram 
gel images (2100 Expert).  
 
2.6 Theory of Illumina sequencing 
Illumina sequencing is a paired-end bridge amplification technology, utilising 
sequencing by synthesis methods (Figure 2.1). Initially, denatured single stranded 
DNA with adapter sequences ligated onto the 5’ and 3’ blunt ends anneal onto 
complementary oligonucleotides on the surface of the flow cell (Buermans and den 
Dunnen, 2014). A new complementary strand of the sequence is created during 
extension. The original library sequence is then cleaved generating a reverse strand 
sequence template copy. An adapter on the newly synthesised complementary 
strand forms a bridge by annealing to another complementary oligonucleotide on 
the flow cell, to create a second synthesis site (Bentley et al, 2008). The sequence 
is resynthesised during extension to create a complementary DNA sequence, which 
matches the original library sequence. Two complementary DNA sequence strands 
are now annealed onto the flow cell surface generating templates for sequencing by 
synthesis (Bentley et al, 2008). Multiple rounds of annealing, extension and 
denaturing creates 1 µm sequence clusters (Bentley et al, 2008).  
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Sequencing by synthesis functions by per base nucleotide incorporation or base 
calling, where each base is labelled with a different fluorophore allowing 
simultaneous sequencing, base incorporation and fluorophore measurement after 
each cycle (Ledergerber and Dessimoz, 2011). Between each cycle a reversible 
terminator prevents multiple extensions (Buermans and den Dunnen, 2014), with 
labels and terminators then removed in preparation for synthesis of the next 
nucleotide (Ledergerber and Dessimoz, 2011). Errors in base incorporation leads to 
lagging (phasing) or addition of multiple bases per cycle (pre-phasing; Ledergerber 
and Dessimoz, 2011). Cycle performance is monitored by Phred score analysis, 
which detects the probability of these base call errors (Bokulich et al, 2013).  
 
Illumina sequencing is a sensitive, specific, low-cost methodology (Caporaso et al, 
2012), with MiSeq creating high quality data compared to other available methods, 
including Ion Torrent or Roche 454 technologies (Pollock et al, 2018). Sequencing 
short read lengths of 250 bp (V4) is shorter than the 1000 bp required by Sanger 
sequencing (Ledergerber and Dessimoz, 2011), but this limits coverage depth which 
may increase basecall errors (Bustin et al, 2009). A further limitation of sequencing 
is the multiple preparation and processing steps, increasing the impact of externally 
contributing contamination (Salter et al, 2014). The high sensitivity of this method 
can increase the amplification and detection of these low abundant contaminants 
(Laurence, Hatzis and Brash, 2014), with this impact greater in low biomass 
samples (Strong et al, 2014). Preventing contamination is difficult, so research 
focuses on post-processing reduction of contamination via data analysis algorithms 
(Davis et al, 2018; Karstens et al, 2019). 
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Figure 2.1 Paired end bridge amplification, with sequencing by synthesis. Template 
DNA (A) are prepared for sequencing by fragmenting the DNA (B) and annealing adaptors 
to the 3’ and 5’ end of the DNA sequence (C). The DNA is then denatured into single 
strands, each strand will then bind to complementary oligonucleotides primed onto the flow 
cell (D). A bridge will be formed as the opposite end of the DNA sequence hybridises to 
another complementary oligonucleotide on the flow cell (E). Polymerase then extends the 
complete sequence of DNA to recreate the double stranded DNA bridge (F). One end of the 
DNA is cleaved from the flow cell and now two strands of complementary DNA are present 
(G). This is then repeated for the reverse strand, with the original strand washed away to 
generate clusters of identical DNA strands (H). Sequencing by synthesis is performed via 
the addition of one base per cycle. The base will bind to the end of the DNA strand and 
fluoresce, allowing specific detection of that base (I). Each base has a unique wavelength 
and fluorescent colour, thus allowing detection on a base-by-base and cycle-by-cycle 
bases. Once bound and detected by the optical scanner, the terminator is cleaved, and 
fluorescence stops (J). Another base is now able to bind onto the sequence (K) and this 
continues for the number of programmed cycles. 
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The main target for sequencing and identification of microbial communities is the 
16S rRNA gene phylogenetic marker. Sequencing the entire gene allows detection 
of conserved gene regions. In addition, variable gene regions allow specific and 
sensitive amplification and detection of bacterial genera and species (Wang and 
Qian, 2009). Primers can bridge the nine hypervariable and conserved regions for 
detection between phylogenetic groups and improve sequencing quality (Wang and 
Qian, 2009). Amplification bias, primer mismatch and sensitivity differences with 
each variable region is present, due to different evolutionary rates and coverage 
(O’Callaghan et al, 2019). The V4 variable region, used in this research is stated to 
be the most reliable region, along with the V5 region when compared across multiple 
sequencing platforms (Clooney et al, 2016), plus the most optimum for short reads 
and high coverage (Ghyselinck et al, 2013). Bias to specific taxa within each variable 
region has been observed, with an underestimation of Proteobacteria, but 
overestimation of Firmicutes from V3 and V4 regions detected using Ion Torrent 
sequencing (Laursen, Dalgaard and Bahl, 2017) or by computational construction 
(Wang and Qian, 2009). Benefits and limitations are present for all variable regions, 
thus matching the primer sequence to application is optimum. 
 
2.6.1 Illumina sequencing method 
To investigate the microbiota of the fetal membranes with and without HCA, Illumina 
amplicon sequencing was performed by Northumbria University (Newcastle) as 
described previously (Kozich et al, 2013), with the universal 16S rRNA gene primer 
specific to the V4 region (V4F: 5’-GTGCCAGCMGCCGCGGTAA-3’, V4R: 5’-
GGACTACHVGGGTWTCTAAT-3’; Biesbroek et al, 2012). Firstly, 17 µl AccuPrime 
PFX SuperMix was added to each well of a 96-well plate, as were 2 µl of each paired 
set of index primers (10 µm). 1 µl of sample, wax or kit negative control was 
transferred into corresponding wells. Each plate also contained one well of negative 
control (dH2O) and one positive control well of PhiX mock microbial community (1 
in 10, 2000 ng; ZymoBIOMICS). Plates were briefly vortexed before DNA was 
amplified in a thermal cycler (Applied Biosystem, 2720) according to PCR cycling 
conditions of: initial denaturation at 95 °C for two minutes, followed by 30 cycles of 
denaturation at 95 °C for 20 seconds, annealing at 55 °C for 15 seconds and 
extension at 72 °C for five minutes, plus a final extension step at 72 °C for ten 
minutes. A 1% agarose gel was prepared to confirm successful amplification. The 
product was normalised by loading 18 µl of PCR product and 18 µl binding buffer to 
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corresponding wells of the normalisation plate (Invitrogen SequalPrep) and 
incubating overnight at RT. Following incubation, the solution was removed from the 
wells, leaving only bound DNA on the plate. Wash buffer (50 µl) was added to wells 
and mixed by pipetting, before removing and repeating. 20 µl elution buffer was 
added, mixed by vortexing and incubated at RT for five minutes. 5 µl of eluted DNA 
from half of the wells were pooled and repeated for the other half of the plate.  
Library quality and optimum dilutions were assessed by chip-based gel 
electrophoresis following dilution of pooled libraries to 1:10, 1:100, 1:1000, 1:2000 
and 1:4000 in PCR grade H2O. Results were used to calculate library concentration, 
with an optimum dilution selected as 1:2000. Libraries were quantified by qPCR with 
6 µl KAPA SYBR Fast qPCR mastermix, plus 4 µl sample dilutions or standards in 
triplicate. Plates were vortexed before amplifying in a thermal cycler (C100; Bio-
Rad) with the conditions of 95 °C for five minutes for initial activation, followed by 35 
cycles of denaturation at 95 °C for 30 seconds and annealing at 60 °C for 45 
seconds. 
Positive sequencing controls were prepared, including a bacteriophage PhiX 
genome at 500 bp used as an in-run control for quality sequencing (2 µl PhiX, 3 µl 
nuclease free H2O, 5 µl 0.2 NaOH), and 10 µl 0.2 NaOH was added to pre-prepared 
libraries. All were incubated for five minutes to denature the DNA, before library 
preparations and 15% PhiX were mixed and loaded onto the flow cell (600 µl). 
Forward and reverse sequence primers (3 µl), plus index primers (3 µl) were added 
to three independent wells. The flow cell was washed with dH2O and blotted dry, 
before adding the reagent cartridge and flow cell to the MiSeq. 
 
2.6.2 Microbiota data processing  
Sequencing is high throughput, which results in increased data output available for 
analysis. FastQ files of forward (read 1) and reverse (read 2) sequences require 
post-processing to align, trim and filter via DADA2 (Callahan et al, 2016b), 
Bioconductor (Version 2; Callahan et al, 2016a) and Phyloseq (McMurdie and 
Holmes, 2013) pipelines and packages in R (R Core Team, 2017). Sequences are 
initially trimmed and filtered to remove low quality reads (quality score <30) and 
ensure consistent sequence lengths, this determined by forward and reverse error 
profiles (Callahan et al, 2016b).  
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Traditional methods clusters sequences into Operational Taxonomic Units (OTUs) 
at 97% similarity but may overestimate evolutionary similarity between sequences 
(Nguyen et al, 2016). In OTU analysis the inability to replicate or compare findings 
due to the arbitrary clustering percentage is a limitation (Callahan, McMurdie and 
Holmes, 2017). DADA2 clusters sequences into amplicon sequence variants 
(ASVs), with clusters differentiated by only one nucleotide alteration. This improves 
specificity, accuracy and resolution of bacterial detection (Callahan, McMurdie and 
Holmes, 2017). ASV analysis allows for improved comparison across studies, due 
to clustering via the specific DNA sequence (Callahan, McMurdie and Holmes, 
2017). Low read counts are likely due to sequencing errors or contamination, with 
removal beneficial for downstream analysis (Dhariwal et al, 2017; Jervis-Bardy et 
al, 2015). 
 
2.6.2.1 Sequencing data processing and statistical analysis methods 
Sequencing data FastQ files were processed by Bioconductor workflow (Version 2; 
Callahan et al, 2016a) in R (R Core Team, 2017). Sequencing results were trimmed 
and filtered with a Q score of <30. Using DADA2 1.4 (Callahan et al, 2016b) 
sequence data was demultiplexed and dereplicated, with errors detected and 
removed. Forward and reverse paired sequences were merged, clustered into ASVs 
and chimeras removed. Low read count features with <2 for 20% ASVs were 
removed before assigning taxonomy via GreenGenes training set (Callahan, 2016). 
DECIPHER and phangorn packages were used to construct the phylogenetic tree. 
A Phyloseq object including sequencing table, taxonomy table and metadata was 
then created for further downstream analysis.  
Filtered samples were analysed in the remaining analysis methods, this included 
removing <2 read counts in 20% of ASVs and ASVs with <10 counts merged. The 
filtered sample sets were processed through Phyloseq (McMurdie and Holmes, 
2013) and Microbiome Analyst (Dhariwal et al, 2017) for abundance (relative and 
absolute), alpha diversity (Shannon), beta diversity (GUniFrac, PERMANOVA) and 
univariate analysis (nonparametric Man-Whitney or nonparametric Kruskal-Wallis). 
Results were then further analysed in R by nonparametric Kruskal-Wallis and 
nonparametric Pairwise Wilcoxon Rank-Sum (R Core Team, 2017). 
Statistical analysis of sequencing data involves applying relative abundance 
measurements. This method analyses percentage composition of a genus in relative 
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comparison to total genera, at an overall abundance of 100% (Badri et al, 2018). 
This avoids bias and allows visualisation and comparison between subgroups 
independent of given bacterial abundance, which may not capture all DNA within a 
sample (Badri et al, 2018).  
Diversity analyses includes Shannon alpha diversity indices and PERMANOVA for 
beta diversity. Alpha diversity assesses local bacterial sample composition, 
determining variety and number of bacterial genera (Shannon, 1958). Shannon 
diversity indices is the sum of a proportion of species relative to total number or 
species in community, accounting for species richness, abundance and evenness 
(Jovel et al, 2016; Schloss et al, 2016). This method is beneficial for low read counts 
and low biomass samples as it accounts for the impact of rare taxa (Schloss et al, 
2016). Beta diversity investigates community level similarities (Jovel et al, 2016; 
Knight et al, 2018; McMurdie and Holmes, 2014). PERMONOVA investigates 
diversity clustering between groups and pairwise distances, with GUniFrac alpha 
0.5 aiming to avoid dominance of highly abundant ASVs (Knight et al, 2018).  
 
Initial analysis included all samples and negative controls. Following this, negative 
controls were removed, including wax controls from the FFPE subset. Samples were 
reprocessed through Phyloseq and Microbiome Analyst in an identical manner.  
 
2.6.2.2 Decontam processing for FFPE samples 
Alongside preventing contamination during pre-processing, post-processing filtering 
methods to detect and report contaminating sequences has been established (Davis 
et al, 2018; Oh et al, 2015). Some filtering methods may lead to the removal of 
genuine sequences alongside contaminants, as they remove any sequence 
detected in negative controls. But genuine sample originating sequences may be in 
low abundance within controls due to cross contamination (Davis et al, 2018). The 
R based decontam method has been utilised to detect contaminants, but avoid the 
removal of genuine sequence (Davis et al, 2018). The prevalence filtering method 
detects the presence/absence of genuine or contaminating ASVs from Phyloseq 
objects, determined by abundance of the ASV sequences in samples compared to 
a set of negative controls. This method works under the assumption that sequences 
present in higher abundance in negative controls are contaminants and those 
present in higher abundance in samples are genuine bacterial signals. However, 
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this does not account for DNA concentration (Davis et al, 2018). Alongside 
packages used previously, this post-processing method was applied to FFPE fetal 
membranes. The R code below was used to detect genuine sequences from FFPE 
samples. This method is preferable when samples are of low abundance with the 
possibility that contamination is dominant over genuine bacterium (Davis et al, 
2018). 
>isNotContaminant(physeq,neg="is.neg",method="prevalence",threshold=0.5,nor
malize=TRUE,detailed=TRUE) 
Once detected ASVs were then separated into two independent Phyloseq objects; 
one containing only genuine sequences and the second only sequences identified 
as contaminants.  
 
2.7 BactQuant quantitative PCR  
qPCR is currently used for diagnosis of bacterial infection and clinical pathologies 
(Bustin, 2010; Kasper et al, 2010; Patel, Harris and Fitzgerald, 2017) for improved 
accuracy of bacterial load investigation and can be combined with culture and 
sequencing results to validate findings (Kralik and Ricchi, 2017; Parnell et al, 2017). 
To detect the bacterial load in fetal membranes with and without HCA, qPCR was 
performed using BactQuant 16S rRNA gene primers (Liu et al, 2012) on previously 
extracted DNA.  
 
2.7.1 Theory and review of qPCR 
qPCR is a molecular biology method used to amplify target sections of DNA, 
detecting and monitoring amplification in real-time using fluorescent primers and 
probes (Bustin, 2010). qPCR functions similarly to conventional PCR; with cycles 
containing a denaturation, annealing and extension step. However, rather than 
requiring external quantification of PCR product (e.g. agarose gel electrophoresis), 
a quantifiable output is generated following each qPCR cycle, which increases 
precision and decreases post-processing requirements (Bustin et al, 2009; Lind et 
al, 2006; Schrader et al, 2012).  
Initial denaturation at high temperatures (95 °C) disrupts hydrogen bonds to 
separate double stranded DNA (dsDNA) and loosen the secondary structure in the 
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newly created single stranded DNA (ssDNA; Figure 2.2A). Complementary template 
DNA sequences are then hybridised by the primer of choice during annealing at a 
primer dependent melting temperature (Thermo Fisher Scientific Inc, 2014)(Figure 
2.2B). Taq (Thermus aquaticus) DNA polymerase extends the DNA sequence 
(Figure 2.2C), to generate dsDNA of the target sequence (Thermo Fisher Scientific 
Inc, 2014)(Figure 2.2D). Conditions are then repeated for an optimum number of 
cycles to increase PCR target product (Figure 2.2E). An additional incubation step 
may be required prior to denaturation if uracil N-glycosylase (UNG) is incorporated 
into the assay. This enzyme degrades remnant contaminating products including 
residual uracil, to avoid non-specific amplification (Pruvost, Grange and Geigl, 
2018).  
 
Figure 2.2 Diagrammatic representation of quantitative polymerase chain reaction. 
qPCR cycling methodology including input double stranded DNA (A), denaturation to create 
single stranded DNA (B), annealing of primers (C) and extension to create double stranded 
DNA of the target sequence (D). This process is repeated over multiple cycles to amplify 
the target DNA fragment product (E).  
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2.7.2 Absolute qPCR with standard curve 
Absolute qPCR detects absolute copy number of a DNA target sequence within an 
input sample by comparing to a standard curve of known copy number (e.g. 16S 
rRNA gene; Ruijter et al, 2012). To determine sample copy numbers a ten-fold 
dilution of standards with a known starting quantity (SQ) is used to generate a 
reference standard curve for comparison. From this, the unknown SQ from a sample 
can be determined, with quantification cycle (CQ) inversely related to the SQ of 
target DNA (Forootan et al, 2017; Thermo Fisher Scientific Inc, 2014). CQ is the 
qPCR cycle number which the fluorescent signal of the amplified product crosses 
the cycle threshold representing background signal (Yuan et al, 2006). Using the 
standard curve as a reference CQ values are converted to SQ and can be calculated 
relative to sample requirements e.g. /µl or /mg of tissue, plus log10 transformed for 
visual analysis. 
Standard curves are created mostly via a purified plasmid serial dilution, due to ease 
of use and stability (Kuperman et al, 2020; Theis et al, 2019). Standard curve 
dilutions should aim to cover the expected range of the assay (Bustin et al, 2009), 
pus 20% either side (Svec et al, 2015). Standard curves are especially important 
with expected low copy number samples, to ensure confidence in negative findings 
(Bustin et al, 2009).  
qPCR is a highly sensitive method, with the theoretical ability to detect low amounts 
of DNA (<101; Bustin et al, 2009). However, a limit of detection (LOD) must be 
determined for each assay. LOD is the minimum concentration detected as 
significant from the control, with reasonable certainty across replicates within the 
experiment (Bustin, 2010; Bustin et al, 2009; Forootan et al, 2017; Kralik and Ricchi, 
2017). The theoretical LOD is rarely met (101) due to experimental variation, 
background noise from samples and DNA carryover (Bustin et al, 2009).  
 
2.7.3 Primer design  
Primer choice for qPCR is dependent on the target of interest. For bacterial targets 
the broad range 16S rRNA gene covering the whole sequence has been applied 
(Nadkarni et al, 2002). Alongside specific variable regions of the 16S rRNA gene 
(Klindworth et al, 2013; Lauder et al, 2016; Liu et al, 2012; Theis et al, 2019). 
Recently, multiple studies have aimed to develop the most efficient primers for 
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variable region 16S rRNA gene targets, aiming to cover the broadest range of 
genera and species (Brukner et al, 2015; Lind et al, 2006; Liu et al, 2012).  
The BactQuant primer and probe set is one of the developed methods which targets 
the V3-V4 region of the 16S rRNA gene (341-805 E. coli region) giving a 466 bp 
target (Liu et al, 2012). This primer covers 96.3% at the genus level, with a dynamic 
range of 102-108 copies at 95% efficiency (Liu et al, 2012). BactQuant presented 
with the least biased result (Hugerth et al, 2014), and covered the broadest phylum 
spectra in primer comparison research (Klindworth et al, 2013). This method has 
been beneficially applied to low biomass samples including reproductive tissues of 
vaginal (Brown et al, 2018), cervicovaginal (Shannon et al, 2017), and fetal tissues 
(Vitrenko et al, 2017); plus recently placenta and fetal membranes (Kuperman et al, 
2020). 
 
2.7.4 SYBR or TaqMan fluorescently labelled probes 
Classic fluorescent probes for example SYBR, bind to all newly synthesised dsDNA. 
This creates non-specific binding, amplification and detection of high fluorescent 
signals (Lind et al, 2006). Target specific probes aim to increase specificity of the 
assay. Unlike SYBR probes, TaqMan probes are sequence specific, thus only 
fluoresce when bound to a targeted sequence, rather than all dsDNA contributing to 
fluorescence (Nagy et al, 2017). This reduces non-specific amplification and 
minimises the impact of primer dimers, which is a recognised issue with SYBR 
probes (Lind et al, 2006).  
TaqMan hydrolysis probes utilise Fluorescence Resonance Energy Transfer 
(FRET). A fluorescent signal is only detected when a specific hybridisation event 
occurs (Dietrich et al, 2013). The short, sequence specific oligonucleotides have a 
reporter fluorescence dye at the 5’ and a quencher at the 3’ end, to form a donor 
and acceptor FRET pair (Ruijter et al, 2012). Multiple donor and acceptor pairs are 
available including molecular beacons and light up probes (Lind et al, 2006). 
However, focus here will be on 6-FAM and MGBNFQ. 6-Carboxyfluorescein (6-
FAM) is the fluorescent donor of the pair (Lind et al, 2006), with minor groove binder 
non-fluorescent quencher (MGBNFQ) as the acceptor (Thermo Fisher Scientific Inc, 
2014). Prior to amplification the fluorescent 6-FAM is quenched by close proximity 
to the second quencher probe (MGBNFQ; Nadkarni et al, 2002), As the 
donor/fluorophore transfers its high emission energy to the low emission 
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quencher/acceptor. The fluorophore is supressed, and no fluorescence is detected 
(Thermo Fisher Scientific Inc, 2014)(Figure 2.3A). During amplification the TaqMan 
probe hybridises only to the target sequence downstream of the primer and extends 
by DNA polymerase mediated activity in the 5’-3’ direction (Trombley Hall et al, 
2013)(Figure 2.3B). When MGBNFQ binds to target DNA it creates a minor groove 
within the DNA to strengthen probe binding, plus increase specificity and accuracy 
(Thermo Fisher Scientific Inc, 2014). Hydrolysis of the probe disrupts the FRET pair 
and displaces the fluorophore from the probe (Gallup and Ackermann, 2008; Nagy 
et al, 2017; Trombley Hall et al, 2013). Fluorescence is then released from the 
fluorophore as this is no longer in close proximity to the quencher, causing 
florescence at the dye specific wavelength to be detected (Gallup and Ackermann, 
2008)(Figure 2.3C). The fluorescent signal released is proportional to the amount of 
starting template (Nagy et al, 2017)(Figure 2.3D). 
 
2.7.5 qPCR methodology limitations 
Inhibition in qPCR can lead to incorrect reporting of results. This occurs due to non-
specific binding, DNA degradation or crosslinkage (Schrader et al, 2012). Inhibition 
can derive from sample matrices (Pennington, 2014; Schrader et al, 2012), sample 
storage buffers, sample handling or environmental plasticware (Gallup and 
Ackermann, 2008; Schrader et al, 2012). Inhibition can prevent amplification or lead 
to an inverse in expected CQ values (Pennington, 2014; Trombley Hall et al, 2013). 
Diluted samples are expected to contain lower target DNA, thus a higher CQ. 
However, inhibition may lead to a reverse in detection, with a diluted sample 
presenting with a lower CQ value falsely indicating increased SQ.  
Although individual qPCR optimisation is beneficial, non-standardised protocols 
create inconsistency and reduce comparison across research. The MIQE qPCR 
guidelines (Bustin et al, 2009) have assisted with replication by encouraging 
researchers to supply maximum information on methodology within publications 
(Bustin, 2010). 
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Figure 2.3 TaqMan qPCR probe technology. Diagrammatic representation of probe-
based fluorescence activation utilised in qPCR methodology for improved sensitivity and 
specificity of target amplification and detection. When unbound, Florescence Resonance 
Energy Transfer (FRET) supresses fluorescence of the fluorophore (A). The sequence 
specific probe binds to target DNA (B). Hydrolysis during qPCR extension creates target 
specific fluorescence due to displacement of the fluorophore from the probe (C). 
Fluorescence is detected each cycle relative to the amount of specific target sequence 
amplified (D).  
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2.7.6 BactQuant qPCR methods 
2.7.6.1 Creating a plasmid for the standard curve 
Comparison of sample results to a reference of known quantity via standard curve 
is required to quantify bacterial load in absolute qPCR. Plasmid standards (16S 
rRNA gene) were created using Escherichia coli genomic DNA from Luria-Bertani 
(LB) agar streak plates prepared following overnight incubation in LB media. 16S 
rRNA gene end point colony PCR was performed to amplify E. coli bacterium. The 
PCR reaction was set up as follows: 2X PCR mastermix (Promega), 0.2 µm 27F 
primer (5’-AGAGTTTGATCMTGGCTCAG-3’), 0.2 µm 1492R primer (5’-
TACGGYTACCTTGTTACGACTT-3’, Eurofins), 2 µl template DNA, 1.25 µl Bovine 
Serum Albumin (BSA, New England BioLabs) and nuclease free H2O to a total of 
25 µl. PCR was performed in a thermal cycler (C100, Bio-Rad) with the conditions 
of initial denaturation at 95 °C for two minutes, followed by 35 cycles of denaturation 
at 95 °C for one minute, annealing at 54 °C for one minute and extension at 72 °C 
for 1.5 minutes, followed by a final extension at 72 °C for 15 minutes. Amplification 
of the 1465 bp product was confirmed via agarose gel electrophoresis.  
PCR amplicons were purified by combining 4 µl ExoSap-IT reagent (ExoSap-IT PCR 
clean up Kit; Applied Biosystems) with 10 µl PCR product and incubated at 37 °C 
for 15 minutes to degrade remaining primers. Active enzymes were then deactivated 
by a 15 minute incubation at 80 °C.  
Purified PCR products were cloned into TOP10 competent E. coli cells (Invitrogen) 
via PGEM-T Easy Vector System (Promega). Firstly, insert:vector was calculated: 
ng of insert = ng of vector x kb size of insert ÷ kb size of vector x insert:vector ratio 
10 ng = 50 ng/µl x 0.2 ng ÷ 3.015 kb x 3:1  
Ligation reactions were then prepared to a total volume of 10 µl as per Table 2.2, 
including PCR product, positive controls of PCR and cloning kit positives, plus 
negative controls of PCR and cloning kit negative controls. 
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Component 
PCR 
ligation 
product 
(µl) 
PCR 
positive 
control (µl) 
Cloning kit 
positive 
control (µl) 
PCR 
negative 
control (µl) 
Cloning kit 
negative 
control (µl) 
2X rapid ligation 
buffer 
5 5 5 5 5 
PGEM-T vector 
(50 ng) 
1 1 1 1 1 
PCR product 2.5 2.5 - 1 - 
Control insert DNA - - 2 - - 
T4 DNA ligase (3 
Weiss) 
1 1 1 - - 
Nuclease free H2O 0.5 0.5 1 3 4 
Total 10 10 10 10 10 
 
Table 2.2 Ligation reaction components. Volume of components for cloning PCR product 
to prepare plasmids for standard curve analysis in qPCR. Reactions included PCR product, 
or positive controls of PCR and cloning positives, plus negative controls of PCR and cloning 
kit negative controls to a total volume of 10 µl. 
 
Once prepared, ligation reactions were mixed by pipetting and incubated overnight 
at 4 °C to provide maximum number of transformants. Plasmids were transformed 
via the addition of 2 µl ligation reaction to 50 µl One Shot TOP10 competent E. coli 
cells and flicked to mix. Tubes were incubated on ice for 20 minutes, then added to 
a water bath to heat shock at 42 °C for 50 seconds, before returning immediately to 
ice. Cells were transferred to sterile tubes, combined with 950 µl RT SOC medium 
(Invitrogen), and incubated at 37 °C with shaking for 90 minutes. Tubes were 
centrifuged at 1000 xg for ten minutes and resuspended in 200 µl SOC. The above 
method was also performed with 10 µl pUC-19 DNA (Invitrogen) to determine 
transformation efficiency. 100 µl of each reaction was spread onto duplicate pre-
prepared LB agar plates containing 10 mg/ml ampicillin (AMP, Gibco) and 50 mg/ml 
X-GAL (Invitrogen). Plates were incubated at 37 °C for 18 hours and blue:white 
transformation efficiency percentage was calculated. Positive methodology was 
accepted if the kit positive showed >60% white colonies and if kit negatives had no 
white colonies. 
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One white colony from one plate showing positive transformation was cultured 
overnight in LB/AMP broth and re-plated on LB/AMP agar plates. Following 
overnight incubations, the 16S rRNA plasmids were isolated as described below 
(PureYield Plasmid MiniPrep; Promega). Optical densities (OD600) were measured 
via a UV spectrophotometer (Jenway 7305), with biomass of >1.4 processed (OD600 
x µl of culture). A 1 ml overnight culture was centrifuged at 13,000 xg for 30 seconds, 
supernatant was discarded, and this step was repeated. Pellets were resuspended 
in 600 µl molecular grade H2O. The suspension was combined with 100 µl cell lysis 
buffer and inverted to lyse cells. Within three minutes, 350 µl neutralisation solution 
was added to tubes to prevent further lysis, inverted and centrifuged at 13,000 xg 
for three minutes. Supernatant (950 µl) was transferred to PureYield minicolumns 
and centrifuged at 13,000 xg for 15 seconds. Contents were discarded and 200 µl 
endotoxin removal was added to the minicolumns and centrifuged as previously. 
Column wash solution (400 µl) was introduced and tubes were centrifuged at 13,000 
xg for 30 seconds. Minicolumns were transferred to sterile tubes and 30 µl elution 
buffer was added. Tubes were incubated at RT for seven minutes and centrifuged 
at 13,000 xg for 15 seconds to elute all DNA. To confirm successful extraction, a 
0.8% agarose gel electrophoresis was performed, and vector size was confirmed 
via restriction enzyme digest. EcoRI reaction buffer (2 µl, New England BioLabs) 
and nuclease free H2O (7 µl) were combined in sterile tubes, along with extracted 
plasmid DNA (10 µl) and EcoRI enzyme (1 µl, New England BioLabs). Reactions 
were mixed gently before incubating at 37 °C for 3.5 hours. The enzyme was then 
inactivated by incubating at 70 °C for 20 minutes in a thermal cycler (C100, Bio-
Rad). A 0.8% agarose gel was performed to check restriction enzyme digest 
product. Plasmid DNA was replaced by nuclease free H2O (10 µl) for negative 
controls. Eluted plasmids were pooled, and concentration measured via NanoDrop 
spectrophotometer (NanoDrop One V1.4, Thermo Fisher). 
 
2.7.6.2 Creating a standard curve 
Firstly, the plasmid size was calculated by combining the size of plasmid used (3015 
bp) and size of gene insert (1465 bp). The mass of a single plasmid molecule was 
calculated by combining calculated plasmid size (4465 bp) and average weight of 
one base pair (1.096 x 10-21; Avogadro’s constant). The mass of plasmid DNA 
required to contain the copy number of interest was calculated by multiplying the 
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copy number of interest (30-300,000) by mass of a single plasmid (4.894 x 10-18). 
The mass of final plasmid DNA required per reaction was calculated by dividing the 
mass of plasmid DNA by volume of plasmid per reaction (1 µl), thus final plasmid 
DNA remained at 1.468 x 10-12-10-16. Working volumes were then calculated to 
generate a serial dilution for standard curves. The required volume of plasmid was 
determined via rearranging C1V1=C2V2 to C2xV2÷C1=V1. Where C1 was the 
pooled plasmid concentration determined by NanoDrop spectrophotometer. V1 and 
V2 are the respective volumes required for dilution four in the series, and C2 is the 
desired concentration (Table A.2). For example: 
(1.468 x 10-12 x 100) ÷ 2.68 x 10-11 = 5.48 µl. 
 
2.7.6.3 PCR optimisation 
To ensure positive methodology, PCR reagents, primers and conditions were 
optimised. Firstly, a temperature gradient PCR was performed to optimise primer 
annealing temperature. PCR reactions contained 2X PCR master mix (Promega), 1 
µl plasmid standard, 1.8 µm BactQuant forward and reverse primers (F=5’-
CCTACGGGDGGCWGCA-3’ E. coli 341-356, R=5’-
GGACTACHVGGGTMTCTAATC-3’ E. coli 786-806, Liu et al, 2012), 0.05 µg/ml 
BSA and nuclease free H2O to a total of 10 µl. PCR conditions were; initial 
denaturation at 95 °C for two minutes, followed by 40 cycles of denaturation at 95 
°C for one minute, annealing at 45-65 °C temperature gradient for one minute, 
extension at 72 °C for one minute, and a final extension at 72 °C for 15 minutes.  
Further optimisation was performed for MgCl2 concentration (3-7 mM, Promega) 
and formamide levels (0-10%, Sigma-Aldrich). PCR conditions were as above with 
the annealing temperature selected at 55 °C due to optimum amplification in 
previous steps. Following each protocol, an agarose gel electrophoresis was 
performed to detect optimum conditions for sample analysis. 
 
2.7.6.4 BactQuant qPCR protocol 
Absolute qPCR aimed to determine 16S rRNA gene bacterial load within fetal 
membranes. Reactions contained 1.8 µm BactQuant primers (F=5’-
CCTACGGGDGGCWGCA-3’; R=5’-GGACTACHVGGGTMTCTAATC-3’), 225 nM 
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probe ((6FAM) 5’-CAGCAGCCGCGGTA-3’ (MGBNFQ) E. coli 518-532; Eurofins, 
Liu et al, 2012), 0.05 µg/µl BSA 4 mM MgCl2, 1% formamide, 1X Taqman Fast 
Advanced Master Mix (Applied Biosystems) and 1 µl fetal membrane DNA, plasmid 
standard for reference, or nuclease free H2O for the no template control (NTC), to a 
total of 10 µl. CFX Connect Real Time System (Bio-Rad) was used to perform 
amplification as per BactQuant protocol (Liu et al, 2012), with additional UNG 
activation beneficial to degrade non-specific amplification products. Conditions were 
initial UNG activation at 50 °C for three minutes, Taq polymerase activation at 95 °C 
for ten minutes, followed by 40 cycles of denaturation at 95 °C for 15 seconds, 
annealing at 55 °C for one minute and extension at 60 °C for one minute. Extracted 
DNA from frozen amnion and chorion samples, DNA extraction kit negative controls, 
plus standard curve and NTCs were assayed in triplicate.  
 
2.7.6.5 Statistical analysis of qPCR data 
Analysis included collecting the CQ and SQ per sample and control and calculating 
16S rRNA gene copy number/µl by comparison to in-run standard curves. Copy 
number/µl were converted to copy number/mg of tissue or log10 transformed. 
Replicates with a standard deviation >0.4 were removed, optimum R2 standard 
curve was >0.98. The same pool of prepared standards were used in each run, 
however preparation was repeated if cycle numbers varied between consecutive 
assays. Inhibition was assessed via sample dilutions of neat, 1 in 2, 1 in 10 and 1 in 
20.  
Results were assessed by individual sample, per patient, per condition (HCA, PTB, 
term and low risk term), tissue type (amnion or chorion) and sample type (sample 
and negative controls). Investigations were conducted via nonparametric Kruskal-
Wallis followed by nonparametric Pairwise Wilcoxon Rank-Sum and visual results 
created by ggplot2 in R (R Core Team, 2017). Histological inflammatory staging and 
grading were correlated to 16S rRNA gene copy number via nonparametric 
Spearman’s Rho Bonferroni adjustment.  
 
2.7.6.6 Relative qPCR for inflammatory gene fold change 
Analysis of TLR signalling pathway gene expression was undertaken previously by 
relative qPCR (Waring et al, 2015). Briefly, genes showing significant change in 
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expression on signalling arrays were individually validated using relative qPCR 
compared to GAPDH as the endogenous control, due to consistent results as a 
house keeping gene in the signalling array study. Marker genes investigated were 
TLR1, TLR2, TLR4, TLR6, SARM1, MyD88, LY96, IL-8, IRAK2, HMGB1, SIGIRR 
and TIRAP. Each assay was performed in triplicate. Further methodological 
information can be found in Waring et al (2015). Inflammatory marker data from the 
previous study were correlated to bacterial loads from this research via 
nonparametric Spearman’s Rho Bonferroni adjustment. 
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Chapter Three: The microbiota of frozen fetal membranes with and without 
histological chorioamnionitis. 
 
Abstract 
Aim 
The aim of this chapter was to investigate the microbiota of frozen fetal membranes 
with histological chorioamnionitis (HCA) and compare this to fetal membranes from 
preterm and term birth without HCA. This aims to explore the relationship between 
the microbiota, bacterial profile and individual bacterial abundance to inflammation.  
Methods 
Amnion and chorion membrane from patients with preterm birth and HCA (n=12), 
preterm without HCA (n=6) and term birth without HCA (n=6) underwent sequencing 
via the V4 region of the 16S rRNA gene primer using Illumina MiSeq technology. 
Results 
Beta diversity differences were present between HCA, preterm and term amnion 
and chorion. A trend for increased Prevotella was detected at the genus level with 
HCA and increasing inflammation, with a significant increase in one Prevotella at 
the ASV level, with the same sequence significantly increased with higher level 
inflammation. Beta diversity differed between HCA inflammatory stage and grade in 
the chorion. A single Lactobacillus ASV was increased in samples with lower 
inflammation. Samples and negative controls have distinct bacterial profiles, with a 
significant increase of Escherichia/Shigella, Pseudomonas, Blautia and 
Lactobacillus in negative controls, at both the genus and ASV level. 
Conclusion 
Overall, chapter three highlights that HCA samples have a distinct bacterial profile, 
with a possible association to increased Prevotella in HCA. The microbiota may also 
be influenced by the severity of HCA, yet specific ASVs are only linked to 
inflammatory grading, and not staging. Amnion and chorion have different profiles 
for HCA inflammatory staging and grading, thus require individual analysis. Frozen 
samples and negative controls are distinct in bacterial profiles and four specific 
genera, questioning the origin of these bacteria. 
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3.1 Introduction 
The detection of a genuine, consistent placental and fetal membrane microbiota 
remains widely debated (Aagaard et al, 2014; Jones et al, 2009; Leiby et al, 2018). 
Conflicting studies have suggested that the placenta and fetal membranes may be; 
sterile (Theis et al, 2019), typically sterile, unless a maternal condition is present 
(Bassols et al, 2016; Fichorova et al, 2011), or universally colonised with low 
abundant, non-pathogenic bacteria (Aagaard et al, 2014). These theories were 
discussed in detail within the first chapter. Agreement on the microbiota in fetal 
membranes with chorioamnionitis is yet to be reached (Bassols et al, 2016; 
Fichorova et al, 2011). Specific properties have been linked to HCA, with 
monomicrobial characteristics in 83% of HCA cases (Sweeney et al, 2016), 
supported by findings of low species richness in placenta and fetal membranes from 
HCA patients (Doyle et al, 2017). Multiple bacterial genera have been associated to 
the condition, with Ureaplasma the main genus detected in HCA, within 59% and 
60% of preterm and term membranes, respectively (Sweeney et al, 2016). 
Alternatively, a polymicrobial distinct cluster of highly abundant urogenital and oral 
bacteria, including Streptococcus and Fusobacterium has been suggested (Prince 
et al, 2016). Similarly, in fetal membranes with HCA 14/20 operational taxonomic 
units (OTUs) were linked to vaginal and 2/20 OTUs were linked to bacteria of oral 
origin (Doyle et al, 2017). In contrast, 16S rRNA gene sequencing studies have 
reported no distinct bacterial communities in HCA membranes compared to 
environmental controls (Leiby et al, 2018). 
 
The microbiota of the amnion and chorion fetal membranes individually is yet to be 
studied in HCA research. Thus, the aim of this section was to investigate the 
microbiota of individual fetal membranes with and without HCA via Illumina 
sequencing. In addition to determine the relationship between microbial profiles and 
HCA inflammation. 
 
3.2 Microbiota method recap 
To study the microbiota of fetal membranes with HCA, genomic DNA was extracted 
from 24 patients, including; preterm with HCA (n=12), plus preterm (PTB; n=6) and 
term birth without HCA (n=6), giving 78 samples. Nine DNA extraction kit negatives 
(Qiagen) were also processed alongside samples according to identical protocols. 
Sequencing of extracted DNA samples and negative controls were performed using 
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MiSeq (Illumina) wet lab standard operating procedure (SOP), with the universal 
16S rRNA gene primer specific to V4 region (Callahan et al, 2016a; Callahan et al, 
2016b; Kozich et al, 2013) by Northumbria University (Newcastle), as described 
previously. Data analysis of FastQ files were processed using R (R Core Team, 
2017), package DADA2 1.4 (Callahan et al, 2016b), Bioconductor (Version 2; 
Callahan et al, 2016a), Phyloseq (McMurdie and Holmes, 2013) and Microbiome 
Analyst (Dhariwal et al, 2017) as previously described. 
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3.3 Results 
3.3.1 Patient characteristics  
Characteristics from patients, neonates and samples are listed in Table 3.1. 
Significance was detected between all HCA, PTB and term patients for gestational 
age and birthweight (p=0.001). This was expected due to increased gestational 
period in term cohorts, compared with PTB (p=<0.001), and HCA (p=<0.001). 
However, there was no difference in gestational age (p=0.799), or birthweight 
(p=0.160) between PTB and HCA only. 
 
Significant differences were detected across tissue type, as only chorion samples 
were available from term patients (p=0.004). Significantly more males were 
delivered following PTB and more females from HCA and term (p=0.013). Apgar 
scores were greater in term compared to HCA and PTB (p=0.033). Apgar scores 
represent neonatal response and physical condition shortly after delivery (Apgar, 
1953). Higher scores represent good to excellent health (7-10) and lower scores 
represent negative neonatal outcomes, possibly requiring medical interventions (<7; 
Apgar, 1953; Casey, McIntire and Leveno, 2001). 
 
Characteristics only available from preterm patients were compared, including HCA 
and non-HCA PTB patients (Table 3.2). Maternal inflammatory stage (p=<0.001) 
and grade (p=0.036) were significantly greater from HCA compared to PTB without 
HCA. C-reactive protein (CRP) levels were also significantly increased in HCA 
(p=0.006). CRP is an innate immune system reactant protein investigated as an 
inflammatory marker (Catano Sabogal, Fonseca and Garcia-Perdomo, 2018). No 
other characteristic diverged significantly between groups. 
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 HCA (n=12) PTB (n=6) 
Term 
(n=6) 
p.value  
HCA PTB 
Term 
p.value 
HCA 
PTB 
Chorion                Yes 11.0 (91.7) 6.0 (100.0) 6.0 (100.0) 1.000 1.000 
                          No 1.0 (8.3) 0.0 (0.0) 0.0 (0.0)   
Amnion                Yes 9.0 (75.0) 5.0 (83.3) 0.0 (0.0) 0.004* 1.000 
                          No 3.0 (25.0) 1.0 (13.7) 6.0 (100.0)   
Gestational age 
(mean (SD)) 
29.6 (2.9) 29.9 (4.0) 40.4 (0.6) 0.001* 0.779 
Birthweight (mean 
(SD)) 
1387.0  
(504.4) 
1736.7 
(402.3) 
3250.0 
(495.6) 
0.001* 0.291 
Maternal age 
(mean (SD)) 
29.3 (8.0) 27.0 (5.5) 32.2 (6.0) 0.411 0.511 
Maternal BMI 
(mean (SD)) 
22.0 (9.2) 22.5 (4.5) 22.3 (2.1) 0.515 0.580 
Smoker                 Yes 4.0 (33.3) 2.0 (33.3) 0.0 (0.0) 0.329 0.806 
                          No 6.0 (50.0) 4.0 (66.7) 6.0 (100.0)   
                          NA 2.0 (16.7) 0.0 (0.0) 0.0 (0.0)   
Parity (mean (SD)) 1.6 (2.2) 1.5 (1.8) 0.7 (1.2) 0.660 1.000 
Fetal sex            Male 5.0 (41.7) 6.0 (100.0) 1.0 (16.7) 0.013* 0.232 
                   Female 7.0 (58.3) 0.0 (0.0) 5.0 (83.3)   
Apgar (mean (SD)) 6.3 (2.8) 6.5 (3.6) 8.9 (0.2) 0.033* 0.885 
 
Table 3.1 Patient demographics of frozen fetal membranes. Patient characteristic data 
from all patients providing fetal membrane samples for the study. Characteristics were 
assessed between conditions of preterm with chorioamnionitis (HCA), plus preterm (PTB), 
and term birth without chorioamnionitis (Term). Comparison between all three groups was 
performed via nonparametric Kruskal-Wallis and characteristics monitored in HCA and PTB 
groups only via nonparametric Wilcoxon Rank-Sum. Categorical data was assessed using 
nonparametric Pearson’s chi-squared and Fisher’s exact test. Significance threshold for 
comparisons was p=≤0.05. Unless stated results are displayed as n (%). 
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 HCA (n=12) PTB (n=6) p.value 
Mode of delivery          Vaginal 8.0 (66.7) 5.0 (83.3) 1.000 
                  Caesarean section 4.0 (33.3) 1.0 (16.7)  
Type of labour     Spontaneous 3.0 (25.0) 2.0 (33.3) 0.600 
                                  PPROM 9.0 (75.0) 3.0 (50.0)  
                                          NA 0.0 (0.0) 1.0 (16.6)  
Days to birth (following 
PPROM) (mean (SD)) 
7.0 (3.2) 1.7 (0.6) 0.051 
Antibiotics                               Yes 7.0 (58.3) 4.0 (66.6) 0.604 
                                           No 5.0 (41.7) 1.0 (16.7)  
                                          NA 0.0 (0.0) 1.0 (16.7)  
Antenatal corticosteroids  Yes 11.0 (91.7) 5.0 (83.3) 1.000 
                                          No 1.0 (8.3) 1.0 (16.7)  
Maternal inflammatory stage 
(mean (SD)) 
2.2 (0.4) 1.0 (0.0) <0.001* 
Maternal inflammatory grade 
(mean (SD)) 
1.6 (0.5) 1.0 (0.0) 0.036* 
Number of clinical CA signs 
(mean (SD)) 
0.9 (1.2) 0.2 (0.4) 0.163 
C-reactive protein (mean 
(SD)) 
55.6 (54.9) 6.4 (2.6) 0.006* 
White blood cell count (mean 
(SD)) 
19.1 (6.9) 12.9 (5.2) 0.069 
Previous PTB                          Yes 5.0 (41.7) 1.0 (16.7) 0.600 
                                           No 7.0 (58.3) 5.0 (83.3)  
Previous early PTB               Yes 2.0 (16.7) 1.0 (16.7) 1.000 
                                          No 10.0 (83.3) 5.0 (83.3)  
 
Table 3.2 Patient demographics from frozen fetal membranes of PTB patients only. 
Patient characteristic data from all preterm patients providing fetal membrane samples for 
the study. Characteristics were assessed between conditions of preterm birth with 
chorioamnionitis (HCA) and preterm without chorioamnionitis (PTB). Comparison between 
groups was performed via nonparametric Wilcoxon Rank-Sum. Categorical data was 
assessed using nonparametric Fisher’s exact test. Significance threshold for comparisons 
was p=≤0.05. Unless stated results are displayed as n (%). 
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3.3.2 Quantification of extracted DNA 
3.3.2.1 NanoDrop spectrophotometer results 
NanoDrop results indicated that significantly greater yields of DNA were extracted 
from frozen chorion (310.7 ng/µl) compared to a lower mean yield from frozen 
amnion (164.3 ng/µl, p=0.018). Qiagen kit negative controls used for the extraction 
of DNA from frozen samples yielded low, but detectable amounts of DNA (1.1 ng/µl) 
significantly lower than frozen samples (p=0.001). There was no difference in the 
concentration of extracted DNA between the two Qiagen extraction kits used (kit 1= 
202.1 ng/µl, kit 2= 296.2 ng/µl; p=0.951).  
HCA samples had the greatest mean quantity of DNA (368.0 ng/µl), with PTB (148.1 
ng/µl) and term (175.0 ng/µl) displaying lower comparable means, with no 
significance detected between HCA and non-HCA samples (p=0.219). A subset of 
NanoDrop result can be found in the appendix (Table A.3). 
 
3.3.3 Sequencing read counts 
Fetal membranes had detectable read counts within all sample replicates, with 2862 
individual amplicon sequence variants (ASVs) within frozen samples. Read counts 
varied from 2 to 64,439, with a mean read count of 3758.4. All DNA kit negatives 
also yielded read counts, with 1767 individual ASVs, an average read count of 
9895.3, ranging from 2 to 64,799. Samples with <2 read counts in 20% of ASVs 
were removed from downstream analysis, due to this being the minimum threshold 
of the negative controls, with limited reliability below this (Dhariwal et al, 2017; 
Jervis-Bardy et al, 2015). 
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3.3.4 The microbiota of fetal membranes: Comparison between HCA and non-
HCA tissues 
3.3.4.1 Relative and percentage abundance 
Within samples, 2862 individual ASVs were detected. From this, 2401 were 
detected in HCA, 1120 detected in PTB and 353 in term samples.  
 
Escherichia/Shigella was the most abundant genus across the majority of groups 
including PTB amnion (47%), HCA chorion (34%), PTB chorion (46%) and term 
chorion (52%; Figure 3.1). HCA amnion was the only patient cohort where 
Escherichia/Shigella was not the most abundant (27%), with increased relative 
abundance from Prevotella (32%; Figure 3.1). Prevotella was the second greatest 
genus in HCA chorion (23%), but contributed 10%, 5% and <1% to term chorion, 
PTB amnion and PTB chorion, respectively. HCA patients had the greatest levels of 
Ureaplasma in the amnion (16%) and chorion (11%), but PTB chorion also displayed 
11% from Ureaplasma, with this reduced to 5% from PTB amnion and <1% from 
term chorion. Term chorion had the greatest relative abundance for Lactobacillus 
(18%), with preterm chorion and amnion presenting with 17% and 12% respectively, 
and this decreased in HCA chorion (4%) and HCA amnion (2%). 
None of the genera displayed significant differences in relative abundance between 
HCA and PTB in the amnion or HCA, PTB and term in the chorion. In the amnion a 
trend for increased relative abundance of Prevotella in HCA was detected, but not 
significant following false discovery rate (FDR) correction (p=0.029, FDR=0.413). 
This trend was not reflected in the chorion (p=0.104, FDR=0.619). 
 
At the ASV level, only one ASV was significantly greater in HCA amnion compared 
to PTB amnion (p=0.002, FDR=0.048). This ASV was assigned to Prevotella, and 
was the second highest abundant ASV in HCA patients (Table 3.3). A trend for 
greater Lactobacillus was observed in PTB amnion, but not significantly different 
following FDR correction (p=0.034, FDR=0.364). In the chorion, none of the ASVs 
were significantly different across HCA, PTB and term. A trend for increased 
Lactobacillus in term chorion was observed, from two individual ASVs assigned to 
this genus. Yet these were not significantly different between HCA, PTB and term 
following FDR corrections (p=0.007, FDR=0.110 and p=0.012, FDR=0.110).  
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Figure 3.1 Relative abundance of amnion and chorion fetal membranes. Relative abundance plots from V4 16S rRNA amplicon sequencing of extracted 
DNA from frozen fetal membranes. ASVs were clustered into genera for visual analysis plots created using ggplot2 (R Core Teams, 2017). Samples were 
divided by tissue type of amnion (A) and chorion (B). Samples were then further divided by condition of chorioamnionitis (HCA), preterm without 
chorioamnionitis (PTB) and term without chorioamnionitis (Term). 
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 All samples HCA PTB Term 
1 Escherichia/Shigella Ureaplasma Escherichia/Shigella Escherichia/Shigella 
2 Ureaplasma Prevotella 
Alpha-
proteobacteria* 
Lactobacillus 
3 Prevotella Escherichia/Shigella Prevotella Campylobacter 
4 Prevotella Prevotella Prevotella Fusobacterium 
5 Prevotella Prevotella Staphylococcus Paraprevotella 
6 Faecalibacterium Faecalibacterium Ureaplasma Faecalibacterium 
7 Prevotella Prevotella Acinetobacter Prevotella 
8 Streptococcus Streptococcus Streptococcus Prevotella 
9 Streptococcus Streptococcus Lactobacillus Streptococcus 
10 Faecalibacterium Faecalibacterium Acidobacteria* Faecalibacterium 
 
Table 3.3 Ten most abundant ASVs in frozen fetal membranes. Top ten most abundant 
amplicon sequence variants (ASVs) present in frozen fetal membrane samples and broken 
down into sample subtype of chorioamnionitis (HCA), plus preterm (PTB) and term without 
chorioamnionitis (Term). All bacterium displayed are classification genera, if this information 
was not available the next highest order is displayed (*). Bacteria presented in bold were 
only present in the respective group. 
 
3.3.4.2 Bacterial diversity structure 
Diversity analysis was performed by Shannon diversity, GUniFrac distance and 
PERMANOVA analysis. 
HCA amnion had a lower mean diversity compared with PTB amnion, yet not 
significant (0.743 vs 1.047, p=0.110; Figure 3.2A). Across chorion tissues, HCA 
displayed the lowest mean diversity (0.796), compared to PTB (1.207) and term 
(1.104), though none were significant (HCA vs PTB p=0.480, HCA vs Term p=0.170, 
PTB vs Term p=0.170; Figure 3.2C). 
 
For beta diversity analysis, significantly different distinct clusters were also 
displayed between HCA, PTB and term chorion (R2=0.227, p=0.010; Figure 3.2B). 
Significant differences between HCA and PTB were detected in the amnion, with a 
distinct cluster for PTB observed yet greater beta diversity distances between HCA 
patients (R2=0.162, p=0.015; Figure 3.2D). 
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Figure 3.2 Diversity analysis of frozen fetal membranes. Alpha and beta diversity 
analysis of ASV data from V4 16S rRNA amplicon sequencing of frozen fetal membranes. 
Samples were divided into amnion (A+B) or chorion only (C+D), plus groups of 
chorioamnionitis (HCA), preterm without chorioamnionitis (PTB) and term without 
chorioamnionitis (Term). Diversity analysis was performed by Shannon alpha diversity 
(A+C) or GUniFrac PERMANOVA for beta diversity (B+D). Significance was analysed via 
nonparametric Kruskal-Wallis and nonparametric Pairwise Wilcoxon Rank-Sum to a 
threshold of p=≤0.05. 
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3.3.5 Maternal stage and grade related to the microbiota in fetal membranes 
3.3.5.1 Relative and percentage abundance for inflammatory stage  
Prominent bacterial relative abundance differs across inflammatory staging.  
In the amnion, Escherichia/Shigella was the most abundant genus across all 
inflammatory staging, apart from the highest inflammatory stage. 
Escherichia/Shigella relative abundance decreased as stage increased as this was 
65% from stage zero, 41% from stage one and 30% from stage two, but <1% from 
stage three (Figure 3.3A). The genus contributing the greatest to stage three was 
Prevotella (97%). This was detected at 25% in stage two, 5% stage one and 9% 
stage zero. Ureaplasma was higher in stage two (18%) compared to stage one (7%), 
zero (1%) and three (<1%). Lactobacillus was the greatest in stage one (14%), 
contributing 7%, 2% and <1% to stage zero, two and three, respectively. 
At the genus level, no significant difference in abundance between inflammatory 
staging on the amnion was present. A trend for increased Prevotella in high stage 
inflammation (stage three) was detected, but not significantly increased following 
FDR correction (p=0.028, FDR=0.395). 
 
Similar results were found in the chorion, with the greatest relative abundance of 
Escherichia/Shigella from the lowest inflammatory stage, decreasing as 
inflammatory staging increased (Figure 3.3B), as Escherichia/Shigella contributed 
60% at stage zero, 40% at stage one, 28% at stage two and 11% at stage three. 
Once again, the genus contributing the greatest to stage three in the chorion was 
Prevotella (50%), with this reducing throughout inflammatory stages of stage two 
(17%), stage one (11%) and stage zero (10%). Ureaplasma was highest from stage 
two (14%) followed by stage one (13%), but reduced in stages zero and three (<1%). 
Lactobacillus was the greatest in stage one (19%), reducing in stage zero (15%), 
two (4%) and three (1%). At the genus level no significant differences in abundance 
between inflammatory staging on the chorion was detected.  
 
At the ASV level, no ASVs were significantly different across inflammatory stages in 
the amnion or chorion. In the amnion one Prevotella ASV showed a trend for 
increased abundance in stage three inflammation, but was not significant following 
FDR correction (p=0.004, p=0.084; Table 3.4). In the chorion, two ASVs showed a 
trend for increased levels in stage one, but were not significant. Both ASVs were 
assigned to the Lactobacillus genera (p=0.029, FDR=0.282; p=0.031, FDR=0.282).  
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Figure 3.3 Relative abundance of inflammatory stage in the amnion and chorion. Relative abundance plots from V4 16S rRNA amplicon sequencing of 
extracted DNA from frozen fetal membranes. ASVs were clustered into genera for visual analysis plots created using ggplot2 (R Core Teams, 2017). Samples 
were divided by tissue type of amnion (A) or chorion (B) for relative abundance analysis of inflammatory stage, which is a histological diagnostic criteria for 
chorioamnionitis severity. 
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 Stage zero Stage one Stage two Stage three 
1 Escherichia 
/Shigella 
Escherichia 
/Shigella 
Escherichia 
/Shigella 
Prevotella 
2 
Acinetobacter 
Alphaproteo-
bacteria* 
Ureaplasma Faecalibacterium 
3 Campylobacter Prevotella Prevotella Faecalibacterium 
4 Lactobacillus Prevotella Prevotella Clostridium_IV 
5 Acidobacteria_ 
Gp4* 
Ureaplasma Bacillus Lactobacillus 
6 Spartobacteria* Staphylococcus Streptococcus Faecalibacterium 
7 Unclassified 
bacteria* 
Streptococcus Bulleidia Ruminococcaceae* 
8 Streptococcus Lactobacillus Haemophilus Clostridium_XIVa 
9 Faecalibacterium Cloacibacterium Faecalibacterium Bifidobacterium 
10 Fusobacterium Enterococcus Prevotella Lactobacillus 
 
Table 3.4 Ten most abundant ASVs in fetal membranes across inflammatory staging. 
Top ten most abundant amplicon sequence variants (ASVs) displayed by inflammatory 
stage of zero, one, two or three. Inflammatory staging is a histological diagnostic criteria for 
chorioamnionitis severity. All bacterium displayed are classification genera, if this was not 
available bacteria is displayed as the next highest order (*). Bacteria in bold were detected 
for that group only. 
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3.3.5.2 Relative and percentage abundance for inflammatory grade 
In the amnion, Escherichia/Shigella was the most abundant genus from the lowest 
grade inflammation (zero, 95%), followed by grade one (34%) and grade two (30%; 
Figure 3.4). Prevotella contributed the greatest relative abundance in grade two 
(41%), with this decreased in grade one (5%) and grade zero (9%). Ureaplasma 
was the greatest in grade one (16%), compared to grade two (10%), and not 
detected in grade zero. Lactobacillus was the greatest from grade one (10%), 
reduced in grade zero (7%) and grade two (2%). No significant differences were 
detected across relative abundance of genera and inflammatory grading in the 
amnion. A trend for increased Prevotella with greater inflammatory grading was 
detected, but not significant following FDR correction (p=0.015, FDR=0.208).  
 
In the chorion, Escherichia/Shigella was the most abundant genera across all 
inflammatory grades, including zero (56%), one (33%), and two (37%). At 
inflammatory grade two, Prevotella was the second greatest contributor to relative 
abundance at 27%, with this decreased in grade one (13%) and zero (10%). 
Ureaplasma was the greatest at grade one (23%), with this <1% from both grade 
zero and two. Lactobacillus contributed 15% and 14% to grade zero and one, 
respectively, but only 1% in grade two. No genera were significantly different across 
inflammatory grading in the chorion. Lactobacillus showed a trend for increased 
abundance in lower inflammatory grading levels, yet not significant after FDR 
correction (p=0.012, FDR=0.411).  
 
At the ASV level, one ASV was significantly increased as inflammatory grading 
increased in the amnion. This ASV was assigned to Prevotella and was the most 
abundant ASV from grade two compared to grade one and zero (p=0.002, 
FDR=0.039; Table 3.5). In the chorion, one ASV representing Lactobacillus was 
related to inflammatory grading, as this was significantly decreased as inflammatory 
grading increased in the chorion (p=<0.001, FDR=0.004). 
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Figure 3.4 Relative abundance of inflammatory grade in the amnion and chorion. Relative abundance plots from V4 16S rRNA amplicon sequencing of 
extracted DNA from frozen fetal membranes. ASVs were clustered into genera for visual analysis plots created using ggplot2 (R Core Teams, 2017). Samples 
were divided by tissue type of amnion (A) or chorion (B) for relative abundance analysis of maternal inflammatory grade, which is a histological diagnostic 
criteria for chorioamnionitis severity.
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 Grade zero Grade one Grade two 
1 Escherichia/Shigella Escherichia/Shigella Prevotella 
2 Acinetobacter Ureaplasma Escherichia/Shigella 
3 Campylobacter Prevotella Faecalibacterium 
4 Lactobacillus Prevotella Ureaplasma 
5 Acidobacteria_Gp4* Streptococcus Bulleidia 
6 Spartobacteria* Haemophilus Faecalibacterium 
7 Unclassified bacteria* Prevotella Staphylococcus 
8 Streptococcus Faecalibacterium Streptococcus 
9 Faecalibacterium Streptococcus Clostridium_IV 
10 Fusobacterium Faecalibacterium Lactobacillus 
 
Table 3.5 Ten most abundant ASVs in fetal membranes across inflammatory grading. 
Top ten most abundant amplicon sequence variants (ASVs) displayed by inflammatory 
grade of zero, one and two. Inflammatory grading is a histological diagnostic criteria for 
chorioamnionitis severity. All bacterium displayed are classification genera, if this was not 
available bacteria is displayed as the next highest order (*). Bacteria in bold were detected 
for that group only. 
 
3.3.5.3 Bacterial diversity structure across HCA inflammatory staging and 
grading 
No significant differences in alpha diversity were detected for HCA severity on 
amnion and chorion tissues. Greater alpha diversity was detected with lower stage 
inflammation in the chorion, at stage zero and one (1.133 and 1.130), compared to 
stage two (0.824) and stage three (0.747), yet not significant (p=0.472, Figure 3.5A). 
For inflammatory grading, grade zero (1.133) and grade one (1.107) displayed the 
greatest alpha diversity, compared to grade two (0.695) yet not significant (p=0.472; 
Figure 3.5B). Within the amnion, the greatest alpha diversity was from stage zero 
(1.064), compared to stage one (0.899), two (0.827) and three (0.177), yet not 
significant (p=0.467; Figure 3.6A). Inflammatory grading followed a similar trend, 
with lower grading displaying greater diversity. Comparison yielded no significance 
between grade zero (1.040), one (0.852) and two (0.762, p=0.467; Figure 3.6B).  
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Beta diversity differed between HCA staging and grading of inflammatory factors in 
chorion (Figure 3.5) and amnion tissues (Figure 3.6). Inflammatory level two and 
zero display distinct clusters for both stage and grade, with wider diversity at level 
one and three overlapping other inflammatory levels. PERMANOVA analysis 
highlighted differences in bacterial diversity within chorion tissues for staging 
(R2=0.271, p=0.001; Figure 3.5C) and grading of inflammatory factors (R2=0.190, 
p=0.003; Figure 3.5D). Similar beta diversity was detected within amnion tissues for 
staging (R2=0.271, p=0.084; Figure 3.6C) and grading of inflammatory factors, with 
no distinct clusters detected (R2=0.184, p=0.138; Figure 3.6D). 
 
             
 
 
Figure 3.5 Diversity analysis of inflammatory grading and staging within the chorion. 
Alpha and beta diversity analysis of ASV data from V4 16S rRNA amplicon sequencing from 
frozen chorion samples categorised by staging and grading of the fetal membranes, which 
are histological diagnostic criteria for chorioamnionitis severity. Samples were divided into 
inflammatory stage (A+C) and grade (B+D) in chorion samples. Alpha diversity was 
measured using Shannon diversity indices for stage (A) and grade (B) and beta diversity 
was analysed via GUniFrac PEMANOVA for stage (C) and grade (D) to a significance of 
p=≤0.05 via nonparametric Kruskal-Wallis test. 
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Figure 3.6 Diversity analysis of inflammatory grading and staging within the amnion. 
Alpha and beta diversity analysis of ASV data from V4 16S rRNA amplicon sequencing from 
frozen amnion samples categorised by staging and grading of the fetal membranes, which 
are histological diagnostic criteria for chorioamnionitis severity. Samples were divided into 
inflammatory stage (A+C) and grade (B+D) in amnion samples. Alpha diversity was 
measured using Shannon diversity indices for stage (A) and grade (B) and beta diversity 
was analysed via GUniFrac PEMANOVA for stage (C) and grade (D) to a significance of 
p=≤0.05 via nonparametric Kruskal-Wallis tests. 
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3.3.6 The microbiota of frozen fetal membrane tissues and negative controls 
As the detection of a genuine bacterial profile in fetal membranes is questioned, 
sample results were compared to DNA kit negative controls. 
 
3.3.6.1 Relative and percentage abundance in samples and controls 
Escherichia/Shigella had the highest relative abundance in both samples and 
controls, contributing 41% to samples and 55% to negative controls (Figure 3.7A). 
When segmenting samples by membrane, the majority of Escherichia/Shigella 
originated from the amnion (74%), with less from the chorion (11%; Figure 3.7B). 
Prevotella was the second most abundant genera from samples (25%) and 
decreased in negative controls (6%). This mainly originated from the chorion (36%), 
with less from the amnion (16%). Ureaplasma was greater in samples (17%), 
compared to negative controls (<1%), with this mainly originating from the chorion 
(28%), and less from the amnion (4%).  
 
At the genera level, four genera were significantly increased in negative controls 
compared to samples. These were Escherichia/Shigella (p=<0.001, FDR=<0.001), 
Pseudomonas (p=<0.001, FDR=0.003), Blautia (p=0.006, FDR=0.028) and 
Lactobacillus (p=0.011, FDR=0.037). 
 
Within samples and negative controls, 2862 and 1767 individual ASVs were 
detected within each respective subset. At the ASV level, seven ASVs were 
significantly greater in negative controls compared to samples. These include one 
ASV assigned to Escherichia/Shigella (p=<0.001, FDR=<0.001; Table 3.6), one 
Lactobacillus (p=0.003, FDR=0.018), one Blautia (p=0.006, FDR=0.029), plus two 
Faecalibacterium (p=<0.001, FDR=0.003; p=0.008, FDR=0.032) and two 
Pseudomonas (p=0.001, FDR=0.008; p=0.014, FDR=0.049). 
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Figure 3.7 Relative abundance of frozen tissues and negative controls. Relative abundance plots from V4 16S rRNA amplicon sequencing of extracted 
DNA from frozen fetal membranes and DNA extraction kit negative controls to investigate kit contamination. ASVs were clustered into genera for visual 
analysis plots created in ggplot2 (R Core Teams, 2017). Samples were divided by fetal membrane samples and kit negative controls (A), with samples further 
subdivided by tissue type of amnion or chorion (B).  
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 Fetal membranes Negative controls 
1 Escherichia/Shigella Escherichia/Shigella 
2 Ureaplasma Bacteroides 
3 Prevotella Bacillus 
4 Prevotella Faecalibacterium 
5 Prevotella Roseburia 
6 Faecalibacterium Bacteroides 
7 Prevotella Prevotella 
8 Streptococcus Acinetobacter 
9 Streptococcus Prevotella 
10 Faecalibacterium Faecalibacterium 
 
Table 3.6 Ten most abundant ASVs in frozen fetal membranes and negative controls. 
Top ten most abundant amplicon sequence variants (ASVs) displayed by frozen fetal 
membranes or DNA extraction kit negative control. Bacteria in bold were detected for that 
group only. 
 
3.3.6.2 Bacterial diversity structure in samples and controls 
Samples displayed a higher mean alpha diversity (1.620) than negative controls 
(1.584), yet not significant (p=0.909; Figure 3.8A). When comparing across tissue 
type to negative controls, the chorion yielded the greatest mean alpha diversity 
(2.037), followed by amnion (1.620) and the lowest from negative controls (1.333), 
yet no significance was detected (p=0.393; Figure 3.8B). 
 
A significant difference in beta diversity between fetal membrane samples and 
negative controls were present (R2=0.042, p=0.001; Figure 3.8C). Diversity was also 
significantly different between tissue type of amnion and chorion, compared to 
negative controls, yet no distinct clusters were observed (R2=0.060, p=0.004; Figure 
3.8D). 
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Figure 3.8 Diversity analysis of frozen tissues and negative controls. Alpha and beta 
diversity analysis of ASV data from V4 16S RRNA amplicon sequencing from fetal 
membrane samples and DNA extraction kit negative controls. Diversity values presented 
as samples and negative controls (A), then samples further divided by tissue type of amnion 
and chorion compared to negative controls (B), plus GUniFrac PERMANOVA beta diversity 
analysis from samples and negative controls (C) and subdivided by tissue types (D). 
Significance was analysed via nonparametric Kruskal-Wallis and nonparametric Pairwise 
Wilcoxon Rank-Sum to a threshold of p=≤0.05. 
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3.4 Discussion 
The aim of this chapter was to investigate the microbiota in fetal membranes with 
and without HCA by Illumina amplicon sequencing. Also, to explore the microbiota 
in HCA related to maternal inflammatory staging and grading. 
Overall, chapter three highlights that bacterial profiles differ between HCA and non-
HCA fetal membranes, with a trend for increased Prevotella in HCA and higher 
inflammatory levels. Inflammatory staging and grading have distinct bacterial 
profiles, but specific bacteria are only linked to inflammatory grading and not 
staging, with increased Prevotella and decreased Lactobacillus as inflammatory 
grading increases in severity. Frozen tissues and negative controls are distinct in 
bacterial profile structure and four specific genera. 
 
3.4.1 Optimum DNA quantity from frozen fetal membranes. NanoDrop and 
agarose gel electrophoresis results confirmed that optimum quality and quantity of 
DNA was extracted from all frozen fetal membranes, this was required to be >1 pg/µl 
for successful sequencing (Biesbroek et al, 2012). HCA yielded a greater DNA 
quantity compared to non-HCA patients, which is also reflected in sequencing read 
count values. However, during library preparation all samples were diluted to equal 
concentrations. Post-process rarefying of data has also been suggested as a 
method to normalise read counts. However, this can lead to discarding important 
samples in low library sizes and errors when differential abundance is displayed 
(McMurdie and Holmes, 2014), thus was not applied here. 
 
3.4.2 Sequencing read counts from frozen fetal membranes. All frozen fetal 
membranes had detectable read counts from sequencing methodology, including 
non-HCA preterm and term membranes. Although the greatest read count was from 
HCA samples from both the amnion and chorion. Previous research has detected 
read counts in 68.1% of fetal membranes and 46.8% of placental samples from 
sequencing (Doyle et al, 2017), with mean read counts lower than detected here at 
11,803. Leiby et al (2018) also detected read counts in 61.3% of placentas, with 
detection only confirmed if samples contained >100 reads. Utilising the 100 read 
count threshold would have led to the removal of 2869 ASVs in this research, which 
could have included rare sequences important to HCA (McMurdie and Holmes, 
2014). Low biomass samples, such as placenta are expected to generate low read 
counts, so the threshold value was selected as <2 counts in 20% of features to 
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prevent the removal of important information (McMurdie and Holmes, 2014), this led 
to the removal of 1429 low abundant features. Read counts are arbitrary and do not 
represent abundance due to inconsistent 16S rRNA gene copy numbers across taxa 
and samples, plus differences in variable regions (Noecker et al, 2017). Greater 
read counts with the V1/V2 compared to the V3/V4 region were detected within a 
sequencing protocol comparison study, albeit using stool samples (Clooney et al, 
2016). The use of qPCR to investigate bacterial load (Chapter five) improves upon 
abundance analysis and can be combined with sequencing to clarify findings and 
create a broad view of the microbiota. 
 
3.4.3 HCA patients have distinctly different bacterial profiles compared to non-
HCA patients in both amnion and chorion tissues when measured by beta diversity. 
A trend for increased Prevotella (38%) and Ureaplasma (24%) at genus level was 
detected in HCA patients compared to non-HCA patients (<10%), and one ASV 
assigned to Prevotella was significantly increased in HCA patients. Prince et al 
(2016) supported different diversity profiles in placental membranes with and without 
HCA (Prince et al, 2016). The research included comparable categories to this 
research project (HCA, PTB and Term), but also included term patients with 
chorioamnionitis. Research showed that bacterial communities at term with HCA 
were most like preterm without HCA (Prince et al, 2016). The inclusion of term 
patients with chorioamnionitis would have been beneficial within this study, however 
the occurrence of this condition in term patients is low, at 2-4% (Kim et al, 2015), 
and none were available at the time of collection for this research.  
 
Although overall bacterial profiles differed between HCA, PTB and term patients, no 
significant differences in the presence or amount of any specific genus was 
detected. Trends for increased Ureaplasma and Prevotella were identified in HCA 
samples, with a trend for greater Lactobacillus in non-HCA fetal membranes. The 
detection of these opportunistic pathogens including Ureaplasma and Prevotella 
were detected in chorioamnionitis fetal membranes and placenta previously (Cox et 
al, 2016; Hecht et al, 2009; Sweeney et al, 2016).  
Prevotella was the most abundant genus in HCA patients, but was also observed in 
PTB and term without HCA. Although insignificant at genus level, one Prevotella 
ASV was significantly greater in the amnion of HCA patients. Previous research 
relates Prevotella to placental inflammation (Hecht et al, 2009), whilst others 
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suggest high colonisation in the placenta but a low ability to elicit an inflammatory 
response, when measured by enzyme linked immunosorbent assay (ELISA; 
Fichorova et al, 2011). Detection in PTB (Han et al, 2009), preterm premature 
rupture of the membranes (PPROM; Brown et al, 2018) and microbial infection in 
amniotic fluid (DiGiulio et al, 2008) via PCR and sequencing highlights its 
involvement in fetal and maternal immune response, but suggests a non-specific 
target for HCA detection. Prevotella has also been observed in healthy placenta 
(Aagaard et al, 2014; Doyle et al, 2017; Leiby et al, 2018), but also as a component 
of the natural vaginal community (MacIntyre et al, 2015; Romero et al, 2014a; 
Satorki et al, 2010), linking it to a possible ascending pathway of initiation. No 
differences were found at the genus level, suggesting that a range of Prevotella 
ASVs were detected across the entire cohort. Seven different ASVs were in high 
abundance from Prevotella. However, a single Prevotella ASV was more abundant 
in HCA samples, suggesting it may illicit an inflammatory response. Within current 
literature, one Prevotella species has been the focus of reproductive health and 
placental research. Prevotella bivia, a common vaginal isolate, has been linked to 
bacterial vaginosis and PTB (Gilbert et al, 2019). Hecht et al (2009) found a two-fold 
increase in P. bivia from higher maternal inflammation (stage three, grade two) 
compared to stage and grade one, from chorion explant cultures (Hecht et al, 2009). 
This species has shown the in vitro capacity to invade human cervical endothelial 
cells to induce an inflammatory response (Strombeck et al, 2007). Species-specific 
qPCR could differentiate and confirm the bacterial load and importance of 
associated ASVs, which may be clinically beneficial for detection of the condition.  
Ureaplasma was the second most abundant genus in HCA, but also present in PTB, 
yet not detected in term patients. Research has detected Ureaplasma as the most 
prevalent genus in chorioamnionitis placenta and fetal membranes, yet the majority 
of research focuses specifically on species of Ureaplasma urealyticum and 
Ureaplasma parvum (Sweeney et al, 2016). Sweeney et al (2016) found that 60% 
of HCA placenta were positive for U. parvum, and 13% for U. urealyticum, with mean 
bacterial loads of 108. Cox et al (2016) identified significantly greater U. parvum from 
chorioamnionitis chorion (33.3%), compared to without chorioamnionitis (9.1%); yet 
comparable levels of U. urealyticum from both groups (3-4%), suggesting species-
specific variation. Thus, it may be important to determine if either of these species 
correlated to ASVs detected in HCA fetal membranes here. Contrastingly, 
Ureaplasma has been implicated in both spontaneous PTB (sPTB) and PPROM 
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(Witt et al, 2005), and is therefore not specific to HCA. Ureaplasma are present in 
the respiratory, urinary and reproductive tract (Urszula et al, 2014). But small 
amounts of this low virulence pathogen may be unable to elicit an inflammatory 
response (Aaltonen et al, 2007). It may be a greater overall bacterial load rather 
than presence required to initiate an inflammatory response, which will be explored 
in chapter five by 16S rRNA gene qPCR methodology. Further research may wish 
to use in vitro fetal membrane explants spiked at varied bacterial loads and for varied 
time points to investigate the impact of Prevotella and Ureaplasma on placental 
inflammation. 
 
Further genera and ASVs detected in greater abundance with HCA, but not 
significantly so were contained within the phylum Firmicutes. This phylum is 
suggested as a primary contributor to the intestinal microbiota (Kim et al, 2015), plus 
highly abundant in the healthy vaginal, placental (Aagaard et al, 2014) and fetal 
membrane microbiota (Huang et al, 2014). Amplification bias towards Firmicutes 
from the V4 primer may increase the abundance in this study (Wang et al, 2009). 
However, this bias would then be expected in comparable amounts across all 
samples. Alternatively, Firmicutes have been linked to contamination due to 
detection in low relative abundance within commercial DNA extraction kit negative 
controls of MoBio PowerMax (Glassing et al, 2016). 
 
The most abundant bacterium across non-HCA patients was Escherichia/Shigella, 
also the third most abundant in HCA patients. Support that Escherichia is the main 
bacteria detected in normal preterm and term placenta and fetal membranes is 
supported by Aagaard et al (2014) and Lee et al (2018). Aagaard et al (2014) stated 
Escherichia, specifically E. coli as the unique signature of a placental microbiota 
when compared to other body sites, including oral and vaginal (Aagaard et al, 2014). 
Prince et al (2016) also found consistent detection of Escherichia across preterm 
and term with and without chorioamnionitis via whole genome sequencing. Thus not 
relating detection to gestational age or inflammation. However, kit negative controls 
were not stated for either study, bringing into question the origin of bacteria (Kilman, 
2014). Alternatively, Hecht et al (2009) detected Escherichia in double the amounts 
from higher grade HCA than mild HCA, relating abundance to severity of the 
condition. Despite analysing 1292 placentas, only patients with HCA delivering by 
caesarean section were included, without a healthy control group or patients 
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delivering vaginally used as a baseline. Thus, methodological limitations could 
possibly skew results. In vivo research corroborates findings as stimulation with 
Escherichia endotoxin increased HCA and inflammation in ovine fetal membranes 
(Kallapur et al, 2001). Lipopolysaccharides are not highly specific, and a number of 
Gram-negative bacteria could initiate the response, for example Prevotella rather 
than Escherichia specifically (Aroutcheva, Ling and Faro, 2008). The genuine 
detection of Escherichia from fetal membranes has been questioned and is the 
focus of many debates due to contamination from methodological processes 
(Kilman, 2014). Escherichia has been stated as a universal contaminant across low 
biomass microbiota research (Theis et al, 2019), as discussed throughout this 
thesis. 
 
3.4.4 HCA inflammation levels are associated with bacterial profiles of the fetal 
membranes. Although no specific genera were significantly linked to HCA 
inflammatory stage or grade in amnion or chorion, there was a trend for increased 
Prevotella and decreased Lactobacillus with increasing histologically confirmed 
inflammation. The negative correlation between Prevotella and Lactobacillus has 
previously been observed in bacterial vaginosis (Si et al, 2010), suggesting that 
dysbiosis of the two bacteria may be linked to pathology. At the ASV level one 
Prevotella sequence was significantly greater in grade two amnion and one 
Lactobacillus ASV was significantly increased in grade one chorion. This highlights 
that individual fetal membranes have distinct influential bacteria across 
inflammatory response levels. It is beneficial to investigate each membrane 
individually prior to clinical diagnosis, as performed here. This is due to different 
structural properties and inflammatory responses to bacterial presence (Waring et 
al, 2015). Also as involvement of the amnion in chorioamnionitis is the most 
advanced stage of the condition (Park et al, 2009), which may explain why only 
increased Prevotella in higher inflammatory response was detected in amnion but 
not the chorion. This indicates that individual fetal membrane analysis is important 
for bacterial progression across the membranes and categorising HCA severity. 
Variation across membranes is also present from inflammatory gene expression 
research, with increased TLR1, TLR2 and LY96 in the chorion, but IL-8 and IRAK2 
in the amnion (Waring et al, 2015). In PPROM, weakening of the chorion may 
compromise protection of the amnion, leading to membrane microbiota changes 
following PPROM (Canzoneri et al, 2013). PPROM was the most prevalent cause 
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of PTB here, occurring in 75% of HCA and 50% of PTB patients, thus it may be of 
interest to investigate HCA microbiota characteristics from PPROM and sPTB 
individually. 
 
3.4.5 Negative controls and samples have distinct bacterial profiles and differ 
by four specific genera. Careful consideration is required when elucidating the 
microbiota of fetal membranes, with the need to investigate the contribution from the 
specific DNA extraction kit reagent microbiota within each study, and to investigate 
the impact of external contamination to avoid false positive conclusions. The use of 
commercial kits and reagents has increased external bacterial contribution 
(Biesbroek et al, 2012; Jervis-Bardy et al, 2015; Laurence, Hatzis and Brash, 2014; 
Salter et al, 2014), especially in low biomass samples, including placental and fetal 
membranes (Eisenhofer et al, 2019; Lauder et al, 2016).  
Escherichia/Shigella, Pseudomonas, Lactobacillus and Blautia were observed in 
significantly greater abundance from DNA extraction kit negative controls compared 
to samples at both the genus and ASV level here, which suggests that these genera 
originated from the extraction process and contributed to sample contamination. 
Escherichia/Shigella and Pseudomonas have previously been detected in 
sequencing blanks and ultrapure water (Grahn et al, 2003; Laurence, Hatzis and 
Brash, 2014). Whilst, Theis et al (2019) detected Escherichia/Shigella as the most 
abundant in both placental samples and negative controls, as was presented here. 
Although findings suggest significant differences in relative abundance bacterial 
profiles between samples and negative controls, we must consider the impact if 
these bacteria are contaminants and question the relevance of highlighted genera. 
DADA2 does not distinguish between Escherichia and Shigella when clustering into 
ASVs, with amplicon sequencing of the V4 region unable to resolve bacteria to the 
species level. To generate a stable conclusion it would be beneficial to perform 
species-specific qPCR to detect the bacterial load of the primary 
Escherichia/Shigella on the tissues and negative controls. 
Lactobacillus was detected in significantly greater amounts from negative controls 
at genus and ASV levels. These vaginal commensal bacteria have a beneficial role 
in vaginal health by maintaining a low pH (Ling et al, 2010). Lactobacillus was 
previously linked to decreased inflammatory grading in HCA chorion from this 
research project. Increased abundance in negative controls questions these 
findings as Lactobacillus has been identified as a contaminant from MoBio 
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PowerMax DNA extraction kit reagents when applied to low biomass samples 
(Glassing et al, 2016). Likewise, the origin of Pseudomonas from negative 
environmental controls of air swab (Leiby et al, 2018) and ultrapure water used in 
sample processing has been noted (Muhl et al, 2010; Salter et al, 2014). Further 
bacteria greater in negative controls were Blautia, Dorea and Faecalibacterium. 
These genera are core bacteria of the adult gut and faecal matter (Gomez-Arango 
et al, 2017). However, have also been detected in negative controls, originating from 
storage buffers (Sinha et al, 2015). Furthermore, half of the most abundant ASVs 
identified within negative controls were previously detected as the main 
contaminants from Qiagen DNeasy tissue extraction kits, including Escherichia, 
Acinetobacter and Staphylococcus (Leon et al, 2018), also Bacteroides, 
Faecalibacterium and Roseburia (Karstens et al, 2019). Post-processing methods 
can remove all bacterial sequences found in negative controls (Jervis-Bardy et al, 
2015), but within this research project specific bacteria detected in greater amounts 
from negative controls were also observed in samples, thus may still belong to the 
fetal membrane microbiota. 
Contamination biases can be introduced by variation in methodology including DNA 
extraction kit manufacturer, 16S rRNA gene variable region and reference database 
(Laurence, Hatzis and Brash, 2014; O’Callaghan et al, 2019; Salter et al, 2014). 
Sources of contamination include PCR and sequencing reagents or molecular 
biology grade water (Grahn et al, 2003; Jervis-Bardy et al, 2015; Laurence, Hatzis 
and Brash, 2014; Leiby et al, 2018). NanoDrop and agarose gel analysis prior to 
sequencing detected low quantity DNA from negative controls, thus sequencing 
reagents used after this may be the main source of contamination. Monitoring DNA 
quantity via NanoDrop or Qubit periodically throughout sample preparation and 
sequencing may be beneficial to determine the primary source of bacterial 
contamination.  
Methodology without the need for DNA extraction kit processing and sequencing 
reagents would be beneficial to reduce contamination in low biomass samples. 
Application of Raman spectroscopy (Chapter six) aims to reduce the possibility of 
environmental and reagent contamination, remove the impact of DNA extraction 
reagents and detect genuine bacterial signals, due to this being a non-destructive 
technique (Pahlow et al, 2015). Raman microspectroscopy would allow visual 
location analysis of specific targeted species to confirm the location and presence 
of the debated bacteria on the fetal membranes. 
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3.5 Conclusion 
Understanding the microbiota of the fetal membranes with HCA remains debated. 
Findings here suggest that a specific bacterial profile is present from fetal 
membranes with HCA, with links to increased Prevotella in higher inflammatory 
grade HCA. Amnion and chorion may react and respond to HCA differently, with 
different bacterial profiles and specific ASVs across membranes. Fetal membrane 
samples are distinct from negative controls in bacterial profiles and four specific 
genera. 
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Chapter Four: The utilisation of Formalin-Fixed Paraffin-Embedded fetal 
membrane samples for microbiota research; FFPE and frozen comparison. 
 
Abstract 
Aim 
The aim of this chapter was to determine if Formalin-Fixed Paraffin-Embedded 
(FFPE) fetal membrane tissues yield comparable DNA quantity and bacterial profile 
to frozen samples, to determine if these routinely collected and archived samples 
could be used in histological chorioamnionitis (HCA) microbiota research. This to 
reduce preparation, storage and costs associated with frozen fetal membrane 
processing and biobanking.  
Methods 
Matched paired analysis (n=21) was performed by comparing FFPE and frozen 
microbiota data. Respective DNA extraction kit negative controls from two different 
manufacturers were also compared. Decontam was integrated into computational 
analysis to identify contaminating sequences in FFPE samples. 
Results 
Frozen fetal membranes yielded greater quality and quantity of extracted DNA 
compared to highly fragmented FFPE DNA. Different bacterial genera were 
observed between sample preparation methods and kit manufacturer. Over half of 
sequences from FFPE samples (52%, 1690), were identified as contaminants via 
decontam, with 318 of the genuine bacteria significantly different between samples 
and controls. The most abundant bacteria across tissues and negative controls 
(Escherichia/Shigella) was detected as a genuine signal. 
Conclusion 
FFPE fetal membranes are not comparable to frozen samples, with reduced DNA 
quality and quantity, plus high levels of contamination. It is not recommended to 
replace frozen tissues with FFPE samples for fetal membrane microbiota research.  
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4.1 Introduction 
The current gold standard tissue preparation method for microbiota research is fresh 
or flash frozen samples (Arreaza et al, 2016; Roberts et al, 2019). However, the 
routine collection, preservation and availability, plus ease of retrospective and 
repeat analysis make Formalin-Fixed Paraffin-Embedded (FFPE) samples a 
potential candidate where frozen samples are not available (Arreaza et al, 2016; 
Roberts et al, 2019).  
FFPE samples are routinely collected, processed, stored and archived for the 
preservation of clinical specimens. They are highly beneficial in tissue comparison 
research, due to structural integrity and morphological retention (Al-Attas et al, 
2016). The procedure consists of collecting the tissue of interest, fixing in neutral 
buffered formalin, dehydrating with ethanol and clearing the sample with xylene 
before embedding in paraffin wax (Nagahashi et al, 2017). The use of formalin 
creates crosslinkage between molecules to stabilise protein composition (Berg et al, 
2011). Dehydration then displaces water in the sample and replaces this with 
paraffin wax to preserve tissue structure (Belloni et al, 2013; Pikor et al, 2011). Initial 
analysis routinely includes sectioning the wax block and staining with haematoxylin 
and eosin (H&E) for microscopic analysis of internal structures (Stout et al, 2013). 
 
4.1.1 Application of FFPE samples 
FFPE sample processing is beneficial for immunohistochemistry and pathological 
diagnosis. Fixing tissues preserves the structural characteristics of the membranes, 
for long term storage at room temperature (RT), allowing retrospective analysis 
(Dietrich et al, 2013; Nagahashi et al, 2017). FFPE samples are a valuable resource 
when there is a shortage of biological samples, or biobank storage limitations 
(Janecka, Adamczyk and Gasinska, 2015). However, the beneficial application to 
microbiota research is yet to be confirmed.  
Utilising one tissue type for both pathological diagnosis and microbiota research 
would be preferable to avoid duplication, plus reduce processing requirements and 
storage costs (Linder et al, 2018). With the ability to then accurately link molecular 
findings to pathological and clinical diagnosis. Thus, utilising remnant FFPE material 
from clinical assessment could be beneficial to advanced clinical research (Wimmer 
et al, 2018). 
FFPE samples have been successfully utilised in sequencing and qPCR research 
applied to heart valve samples (Imrit et al, 2006), plus single nucleotide 
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polymorphism arrays in umbilical cord samples (Ernst et al, 2015). Successful 
application varies by processing and storage duration. The harsh fixative process 
creates a tough physical barrier, as the formalin reacts with amino groups and adds 
a methylol group, which increases crosslinkage between amino acids leading to 
DNA degradation and fragmentation, which may negatively impact downstream 
methodology (Bennike et al, 2016; Huijsmans et al, 2010). Archived ovarian FFPE 
samples display an 89.9% success rate in whole exome sequencing, however, 
fragment size reduced with increasing storage time of 32 years (Carrick et al, 2015). 
Conversely, archived FFPE samples stored for >100 years produced minimal 
difference in DNA damage throughout storage duration when analysed by Illumina 
HiSeq (Ruane and Austin, 2017). Seven years has been suggested as the maximum 
storage duration to ensure optimum results (Nagahashi et al, 2017). Alongside 
storage conditions, different protocols across medical research centres also impacts 
results (Burton et al, 2014). 
 
4.1.2 Placental and fetal membrane FFPE samples 
Placental morphology and characteristics are routinely investigated in a clinical 
setting using FFPE preparations. One application of FFPE fetal membranes is the 
diagnosis of HCA via morphological analysis of maternal inflammatory factors using 
Redline staging and grading criteria (Redline et al, 2003). Following diagnosis, these 
samples are stored but infrequently reused. Recently, IHC has been performed on 
FFPE fetal membranes for microbiological analysis (Kuperman et al, 2020). The 
application of FFPE fetal membranes to HCA microbiota sequencing analysis would 
be beneficial, yet positive usage is yet to be confirmed. 
 
4.1.3 Decontam applied to FFPE samples 
Due to the complex processing steps in FFPE sample preparation, it is important to 
detect external contaminating bacteria during microbiota analysis. Decontam open-
source R package has been created for post-process sequencing analysis (Davis 
et al, 2018). This method uses prevalence or frequency filtering to detect 
contaminating or genuine amplicon sequence variants (ASVs) from sequencing 
outputs (Davis et al, 2018).  
Low abundance and low biomass samples have been criticised for accuracy in 
microbiota research (Laurence, Hatzis and Brash, 2014), including FFPE samples 
(Arreaza et al, 2016), as genuine signals are more susceptible to being concealed 
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by contaminating sequences, thus masking the true microbiota (Glassing et al, 
2016). The use of decontam on low biomass samples has received praise for the 
ability to identify the unique microbiota of the tissue of interest (Callahan et al, 
2016b; Lauder et al, 2016; O’Callaghan et al, 2019; Salter et al, 2014). Decontam 
previously detected <1% bacteria as genuine when applied to healthy term placental 
sequencing research (Davis et al, 2018; Lauder et al, 2016). However, this has not 
yet been investigated in fetal membranes with a negative maternal condition, 
including HCA. 
 
The comparative analysis of FFPE and frozen tissues has been performed 
previously from healthy (Bennike et al, 2016) or cancerous tissues (Coudry et al, 
2007; Mittempergher et al, 2011; Wimmer et al, 2018). But, comparison of DNA 
quality and sequencing output is limited. One study using qPCR analysis highlighted 
high variability in fragmentation and amplification efficiency between FFPE and 
frozen placental tissues, with modified protocols required to achieve successful 
amplification (Dietrich et al, 2013). Alternatively, similar gene expression profiles 
from FFPE and frozen breast tissue have been observed, with the ability to correctly 
identify changes in tumour grades from FFPE samples with comparable accuracy 
to frozen tissues (Mittempergher et al, 2011). 
 
Although project PLACENTA aims to encourage frozen biobanking and develop 
centralised protocols for reproductive tissues (Linder et al, 2018), biobanking 
remains underrepresented due to low funding and increased maintenance (Linder 
et al, 2018). Immediate processing and snap freezing of reproductive samples is not 
always possible in the clinical or home setting (Srinivasan, Sedmak and Jewell, 
2002). Thus, it would be beneficial to utilise the readily available, remnant FFPE 
samples in clinical research. 
 
The aim of chapter four was to compare the microbiota findings from matched paired 
FFPE and frozen patient tissues taken from a clinical setting. This to determine if 
FFPE fetal membrane rolls that are routinely collected and archived are comparable 
to the current gold standard, and could be applied to microbiota research to produce 
high quality DNA and outcomes from sequencing methodology. 
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4.2 Microbiota method recap 
Comparison between tissue preparation methods was performed by combining and 
analysing microbiota data from FFPE and frozen fetal membranes. Only patients 
with both frozen and corresponding FFPE tissue blocks were included for matched 
paired analysis to reduce individual variation and bias (n=21). Individual amnion and 
chorion results from frozen analysis were merged to closer represent the FFPE fetal 
membrane rolls, which combine the amnion and chorion into one tissue segment. 
The frozen sample subset was processed as discussed previously (Chapter two). 
FFPE samples were processed using comparable protocols. However, a different 
DNA extraction methodology (BiOstic FFPE tissue DNA isolation kit, MoBio), and 
one additional method for examining the quality of extracted DNA was applied 
(Bioanalyzer chip-based gel electrophoresis).  
The use of different reagents and manufactured kits may impact microbiota findings 
(Salter et al, 2014), thus respective negative controls taken from the Qiagen kit used 
for frozen (QIAamp Fast DNA Tissue kit; n=9) or MoBio kit used for FFPE sample 
DNA extraction (BiOstic FFPE tissue DNA isolation kit; n=18) were compared. For 
the FFPE subset, additional controls were taken from the surrounding embedded 
wax adjacent to the tissue to identify the microbiota of infiltrating wax.  
 
Sequencing was performed using MiSeq (Illumina) wet lab SOP, with the universal 
16S rRNA gene primer specific to the V4 region (Callahan et al, 2016a; Callahan et 
al, 2016b; Kozich et al, 2013) by Northumbria University (Newcastle) as described 
in chapter two. Pre and post-processing data analysis were also comparable to the 
previous chapter, with FastQ files trimmed, filtered and processed through DADA2 
1.4 (Callahan et al, 2016b), Bioconductor (Version 2; Callahan et al, 2016a), 
Phyloseq (McMurdie and Holmes, 2013) pipelines and packages in R (R Core 
Team, 2017), and Microbiome Analyst (Dhariwal et al, 2017) under the same criteria 
and thresholds as previously. Decontam was also integrated into FFPE sample 
analysis (Davis et al, 2018). 
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4.3 Results 
4.3.1 Matched paired patient demographics 
Patient demographics (n=21) are listed in Table 4.1, with those available from the 
preterm and HCA subsets only listed in Table 4.2. 
 
 Patients (n=21) 
Condition                      HCA 9.0 (42.8) 
                                      PTB 6.0 (28.6) 
                                     Term 6.0 (28.6) 
Gestational age (mean (SD)) 33.3 (5.2) 
Birthweight (mean (SD)) 2097.1 (861.3) 
Maternal age (mean (SD)) 28.3 (6.4) 
Maternal BMI (mean (SD)) 23.4 (4.1) 
Smoker                          Yes 5.0 (23.8) 
                                       No 14.0 (66.7) 
                                       NA 2.0 (9.5) 
Parity (mean (SD)) 1.2 (1.6) 
Fetal sex                      Male 9.0 (42.9) 
                                Female 12.0 (57.1) 
Apgar (mean (SD)) 7.6 (2.2) 
 
Table 4.1 Matched paired patient demographics. Patient characteristic data from all 
patients providing fetal membrane samples for the study, assessed from matched paired 
Formalin-Fixed Paraffin-Embedded (FFPE) and frozen fetal membranes. Unless stated 
data is displayed as n (%).  
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HCA and PTB only 
(n=15) 
Mode of delivery                            Vaginal                                                       11.0 (73.3) 
                                     Caesarean section 4.0 (26.7) 
Type of labour                      Spontaneous 5.0 (33.3) 
                                                     PPROM 9.0 (60.0) 
                                                             NA 1.0 (6.7) 
Days to birth (following PPROM) (mean 
(SD)) 
4.4 (3.3) 
Antibiotics                                           Yes 8.0 (53.3) 
                                                             No 6.0 (40.0) 
                                                             NA 1.0 (6.7) 
Antenatal corticosteroids                     Yes 13.0 (86.7) 
                                                             No 2.0 (13.3) 
Maternal inflammatory stage (mean (SD)) 1.8 (0.7) 
Maternal inflammatory grade (mean (SD)) 1.4 (0.5) 
Number of clinical CA signs (mean (SD)) 1.1 (1.0) 
C-reactive protein (mean (SD)) 38.6 (53.4) 
White blood cell count (mean (SD)) 17.6 (7.1) 
Previous PTB                                     Yes 5.0 (33.3) 
                                                            No 10.0 (66.7) 
Previous early PTB                            Yes 2.0 (13.3) 
                                                            No 13.0 (86.7) 
 
 
Table 4.2 Matched paired patient demographics from HCA and PTB only. Patient 
characteristic data from all preterm patients providing fetal membrane samples for the 
study, with matched paired Formalin-Fixed Paraffin-Embedded (FFPE) and frozen fetal 
membranes only available from histological chorioamnionitis (HCA) and preterm birth (PTB) 
patients. Unless stated data is displayed as n (%). 
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4.3.2 Results of matched paired fetal membranes 
4.3.2.1 Sequencing read counts from matched paired patients 
Read counts were detected within all FFPE fetal membrane samples (3178 
individual ASVs), similar to that from frozen samples (3758 ASVs).  
 
4.3.2.2 Relative and percentage abundance of matched paired patients 
Escherichia/Shigella was detected as the most prominent genus, contributing 38% 
to FFPE and 29% to frozen samples (Figure 4.1). Ureaplasma (29%) and Prevotella 
(20%) were also highly abundant genera in frozen tissue preparation, compared to 
<1% and 6% in FFPE tissues, respectively. In FFPE tissues, Pasteurella (5%), 
Bacillus (4%) and Pseudomonas (3%) were all greater compared to frozen samples, 
where these all contributed <1% to relative abundance. 
 
Univariate analysis highlighted 30 genera significantly different between FFPE and 
frozen samples (Table 4.3). The majority of these (28/30) were significantly higher 
in FFPE samples, including Escherichia/Shigella (p=<0.001, FDR=<0.001). 
Pasteurella was also greater in FFPE samples, due to no detection in frozen tissues 
(p=<0.001, FDR=<0.001). Only two genera were significantly greater in frozen 
samples, these were Flavobacterium (p=<0.001, FDR=<0.001) and Collinsella 
(p=0.008, FDR=0.014).  
 
At the ASV level, 61 ASVs were significantly different across sample preparation 
type (Table 4.4). This included three ASVs from Escherichia/Shigella, three 
Prevotella, and one Pasteurella, Flavobacterium and Collinsella. The majority of 
ASVs were of significantly greater abundance in FFPE tissues (56/61), including 
one ASV assigned to Prevotella and Pasteurella, plus a Micrococcus, only detected 
in FFPE samples. Those significantly greater in frozen samples were two ASVs 
assigned to Faecalibacterium, plus one Prevotella, Collinsella, and a 
Flavobacterium, which was only detected in frozen samples. 
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Figure 4.1 Relative abundance of matched paired fetal membranes. Relative 
abundance plots from V4 16S rRNA amplicon sequencing of extracted DNA from matched 
paired fetal membrane samples divided by tissue preparation type of Formalin-Fixed 
Paraffin-Embedded (FFPE) or frozen tissue samples. ASVs were clustered into genera for 
visual analysis plots created in ggplot2 (R Core Team, 2017).  
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 Genus p.value FDR 
1 Escherichia/Shigella <0.001 <0.001 
2 Bacillus <0.001 <0.001 
3 Pseudomonas <0.001 <0.001 
4 Pasteurella <0.001 <0.001 
5 Micrococcus <0.001 <0.001 
6 Enhydrobacter <0.001 <0.001 
7 Flavobacterium <0.001 <0.001 
8 Acinetobacter <0.001 <0.001 
9 Fusobacterium <0.001 <0.001 
10 Bifidobacterium <0.001 <0.001 
11 Blautia <0.001 <0.001 
12 Veillonella <0.001 <0.001 
13 Streptococcus <0.001 <0.001 
14 Methylobacterium <0.001 0.001 
15 Corynebacterium <0.001 0.001 
16 Alistipes <0.001 0.001 
17 Staphylococcus 0.001 0.001 
18 Enterobacter 0.001 0.002 
19 Bacteroides 0.001 0.002 
20 Dietzia 0.001 0.002 
21 Coprococcus 0.004 0.007 
22 Haemophilus 0.004 0.008 
23 Dorea 0.004 0.008 
24 Parabacteroides 0.004 0.008 
25 Roseburia 0.007 0.011 
26 Collinsella 0.008 0.014 
27 Ruminococcus 0.017 0.027 
28 Faecalibacterium 0.019 0.029 
29 Phascolarctobacterium 0.021 0.031 
30 Cloacibacterium 0.033 0.047 
Table 4.3 Univariate analysis of matched paired fetal membranes by genera. 
Comparison of Formalin-Fixed Paraffin-Embedded (FFPE) and frozen fetal membranes by 
univariate nonparametric Kruskal-Wallis analysis and controlled for false discovery rates 
(FDR) to a threshold of p=≤0.05. Bacteria in bold were significantly greater in frozen 
samples, with the remaining greater in FFPE samples. 
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 ASV Genus p.value FDR 
1 C3 Bacillus <0.001 <0.001 
2 C1 Escherichia/Shigella <0.001 <0.001 
3 C31 Pseudomonas <0.001 <0.001 
4 C9 Pasteurella <0.001 <0.001 
5 C231 Escherichia/Shigella <0.001 <0.001 
6 C503 Escherichia/Shigella <0.001 <0.001 
7 C64 Enhydrobacter <0.001 <0.001 
8 C54 Acinetobacter <0.001 <0.001 
9 C361 Flavobacterium <0.001 <0.001 
10 C244 Pseudomonas <0.001 <0.001 
11 C35 Blautia <0.001 <0.001 
12 C181 Micrococcus <0.001 <0.001 
13 C76 Acinetobacter <0.001 <0.001 
14 C39 Fusobacterium <0.001 <0.001 
15 C49 Acinetobacter <0.001 <0.001 
16 C51 Streptococcus <0.001 <0.001 
17 C8 Streptococcus <0.001 <0.001 
18 C83 Pseudomonas <0.001 <0.001 
19 C114 Faecalibacterium <0.001 <0.001 
20 C556 Micrococcus <0.001 <0.001 
21 C129 Methylobacterium <0.001 <0.001 
22 C146 Streptophyta* <0.001 <0.001 
23 C10 Pseudomonas <0.001 0.001 
24 C13 Faecalibacterium <0.001 0.001 
25 C304 Corynebacterium <0.001 0.001 
26 C5 Staphylococcus 0.001 0.002 
27 C109 Enterobacter 0.001 0.003 
28 C32 Acinetobacter 0.001 0.003 
29 C20 Blautia 0.001 0.003 
30 C68 Streptococcus 0.001 0.003 
31 C150 Dietzia 0.001 0.003 
32 C60 Faecalibacterium 0.001 0.003 
33 C174 Veillonella 0.001 0.003 
34 C44 Bifidobacterium 0.002 0.004 
35 C184 Methylobacterium 0.002 0.005 
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36 C11 Bifidobacterium 0.002 0.005 
37 C75 Veillonella 0.002 0.006 
38 C12 Bacteroides 0.003 0.006 
39 C86 Blautia 0.003 0.006 
40 C74 Faecalibacterium 0.003 0.007 
41 C59 Alistipes 0.004 0.008 
42 C21 Bacteroides 0.004 0.009 
43 C79 Haemophilus 0.004 0.009 
44 C34 Dorea 0.004 0.009 
45 C80 Parabacteroides 0.004 0.009 
46 C17 Roseburia 0.005 0.010 
47 C19 Coprococcus 0.005 0.011 
48 C155 Corynebacterium 0.006 0.012 
49 C7 Faecalibacterium 0.006 0.013 
50 C71 Lachnospiraceae* 0.007 0.014 
51 C30 Prevotella 0.008 0.015 
52 C139 Acinetobacter 0.008 0.015 
53 C36 Collinsella 0.008 0.015 
54 C56 Alistipes 0.013 0.024 
55 C69 Bacteroides 0.016 0.028 
56 C37 Ruminococcus 0.017 0.029 
57 C58 Faecalibacterium 0.019 0.031 
58 C22 Prevotella 0.019 0.031 
59 C27 Phascolarctobacterium 0.021 0.034 
60 C16 Prevotella 0.025 0.040 
61 C105 Bifidobacterium 0.030 0.047 
 
Table 4.4 Univariate analysis of matched paired fetal membranes by ASV. Comparison 
of Formalin-Fixed Paraffin-Embedded (FFPE) and frozen fetal membranes by 
nonparametric univariate Kruskal-Wallis analysis and controlled for false discovery rates 
(FDR) to a threshold of p=≤0.05. Amplicon sequence variants (ASVs) highlighted in bold 
were significantly greater in frozen samples, remaining ASVs were all significantly greater 
in FFPE tissue preparations. Bacteria are displayed by cluster number (C), ASV and 
genera, when genus was not assigned, the next highest order was used (*). 
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4.3.2.3 Bacterial diversity structure of matched paired patients 
There was greater alpha diversity from FFPE (2.680) compared to frozen tissue 
preparation (2.253), yet not significant (p=0.232; Figure 4.2A).  
Beta diversity highlighted significance between FFPE and frozen tissues (R2=0.208, 
p=<0.001). Distinct clusters were detected for each preparation type, with FFPE 
samples clustering at a closer distance and frozen with greater beta diversity 
distances (Figure. 4.2B). 
 
 
 
Figure 4.2 Diversity analysis of matched paired fetal membranes. Alpha and beta 
diversity analysis of ASV data from V4 15S RRNA amplicon sequencing from matched 
paired fetal membrane samples. Samples were divided into groups of Formalin-Fixed 
Paraffin-Embedded (FFPE) or frozen sample preparation for Shannon alpha diversity (A), 
or GUniFrac PERMANOVA beta diversity analysis (B). Significance was analysed via 
nonparametric Kruskal-Wallis and nonparametric Pairwise Wilcoxon Rank-Sum to a 
threshold of p=≤0.05. 
92 
 
4.3.3 Quantification of extracted DNA from matched paired patients 
Due to differences detected in the microbiota between FFPE and frozen fetal 
membranes, further investigation was conducted to explore the reason behind this, 
including DNA quantity and quality analysis, plus the impact of different DNA 
extraction reagents and manufacturers. 
 
4.3.3.1 NanoDrop spectrophotometer results from matched paired patients 
Frozen tissues yielded a significantly higher mean quantity of extracted DNA than 
FFPE samples (270.5 ng/µl vs 47.6 ng/µl, p=<0.001). With this ranging from 79.5-
1375.1 ng/µl in frozen, and 12.6-131.6 ng/µl in FFPE samples. Purity levels were 
optimum and comparable across preparation types (1.8 vs 1.8, p=0.940).  
 
4.3.3.2 Agarose gel electrophoresis results from matched paired patients 
High molecular weight DNA was extracted from frozen fetal membrane samples, 
with clear comparable molecular weight banding at >10,037 bp from all samples 
tested (Figure 4.3A). In comparison to highly fragmented, low quality and quantity 
DNA from FFPE samples, with faint banding detected at 200-400 bp (Figure 4.3B).  
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Figure 4.3 Agarose gel electrophoresis from matched paired fetal membranes. 
Agarose gel electrophoresis image of a subset of DNA extracts from fetal membranes 
(n=12; histological chorioamnionitis=7, preterm=4, Term=1) from either frozen membrane 
samples (A), or Formalin-Fixed Paraffin-Embedded (FFPE) samples (B) performed via 
agarose gel electrophoresis and imaged via GBox SynGene Chemi-XX6. Lane one and 
lane 14 represent 1KB reference HyperLadder.  
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4.3.4 FFPE sample comparison to negative controls 
4.3.4.1 Sequencing read counts from FFPE samples and negative controls 
The FFPE tissue sample microbiota was compared to negative controls of sections 
of surrounding paraffin wax and DNA extraction kit reagents. Wax negatives 
displayed the greatest average read counts (21,314.6), followed by samples 
(11,863.2), with the lowest from kit negative controls (4510.7).  
 
A significantly greater quantity of DNA was extracted from samples (47.6 ng/µl), 
followed by wax controls (5.9 ng/µl), and the lowest from kit negative controls (2.4 
ng/µl, p=<0.001). Specifically, DNA yields were significantly greater from FFPE 
samples compared to kit negative (p=<0.001) and wax controls independently 
(p=<0.001), yet wax and kit reagent negative controls were not significantly different 
(p=1.000). 
 
4.3.4.2 Relative and percentage abundance from FFPE samples and negative 
controls 
Escherichia/Shigella was the most abundant genera in samples and controls, 
greatest from kit negatives (68%), followed by samples (46%) and wax controls 
(31%; Figure 4.4). Prevotella was the second most abundant genera in wax controls 
(20%), but this decreased in both samples and kit negatives (<1%).  
At the genera level, 32 genera were significantly different between samples and 
controls (Table 4.5). From this, 14 were significantly greater in samples, 14 
significantly greater in wax controls, and four significantly greater in kit negative 
controls. Escherichia/Shigella was significantly greater from kit controls (p=0.002, 
FDR=0.004), with Prevotella significantly greater in wax controls (p=0.004, 
FDR=0.006). Enterobacter (p=<0.001, FDR=<0.001) and Veillonella (p=<0.001, 
FDR=0.002) were both significantly greater in samples compared to controls, with 
neither detected from kit negative controls. 
 
Within samples, 3178 individual ASVs were detected, with 1682 from wax controls 
and 452 from kit negative controls. At the ASV level, 56 sequences were significantly 
different between samples and controls (Table 4.6). This including three ASVs 
assigned to Escherichia/Shigella and three assigned to Prevotella, plus one ASV 
assigned to Enterobacter and Veillonella.  
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Figure 4.4 Relative abundance of FFPE membrane rolls and negative controls. 
Relative abundance plots from V4 16S rRNA amplicon sequencing of extracted DNA from 
Formalin-Fixed Paraffin-Embedded (FFPE) tissue (samples), corresponding wax control 
and kit negative control, to investigate the bacterial contribution from surrounding wax and 
DNA extraction kit negatives. ASVs were clustered into genera for visual analysis relative 
abundance plots created in ggplot2 (R Core Team, 2017).  
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 Genus p.value FDR Greater in  
1 Micrococcus <0.001 <0.001 Sample 
2 Enterobacter <0.001 <0.001 Sample 
3 Lactobacillus <0.001 <0.001 Sample 
4 Enhydrobacter <0.001 <0.001 Sample 
5 Blautia <0.001 <0.001 Wax 
6 Corynebacterium <0.001 <0.001 Sample 
7 Staphylococcus <0.001 <0.001 Sample 
8 Veillonella <0.001 0.002 Sample 
9 Bacteroides <0.001 0.002 Wax 
10 Dorea <0.001 0.002 Wax 
11 Streptococcus <0.001 0.002 Wax 
12 Pseudomonas <0.001 0.002 Sample 
13 Ruminococcus <0.001 0.002 Wax 
14 Roseburia 0.001 0.002 Wax 
15 Acinetobacter 0.001 0.002 Sample 
16 Bacillus 0.001 0.003 Kit 
17 Coprococcus 0.002 0.004 Wax 
18 Escherichia/Shigella 0.002 0.004 Kit 
19 Fusobacterium 0.003 0.005 Sample 
20 Prevotella 0.004 0.006 Wax 
21 Dietzia 0.004 0.006 Sample 
22 Alistipes 0.006 0.008 Wax 
23 Collinsella 0.007 0.009 Wax 
24 Pasteurella 0.009 0.011 Sample 
25 Faecalibacterium 0.009 0.011 Wax 
26 Cloacibacterium 0.009 0.011 Sample 
27 Rhodococcus 0.010 0.011 Sample 
28 Anaerostipes 0.012 0.013 Wax 
29 Methylobacterium 0.023 0.026 Kit 
30 Gemmiger 0.027 0.028 Wax 
31 Haemophilus 0.042 0.044 Wax 
32 Bifidobacterium 0.050 0.050 Kit 
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Table 4.5 Univariate analysis of FFPE samples compared to negative controls by 
genera. Comparison of Formalin-Fixed Paraffin-Embedded (FFPE) fetal membrane 
samples with negative controls from DNA extraction kit reagents and surrounding wax block 
controls. Univariate analysis was performed by nonparametric Kruskal-Wallis and controlled 
for false discovery rate (FDR) to a threshold of p=≤0.05. 
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  ASV Genus p.value FDR 
1 C181 Micrococcus <0.001 <0.001 
2 C109 Enterobacter <0.001 <0.001 
3 C51 Streptococcus <0.001 <0.001 
4 C304 Corynebacterium <0.001 <0.001 
5 C244 Pseudomonas <0.001 <0.001 
6 C83 Pseudomonas <0.001 <0.001 
7 C64 Enhydrobacter <0.001 <0.001 
8 C25 Lactobacillus <0.001 <0.001 
9 C40 Lactobacillus <0.001 <0.001 
10 C146 Streptophyta* <0.001 <0.001 
11 C35 Blautia <0.001 <0.001 
12 C76 Acinetobacter <0.001 <0.001 
13 C2 Prevotella <0.001 <0.001 
14 C54 Acinetobacter <0.001 <0.001 
15 C150 Dietzia <0.001 <0.001 
16 C21 Bacteroides <0.001 <0.001 
17 C5 Staphylococcus <0.001 <0.001 
18 C13 Faecalibacterium <0.001 <0.001 
19 C49 Acinetobacter <0.001 0.001 
20 C20 Blautia <0.001 0.001 
21 C503 Escherichia/Shigella <0.001 0.001 
22 C75 Veillonella <0.001 0.001 
23 C34 Dorea <0.001 0.001 
24 C7 Faecalibacterium <0.001 0.002 
25 C231 Escherichia/Shigella 0.001 0.002 
26 C37 Ruminococcus 0.001 0.002 
27 C139 Acinetobacter 0.001 0.002 
28 C17 Roseburia 0.001 0.002 
29 C3 Bacillus 0.001 0.003 
30 C31 Roseburia 0.002 0.003 
31 C58 Faecalibacterium 0.002 0.003 
32 C11 Bifidobacterium 0.002 0.004 
33 C12 Bacteroides 0.002 0.004 
34 C129 Methylobacterium 0.002 0.004 
35 C19 Coprococcus 0.002 0.004 
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36 C1 Escherichia/Shigella 0.003 0.004 
37 C4 Prevotella 0.003 0.004 
38 C30 Prevotella 0.003 0.004 
39 C155 Corynebacterium 0.003 0.004 
40 C10 Pseudomonas 0.003 0.004 
41 C39 Fusobacterium 0.003 0.005 
42 C68 Streptococcus 0.003 0.005 
43 C32 Acinetobacter 0.003 0.005 
44 C59 Alistipes 0.006 0.008 
45 C36 Collinsella 0.007 0.009 
46 C8 Streptococcus 0.007 0.009 
47 C9 Pasteurella 0.009 0.011 
48 C201 Cloacibacterium 0.009 0.011 
49 C209 Rhodococcus 0.010 0.012 
50 C84 Lachnospiraceae* 0.010 0.012 
51 C105 Bifidobacterium 0.011 0.012 
52 C41 Anaerostipes 0.012 0.013 
53 C26 Gemmiger 0.027 0.030 
54 C47 Lachnospiraceae* 0.027 0.030 
55 C74 Faecalibacterium 0.036 0.040 
56 C79 Haemophilus 0.042 0.045 
 
Table 4.6 Univariate analysis of FFPE samples compared to negative controls by 
ASV. Comparison of Formalin-Fixed Paraffin-Embedded (FFPE) fetal membrane samples 
with negative controls from DNA extraction kit reagents and surrounding wax block controls. 
Displayed as amplicon sequence variant (ASV) cluster number (C) and genus. Univariate 
analysis was performed by nonparametric Kruskal-Wallis and controlled for false discovery 
rate (FDR) to a threshold of p=≤0.05. 
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4.3.4.3 Bacterial diversity structure from FFPE samples and negative controls 
There were significant differences in alpha diversity between FFPE samples, kit 
negative and wax controls (p=<0.001; Figure 4.5A). Samples displayed the greatest 
alpha diversity score (2.107), significantly greater than wax controls (1.636, 
p=0.030) and kit negative controls, independently (1.221, p=<0.001). A trend for 
higher alpha diversity in wax controls compared to kit negative controls was present, 
but not significant (p=0.051). 
 
A significant difference in beta diversity between samples, wax and kit negative 
controls was present, with a distinct cluster for samples yet controls displaying 
greater beta diversity distance (R2=0.210, p=<0.001 Figure 4.5B). 
 
Figure 4.5 Diversity analysis of FFPE tissues and negative controls. Alpha and beta 
diversity analysis of ASV data from V4 16S rRNA amplicon sequencing from Formalin-Fixed 
Paraffin-Embedded (FFPE) fetal membrane rolls and negative controls of corresponding 
wax and kit reagent negative controls. Presented by alpha diversity (A) and beta diversity 
(B). Significance was analysed via nonparametric Kruskal-Wallis and nonparametric 
Pairwise Wilcoxon Rank-Sum to a threshold of p=≤0.05. 
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4.3.5 DNA extraction kit comparison 
4.3.5.1 NanoDrop spectrophotometer results from kit comparison 
MoBio FFPE kit yielded a significantly greater quantity of detected DNA within blank 
reagent controls (2.4 ng/µl) compared to Qiagen negative controls (frozen kit; 0.9 
ng/µl, p=0.014).  
 
4.3.5.2 Relative and percentage abundance from kit comparison 
Different contributing genera were detected from DNA extraction kit manufacturers. 
Escherichia/Shigella was the most abundant genus in MoBio, contributing 66% to 
overall genera, with this the second most prominent in Qiagen (12%; Figure 4.6). 
Bacteroides were the greatest contributor to Qiagen negative controls (17%) with 
this reduced in MoBio reagents (<1%). Prevotella was of greater relative abundance 
from Qiagen (10%) compared to MoBio (1%). 
 
Univariate analysis highlighted six genera as significantly different between MoBio 
and Qiagen kit negative controls. Of which, 5/6 were in greater abundance within 
the Qiagen frozen kit controls, including; Enterococcus, (p=0.002, FDR=0.040), 
Chryseobacterium (p=0.005, FDR=0.040), Lactobacillus (p=0.005, FDR=0.040), 
Sphingomonas (p=0.007, FDR=0.040) and Prevotella (p=0.008, FDR=0.040). 
Bacillus was the one genus significantly greater in MoBio FFPE kit, as this was not 
detected in Qiagen frozen kit controls (p=0.008, FDR=0.040).  
 
At the ASV level, 21 ASVs were significantly different between DNA extraction kits, 
the majority of which were greater in Qiagen frozen kit controls (Table 4.7), including 
three ASVs for Prevotella, plus one Enterococcus, Lactobacillus, Sphingomonas 
and Chryseobacterium. One ASV (Bacillus) was significantly greater in MoBio FFPE 
controls and was not detected in Qiagen kit controls (Table 4.7). 
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Figure 4.6 Relative abundance of DNA extraction kit controls. Relative abundance plots 
from V4 16S rRNA amplicon sequencing of extracted DNA from kit negative controls from 
MoBio (FFPE) and Qiagen (Frozen) DNA extraction kit reagents, to investigate the bacterial 
contribution from different commercial manufacturers. ASVs were clustered into genera for 
visual analysis of relative abundance created by ggplot2 (R Core Team, 2017).  
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 ASV Genus p.value FDR 
1 C6 Prevotella <0.001 0.013 
2 C62 Bacteroides 0.001 0.013 
3 C60 Faecalibacterium 0.001 0.013 
4 C180 Lactobacillus 0.001 0.013 
5 C114 Faecalibacterium 0.002 0.013 
6 C28 Enterococcus 0.002 0.013 
7 C990 Blautia 0.002 0.013 
8 C376 Alistipes 0.004 0.023 
9 C283 Bifidobacterium 0.005 0.023 
10 C4 Prevotella 0.005 0.023 
11 C2002 Chryseobacterium 0.005 0.023 
12 C1343 Faecalibacterium 0.005 0.023 
13 C2598 Sphingomonas 0.007 0.028 
14 C688 Pseudomonas 0.007 0.029 
15 C3 Bacillus 0.008 0.030 
16 C21 Bacteroides 0.011 0.035 
17 C73 Bacteroides 0.012 0.039 
18 C13 Faecalibacterium 0.013 0.039 
19 C18 Salmonella 0.014 0.039 
20 C110 Roseburia 0.014 0.039 
21 C2 Prevotella 0.015 0.039 
 
Table 4.7 Univariate analysis of DNA extraction kit controls by ASV. Comparison of 
MoBio Formalin-Fixed Paraffin-Embedded (FFPE) and Qiagen frozen kit negative controls 
by univariate nonparametric Kruskal-Wallis analysis and controlled for false discovery rates 
(FDR) to a threshold of p=≤0.05. Results displayed by cluster number (C) and genus. 
Amplicon sequence variants (ASVs) highlighted in bold were significantly greater in MoBio 
FFPE, with the remaining significantly greater in Qiagen frozen kit controls. 
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4.3.5.3 Bacterial diversity structure from kit comparison 
When comparing kit negative controls only the Qiagen kit for frozen tissue DNA 
extraction displayed significantly higher alpha diversity compared to MoBio kit 
negative controls (2.778 vs 1.687, p=0.014; Figure 4.7A).  
Significant differences in beta diversity were detected between negative controls 
from MoBio and Qiagen kits, with greater beta diversity distances from MoBio kit 
controls (R2=1.357, p=0.012; Figure 4.7B). 
 
 
Figure 4.7 Diversity analysis of DNA extraction kit controls. Alpha and beta diversity 
analysis of ASV data from V4 16S rRNA amplicon sequencing from negative controls only 
from extraction kit reagents segmented into MoBio (Formalin-Fixed Paraffin-Embedded kit; 
FFPE) or Qiagen (Frozen kit) for Shannon alpha diversity (A) or GUniFrac PERMANOVA 
beta diversity analysis (B). Significance was analysed via nonparametric Kruskal-Wallis and 
nonparametric Pairwise Wilcoxon Rank-Sum to a threshold of p=≤0.05. 
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4.3.6 Decontam results from FFPE samples 
Decontam prevalence filtering was applied to ASVs from FFPE samples and DNA 
extraction kit negative controls to detect contaminating sequences arising from 
processing. 
 
Decontam output determined that 52% of ASVs generated in DADA2 were 
contaminants (FALSE=1690), whereas 48% were genuine signals (TRUE=1560). 
From the 1560 genuine ASVs, 318 were significantly different between FFPE 
samples and negative controls. The most prevalent genuine ASVs can be found in 
Table 4.8. None of the bacteria categorised as contaminants were significantly 
different between samples and negative controls, with a subset of contaminants 
displayed in Table 4.9.  
 
The most prevalent ASV detected in both samples and controls was assigned to the 
Escherichia/Shigella genus, which was detected as a genuine signal, and not 
significantly different between samples and negative controls (p=0.205; Table 4.8). 
Out of six ASVs assigned to Escherichia/Shigella, five were identified as genuine 
bacteria including the most prevalent, with one low abundant ASV detected as a 
contaminant. 
For Prevotella, 34 ASVs were identified as genuine and 25 as contaminating 
sequences. The genuine bacteria included four common ASVs detected in previous 
HCA analysis. 
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 ASV Genus Prevalence p.value Not. Contaminant 
1 C1 Escherichia/Shigella 43 0.205 TRUE 
2 C10 Pseudomonas 30 <0.001 TRUE 
3 C11 Bifidobacterium 25 <0.001 TRUE 
4 C2 Prevotella 24 <0.001 TRUE 
5 C3498 Unclassified bacteria* 22 0.030 TRUE 
6 C12 Bacteroides 22 0.003 TRUE 
7 C109 Enterobacter 19 <0.001 TRUE 
8 C4 Prevotella 19 0.002 TRUE 
9 C3 Bacillus 18 <0.001 TRUE 
10 C15 Bacillus 18 0.017 TRUE 
11 C8 Streptococcus 17 <0.001 TRUE 
12 C105 Bifidobacterium 15 0.009 TRUE 
13 C5 Staphylococcus 13 <0.001 TRUE 
14 C7 Faecalibacterium 12 <0.001 TRUE 
15 C113 Roseburia 12 0.026 TRUE 
16 C101 Bacteroides 11 <0.001 TRUE 
17 C1059 Prevotella 11 0.007 TRUE 
18 C503 Escherichia/Shigella 10 <0.001 TRUE 
19 C40 Lactobacillus 10 <0.001 TRUE 
20 C117 Anaerostipes 10 0.001 TRUE 
 
Table 4.8 Genuine bacterial sequences in FFPE samples identified by decontam. Top 
twenty amplicon sequence variants (ASVs) and genera detected as genuine non-
contaminating sequences in decontam when comparing Formalin-Fixed Paraffin-
Embedded (FFPE) samples to negative controls. Bacteria displayed as cluster number (C) 
and genera, ranked by prevalence. If genus was not classified the next highest order is 
displayed (*). 
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 ASV Genus Prevalence p.value Not. Contaminant 
1 C2809 Acetobacteraceae* 11 0.591 FALSE 
2 C827 Clostridia* 10 0.591 FALSE 
3 C2745 Prevotella 7 0.591 FALSE 
4 C629 Unclassified bacteria* 7 0.591 FALSE 
5 C1989 Facklamia 4 0.591 FALSE 
6 C1303 Bacteroides 3 0.591 FALSE 
7 C2481 Leuconostoc 3 0.591 FALSE 
8 C3668 Deinococcus 3 0.591 FALSE 
9 C4468 Actinomycetales* 3 0.591 FALSE 
10 C1027 Blautia 2 0.591 FALSE 
11 C1040 Gammaproteobacteria* 2 0.919 FALSE 
12 C1097 Fusobacterium 2 0.591 FALSE 
13 C1144 Clostridiales* 2 0.591 FALSE 
14 C1177 Roseburia 2 0.591 FALSE 
15 C1189 Pasteurella 2 0.591 FALSE 
16 C1455 Cytophaga 2 0.591 FALSE 
17 C1757 Streptomycetaceae 2 0.591 FALSE 
18 C1760 Ruminococcaceae* 2 0.591 FALSE 
19 C2113 Mannheimia 2 0.591 FALSE 
20 C2132 Pseudomonas 2 0.591 FALSE 
 
Table 4.9 Contaminating bacterial sequences in FFPE samples identified by 
decontam. Top twenty amplicon sequence variants (ASVs) and genera detected as 
contaminating bacteria in decontam from Formalin-Fixed Paraffin-Embedded (FFPE) 
samples compared to negative controls. Bacteria displayed as cluster number (C) and 
genera, ranked by prevalence. If genus was not classified the next highest order is displayed 
(*). 
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4.4 Discussion 
Frozen sample preparation is the current gold standard for microbiota research 
(Dietrich et al, 2013; Roberts et al, 2019). However, FFPE samples are routinely 
collected, processed and stored, for structural preservation with minimal impact on 
integrity (Ruane and Austin, 2017). If FFPE samples are comparable to frozen 
tissues, the use of FFPE samples in microbiota research would be possible, which 
would benefit multiple pathological investigations, including maternal and fetal 
research. Furthermore, use of FFPE tissues would prevent limitations associated 
with frozen tissue storage and biobanking, such as space restrictions and funding 
(Dietrich et al, 2013; Linder et al, 2018). 
The comparison of clinical FFPE and frozen fetal membrane sequencing outcomes 
have not yet been presented in the literature, with most comparison studies 
focussing on high biomass samples, or artificial scenarios (Bennike et al, 2016; 
Coudry et al, 2007; Mittempergher et al, 2011; Wimmer et al, 2018). Thus, the aim 
of this chapter was to compare the DNA quality and bacterial profiles of matched 
paired FFPE and frozen fetal membrane samples to determine if FFPE membranes 
can be beneficially used in microbiota research.  
 
Overall, this chapter highlights a difference in bacterial profiles between freezing 
and fixing identical patient tissues. Decreased DNA quality and quantity were 
observed from FFPE frozen fetal membrane tissues. Furthermore, over half of 
bacteria detected in FFPE fetal membrane rolls were classified as contaminants 
when compared to negative controls using the post-processing decontam package. 
It was observed that 32 specific genera were significantly different between FFPE 
samples and DNA extraction kit negative controls. After applying decontam, 318 
ASVs identified as genuine were significantly different between samples and 
negative controls, yet bacteria assigned as contaminants did not significantly differ. 
Overall, this suggests that FFPE samples are not suitable to replace frozen tissues 
in fetal membrane microbiota research.  
 
4.4.1 FFPE samples have diminished DNA quantity and quality compared to 
frozen tissues, which may decrease the success of downstream methodologies. 
The quality of DNA extracted from FFPE samples was suboptimum, with 
fragmentation detected at 200-400 bp. Fragmentation of FFPE samples was 
previously detected in placental tissues, with 500 bp from FFPE and 5 kb from frozen 
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samples (Dietrich et al, 2013), FFPE prostate samples also displayed heavily 
fragmented DNA at 102, 165, 225 and 300 bp (Patel et al, 2017). Fragmentation 
occurs due to crosslinkage, which increases DNA sensitivity to mechanical stress 
and decreases enzyme accessibility. These factors reduce the impact of extraction 
methods and result in short target fragments (Dietrich et al, 2013). Fragmentation 
of DNA has been linked to processing and storage duration (Ruane and Austin, 
2017). Samples used in this study were stored for a maximum of three years, within 
the seven years the limit for optimum results (Nagahashi et al, 2017). Age related 
pH changes may cause oxidation of formalin to formic acid causing further DNA 
fragmentation and degradation (Imrit et al, 2006; Patel et al, 2017). But high quality 
DNA has been extracted from >100year archived specimens (Ruane and Austin, 
2017). Immediate analysis of samples would have shown the initial fragmentation 
and degradation status, with reanalysis in a longitudinal study showing of the impact 
of storage time on FFPE fetal membranes. Current commercial DNA extraction kits 
aim to limit the issues of crosslinkage by modified methodology (Senguven et al, 
2014). However, full eradication of pre-processing fixative effects is difficult. 
Selecting appropriate measures to monitor the DNA quality and quantity is 
important, with the combination of multiple methods increasing accuracy.  
The short fragment lengths of ~200 bp created by formalin crosslinkage may restrict 
target primer size in qPCR and sequencing methods (Oh et al, 2015; Spencer et al, 
2013). Thus, modification of protocols may be required to enhance the beneficial 
use of FFPE samples, including decreasing the target size to 75 bp in Illumina 
sequencing (Ruane and Austin, 2017), or increasing polymerase and dNTP 
concentration, plus increased elongation time in PCR amplification to improve 
results (Dietrich et al, 2013).  
 
4.4.2 Decontam identifies over half of bacterial sequences from FFPE 
membranes as contaminants, questioning the reliability of FFPE samples for 
microbiota research. However, samples and negative controls did display distinct 
alpha and beta diversity, plus 318 significantly different genuine bacteria after 
applying decontam. Decontam has been beneficially applied to placental research 
previously (Davis et al, 2018; Lauder et al, 2016), where <1% of ASVs were 
assigned to the genuine category, compared to 48% within this research. In the 
Davis et al (2018) and Lauder et al (2016) study, all samples were taken from term 
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patients, and as discussed earlier term patients present with reduced bacterial 
presence.  
Escherichia/Shigella displayed the greatest abundance in all samples, conditions 
and controls, plus was assigned as a genuine bacteria by decontam. However, the 
high abundance in samples and controls questions the origin of these bacteria. High 
detection in all patient samples could be due to high genuine levels in fetal 
membranes, as suggested by Aagaard et al (2014). Alternatively, the high 
abundance in controls could suggest contamination of samples during DNA 
extraction or sequencing methodology (Laurence, Hatzis and Brash, 2014). 
Decontam prevalence filtering relies on the assumption that contaminating 
sequences are greater in negative controls. The opposite was true for 
Escherichia/Shigella here, which was greater in samples, although not significant. 
One ASV was the main contributor to the high abundance of Escherichia/Shigella, 
which suggests the potential impact of this one ASV, highlighting the importance of 
ASV or species level analysis. 
 
This research highlights the beneficial use of decontam, but further post-processing 
may be required. Although beneficial, decontam strictly assigns each ASV to a 
‘genuine’ or ‘contaminant’ category, without the option of being both, which may be 
possible for bacteria of human origin and when studying clinical tissues. A change 
in just one read count value can impact which classification bracket bacterial 
sequences are assigned too (Davis et al, 2018). Heterogeneous samples make 
assigning ASVs in decontam difficult (Davis et al, 2018), with different primary 
bacteria detected from HCA, PTB and term here potentially limiting application. 
Decontam is also unable to reliably distinguish the origin of the bacteria; whether 
arising from the environment or processing conditions (Davis et al, 2018). Only 
samples and kit negative controls were processed in decontam as the negative 
control group is limited to one category. Bacteria identified as genuine in samples 
may have therefore originated from the microbiota of the infiltrating wax, as bacterial 
contribution from wax controls were not assessed or assigned in decontam. None 
of the ASVs assigned as contaminants were significantly different between samples 
and controls, thus the contaminating ASVs may still reside from the FFPE sample 
microbiota.  
Although decontam allows detection of contaminants, the extended time, 
knowledge, skills, and resources required to process samples limits clinical 
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application. The SourceTracker QIIME package has been suggested for improved 
accuracy of classification, with >99.8% of ASVs correctly classified (Karstens et al, 
2019). This method requires prior knowledge of the microbial composition in 
samples and controls, also limiting practicality for clinical samples (Karstens et al, 
2019). Reporting pre and post-processing steps and specific bioinformatic codes 
used within research would be informative to optimise filtering of contaminants in 
low biomass microbiota samples and improve methodological comparison. 
 
4.4.3 Biological and methodological variation across FFPE and frozen tissues. 
Findings highlight distinctive clustering of FFPE and frozen tissues, with negative 
controls also clustering by manufacturer. This was supported by Biesbroek et al 
(2012), presenting distinct clustering from MoBio and Qiagen extraction kits, rather 
than tissue type of saliva, oropharynx and nasopharynx. However, the kits used in 
the Biesbroek et al (2012) study were DNeasy from Qiagen and Powersoil from 
MoBio, thus target different samples yet apply comparable reagents. Whole genome 
sequencing research presented contrasting findings, with matched paired patient 
replicates clustered, rather than clustering by FFPE or frozen preparations 
(Mittempergher et al, 2011).  
The prominent bacteria from each manufacturer studied here varied, with 
Escherichia/Shigella being the primary genera from MoBio FFPE kit extracts and 
Bacteroides the most prominent from Qiagen frozen kit extractions. Bacillus was 
detected in greater abundance from FFPE samples, corresponding with a 
significantly greater detection in the respective MoBio kit negative control. The 
Bacillus genus and specific ASV were not detected in Qiagen frozen kit negative 
controls. Increased DNA quantity was detected in negative controls from MoBio kit 
reagents here, with previous research also detecting greater DNA in MoBio (19-25 
ng/µl) compared to Qiagen negative controls (<1 ng/µl; Glassing et al, 2016). These 
finding suggest that bacteria originated from kit reagents, specifically MoBio FFPE 
kits. 
Awareness of the bias from different manufacturers is needed when analysing 
microbiota data, as the significant differences in the microbiota from different 
manufacturers could impact tissue analysis and lead to incorrect assumptions about 
the genuine microbiota of tissue samples. Most research comparing FFPE and 
frozen samples universally apply the FFPE or tissue specific Qiagen kits to 
respective samples, resulting in concordance across DNA quality and quantity 
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(Simbolo et al, 2013; Spencer et al, 2013; Wang et al, 2013). Using the same kit 
manufacturer across FFPE and frozen tissue extraction may limit differences due to 
comparable reagents (Salter et al, 2014), and may have been beneficial within this 
research. However, respective kits were selected here as they were each 
respectively applied to identical FFPE and frozen samples in previous research 
(Waring et al, 2015), allowing comparison and expansion of this research project. 
 
4.4.4 Further considerations 
The use of different fetal membrane sections were analysed for FFPE and frozen 
patients. For FFPE samples combined fetal membrane rolls were available, 
whereas individual amnion and chorion membranes were used in the frozen sample 
cohort. Computationally combining the amnion and chorion membranes from frozen 
samples following initial analysis aimed to better reflect the FFPE fetal membrane 
rolls. However, the amnion and chorion were initially separated, washed in PBS and 
the chorion scraped upon preparation, resulting in the potential loss of tissue 
components, which would otherwise be intact within combined membrane rolls. This 
could contribute to microbiota differences across FFPE and fetal membranes. To be 
confident with results generated here, tissues and negative controls could be spiked 
with known concentrations of selected microorganisms before processing through 
both FFPE and frozen preparation methods. 
Analysis included a small patient subset (n=12), as the research criteria ensured 
that only patients with both FFPE and frozen membrane samples were included. 
This inclusion criteria aimed to improve sample comparison by reducing the impact 
of individual variation. Matched paired analysis strengthens findings as identical 
patient samples should present comparable microbiotas, if pre and post-processing 
of samples has minimal impact on the tissue microbiota.  
The use of FFPE samples in microbiota research faces the same criticisms as frozen 
tissues (Heydt et al, 2014; Senguven et al, 2014), but additional steps in FFPE 
processing increases the possibility of contamination. Instead of immediate freezing 
for sample preservation, FFPE tissues undergo multiple processing procedures in 
various locations by different technicians and clinical staff. The differences in 
preparation time, storage condition (Arreaza et al, 2016), storage duration (Carrick 
et al, 2015; Imrit et al, 2006) and length of fixation (Nagahashi et al, 2017), all impact 
DNA quality and the microbiota of FFPE samples. Samples were utilised from a 
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previous study for this research, thus real-time assessment of processing was not 
possible.  
During processing steps the tissue is submerged, embedded and penetrated by the 
paraffin wax which replaces all water content within tissue samples (Belloni et al, 
2013; Pikor et al, 2011). The comparison of samples to wax controls from 
corresponding tissues, as performed here is beneficial. However, it is difficult to 
elucidate the origin of bacteria due to the close interaction between tissues and 
infiltrating wax. Inclusion of a blank paraffin wax block prepared at the time of the 
samples and processed following the identical procedure would be beneficial to 
determine the genuine paraffin wax microbiota. Laser capture dissection to retrieve 
samples from surrounding wax before processing may increase the accuracy of 
separation and decrease wax contamination (Liu et al, 2013). It would be beneficial 
to include both amendments to methodology in future research and clinical 
protocols. 
Modifying existing methodology may improve comparison between FFPE and 
frozen tissue samples. Previous research found that FFPE placental samples failed 
to amplify using standard qPCR methodology (Dietrich et al, 2013), as DNA 
polymerase may fail to recognise cross linkage leading to errors in qPCR and 
sequencing (Oh et al, 2015). Reduction in the target sequence primer to 50 or 75 
bp improved comparison between FFPE and frozen samples (Mittempergher et al, 
2011; Ruane and Austin, 2017). 
An alternative fixative reagent which bridges the gap between FFPE and frozen 
processing methods may improve clinical comparison and application of microbiota 
research. PAXgene tissue fixative reagents have been suggested as this 
intermediate method (Belloni et al, 2013). This uses a reduced four-hour fixative 
time compared to 24 hours in formalin (Belloni et al, 2013). The aim of PAXgene is 
to preserve sample morphology yet decrease fragmentation, leading to increased 
template size for qPCR and sequencing (Belloni et al, 2013). Longitudinal studies 
are required to understand long term preservation following this method.  
 
The application of FFPE tissues to microbiota research has been beneficial in some 
tissues, including the ability to distinguish between diseased and healthy FFPE gut 
samples, with the use of comparable sequencing methodology (Stewart et al, 2019). 
Conversely, reliability of results in low biomass samples is questioned due to 
externally contributing bacteria concealing genuine signals (Glassing et al, 2016). 
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A universal protocol for FFPE sample preparation is not currently available. 
Introducing an SOP and universal tissue banking process for clinicians and 
scientists could widen the use of FFPE samples in clinical diagnostics. This would 
ensure consistent handling and preparation to remove bias from different 
methodologies and improve comparison between studies (Rubin et al, 2014). The 
SOP could include suggested optimum procedures including immediate fixation, 
use of deparaffinisation in extraction protocols and restricting storage time to one 
year before analysis (von Ahlfen et al, 2007). 
 
4.5 Conclusion  
The use of FFPE samples in microbiota research would reduce the time, cost, 
resource requirements, processing steps and storage limitations currently present 
in fresh/frozen tissue analysis. Findings here show that FFPE and frozen fetal 
membranes are not of comparable quality, with differences across bacterial profiles 
from matched paired analysis. This combined with the high level of contamination 
detected in fetal membrane FFPE tissues, questions the genuine representation of 
the fetal membrane microbiota once processed through fixative and embedding 
procedures. Although decontam allows detection of contaminating sequences, the 
extended time, knowledge, skills and resources required to process samples limits 
clinical application. Utilisation of FFPE fetal membranes in microbiota research is 
no more beneficial than the current gold standard of frozen tissues. Thus, FFPE 
samples should not replace frozen tissues in fetal membrane microbiota research. 
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Chapter Five: Bacterial load in fetal membranes with and without histological 
chorioamnionitis. 
 
Abstract 
Aim 
The aim of this chapter was to investigate the bacterial load of low risk term fetal 
membranes using quantitative PCR (qPCR), to determine if bacteria can be 
detected from healthy fetal membranes. Plus to understand bacterial load levels 
related to the maternal inflammatory condition of histological chorioamnionitis 
(HCA). In addition, the relationship between bacterial load on the fetal membranes 
and inflammatory response was investigated.  
Methods 
Bacterial loads were initially assessed on fetal membrane rolls from low risk term 
labour (n=58). A further patient cohort of HCA (n=12), preterm (n=6) and term 
without HCA (n=6) amnion and chorion samples were analysed independently. 
Bacterial load was measured by BactQuant absolute qPCR targeting the 16S rRNA 
V3-V4 gene region. Copy number was calculated /µl and /mg of tissue. Comparison 
across HCA status were analysed via nonparametric Kruskal-Wallis or 
nonparametric Wilcoxon Rank-Sum. Correlation analysis was performed via 
nonparametric Spearmans Rank Bonferroni adjustment.  
Results 
Bacterial signals were detected in 21% of low risk term fetal membranes, increasing 
to 68% of fetal membranes from samples of HCA amnion (100%) and chorion 
(82%), compared to PTB amnion (80%) and chorion (33%). Significantly greater 
bacterial loads were detected from HCA (5013.066 copies/µl) compared to preterm 
(228.873 copies/µl) and term membranes (254.819 copies/µl), with no difference 
detected between non-HCA samples; or between non-HCA samples and negative 
controls (193.601 copies/µl). Bacterial load displayed a significant positive linear 
relationship to inflammatory response and correlated to five inflammatory factors 
across the amnion and chorion, these were TLR1, TLR2, IRAK2, LY96 and IL-8.  
Conclusion 
No support for a distinct bacterial load in low risk and non-HCA fetal membranes is 
present. Findings support the involvement of bacteria in HCA, with greater bacterial 
loads correlating to increasing maternal inflammation. Findings suggest activation 
116 
 
 
of the inflammatory pathway via a dose dependent response following bacterial 
activation. 
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5.1 Introduction 
Bacterial colonisation of the fetus and fetal membranes in utero is questioned in 
healthy pregnancies (Kuperman et al, 2020; Perez-Munoz et al, 2017; Theis et al, 
2019). Current theories suggest that bacteria ascending from the vagina contribute 
to the healthy fetal membrane microbiota in utero (Aagaard et al, 2014). Whereas 
sceptics of this mechanism suggest that organisms are acquired during labour or 
delivery from the vaginal canal or skin microbiota (Jones et al, 2009; Perez-Munoz 
et al, 2017). Further theories suggest that no bacterial colonisation occurs in utero 
but following exposure to environmental sources (Lauder et al, 2016; Theis et al, 
2019). Evidence for bacterial detection in pregnancy related conditions including 
histological chorioamnionitis (HCA) observed that 94% of HCA cases present with 
bacterial colonisation, as detected by 16S rRNA gene qPCR (Musilova et al, 2015). 
Bacterial loads up to 5.2 log10 copies/µl have been detected in fetal membranes with 
HCA (Doyle et al, 2017). In contrast, Romero et al (2014b) detected bacteria in 11% 
of amniotic fluid samples from preterm birth (PTB) with culture confirmed intra-
amniotic inflammation, compared to 26% with a sterile inflammatory response. It is 
important to confirm if bacterial load can be detected on healthy fetal membranes 
prior to investigation of a maternal condition. The majority of research uses 
sequencing methods; thus the exact bacterial load copy number cannot be 
accurately determined. The use of qPCR is the optimum methodology for 
quantifying bacterial load.  
Furthermore, understanding if bacterial load is related to the inflammatory response 
in fetal membranes is important to increase current knowledge of HCA development 
and progression. Inflammatory biomarkers are routinely investigated for risk of PTB 
(Menon, Taylor and Fortunato, 2010) and CCA (Dudzik et al, 2015), including C-
reactive protein (CRP), interleukin-6 (IL-6) and IL-8 (Jung et al, 2010, Tita and 
Andrews, 2010). These biomarkers have been researched in relation to HCA, but 
not yet integrated into a clinical setting due to reduced specificity to HCA. Previous 
findings suggest changes in inflammatory receptors and proinflammatory cytokines 
linked to HCA, including a two-fold increase in Toll-like receptors (TLR1 and TLR2; 
Waring et al, 2015) and IL-8 (Kasper et al, 2010). Both suggesting the involvement 
of bacteria as inflammatory agents, but how these are initiated and linked to the 
amount of bacteria present is unknown. 
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The gene expression of TLR signalling pathway components in HCA patients were 
previously investigated on identical samples used for this thesis and reported in a 
previous paper (Waring et al, 2015). Findings suggested the involvement of TLRs 
in HCA, with an increased gene expression of TLR1, TLR2 and LY96 in chorion, or 
increased IL-8, IRAK2 and TLR4 in amnion with HCA. Plus a positive correlation 
between increased TLR1 and TLR2 gene expression to increased HCA staging in 
both the amnion and chorion (Waring et al, 2015). These findings improved the 
understanding of the inflammatory pathway response in HCA, but further research 
confirming the link between bacterial presence and load to initiate the inflammatory 
response in HCA was required, as performed in this chapter.  
The aim of this chapter was to initially investigate if bacteria can be detected in low 
risk term fetal membranes via TaqMan probe based 16S rRNA gene targeted 
absolute qPCR. Following this, a further aim was to investigate the bacterial load of 
the amnion and chorion with and without HCA, via comparable methodology to 
understand bacterial load levels in an inflammatory condition. Finally, we aimed to 
investigate the relationship between bacterial load on the fetal membranes and HCA 
severity, inflammatory response and inflammatory biomarkers. 
 
5.2 qPCR method recap 
Absolute qPCR was selected to quantify bacterial load from membrane rolls of low 
risk term patients, plus amnion and chorion samples from HCA and non-HCA 
patients. In addition, to understand if bacterial load is related to the inflammatory 
response in fetal membranes.  
 
5.2.1 Sample processing 
qPCR was performed on pre-extracted DNA from two patient subsets. Initially, a low 
risk term cohort was analysed. Samples were collected as part of a British Maternal 
and Fetal Medicine Society Research Project Bursary by Dr Inge Christiaens. 
Samples were collected following written informed consent. Term fetal membrane 
rolls (n=58) were collected from term spontaneous vaginal delivery (n=21), or term 
elective caesarean section (ELCS; n=37). Inclusion criteria required gestation 
between 37-42 weeks and singleton births from low risk patients, defined as the 
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absence of a known maternal or fetal complication. Exclusion criteria was clinical 
signs of infection or chorioamnionitis, antibiotic use in labour, preterm premature 
rupture of membranes (PPROM) >24 hours, fetal growth restriction, pre-eclampsia, 
placental abruption or manual removal of the placenta after delivery.  
Amniochorionic membranes were prepared as per standardised criteria and HCA 
assessed as described previously (Chapter two). Only patients diagnosed as 
negative for HCA were processed. A fetal membrane roll was prepared from each 
patient, ensuring that the amnion and chorion were intact. Fetal membrane rolls 
were stored at -80 °C before use in this study. Total genomic DNA was extracted 
from 25 mg frozen membranes via QIAamp Fast DNA Tissue Kit (Qiagen) as 
described previously (Chapter two). DNA extraction kit negatives (four) were also 
processed alongside samples using identical methodology.  
 
In addition, the previous patient cohort utilised in chapter three sequencing methods 
were also analysed to understand bacterial load in fetal membranes when a 
maternal condition is present. Patients consisted of preterm with HCA (n=12), PTB 
without HCA (n=6) and term birth without HCA (n=6). Following initial extraction, 25 
µl aliquots of DNA were stored for one year at -80 °C prior to qPCR experiments. 
 
5.2.2 BactQuant qPCR method recap 
The BactQuant primer and TaqMan probe methodology was modified as described 
previously (Liu et al, 2012; Chapter two), and amplified to target the 16S rRNA gene 
using a CFX real-time thermal cycler (Bio-Rad). All samples were quantified against 
an E. coli reference standard curve. Findings were calculated to copy number/µl and 
/mg for clinical relevance, before comparing across HCA status and to controls, plus 
correlating to HCA severity and inflammatory biomarkers. CQ values of samples 
were compared to SQ of standard curves to determine copy numbers of 16S rRNA 
gene within each sample.  
 
The initial output from qPCR is provided as SQ per reaction. As 1 µl of template 
DNA was added to reactions no conversion was required to determine copy 
number/µl. For clinical relevance, copy number/mg of tissue was calculated, with 
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knowledge that 25 mg of tissue was used for the initial extraction of 50 µl eluted 
DNA, and 1 µl of template DNA was required per qPCR reaction. Thus, the SQ was 
multiplied by two to generate copy number/mg of tissue. Logarithm of copy numbers 
(log10) were calculated and used for visual analysis. 
 
The MIQE guidelines were followed throughout qPCR experiments (Bustin et al, 
2009). Amplification efficiency was monitored based on the slope of the regression 
line, calculated by ‘Efficiency= 10 –(1/slope) -1’ (Svec et al, 2015). If theoretical doubling 
is met then an optimum efficiency score of 100% and R2 value of 1.000 would be 
expected (Ruijter et al, 2012). However, efficiency of 90-110% or R2 >0.980 are 
accepted (Larionov, Krause and Miller, 2005). Efficiency <90% represents low 
reaction efficiency, with scores >110% suggesting sample inhibition (Thermo Fisher 
Scientific Inc, 2014). If the R2 value of standard curves decreased below the 
threshold (<0.980), the qPCR experiment was rejected and repeated to avoid 
misinterpretation of results.  
Standards and samples were assayed in triplicate (technical replicates), with 
starting quantity (SQ) copy numbers calculated as the average of the three results. 
If standard deviation of the replicates was >4.000 then analysis was repeated, as 
this indicates inaccuracy and unreliable results. However, if the removal of an 
anomalous replicate decreased the standard deviation to an acceptable level 
(<4.000), then two replicates were used to calculate the average copy number. 
The limit of detection (LOD) for this assay was <100 copies/µl due to sensitivity 
range of the BactQuant primer and probe (Liu et al, 2012), confirmed by standard 
curve limits. Samples falling below the threshold were stated as out of range (OOR) 
and not analysed to ensure accuracy of results.  
No template controls (NTCs) were processed alongside standards and samples to 
monitor contamination. NTCs contain all reaction components apart from the sample 
to act as a background negative control and aid in detecting contamination (Bustin 
et al, 2009). The expected copy number from NTCs is zero, due to the absence of 
target DNA for the primer sequence to bind and amplify (Thermo Fisher Scientific 
Inc, 2014). Contamination was suspected if amplification was observed greater than 
the threshold and/or within ten cycles of the most dilute standard. If detected, the 
experiment was rejected and repeated with fresh reagents. To further reduce the 
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possibility of contamination, assays were prepared in a designated restricted access 
qPCR area. Designated pipettes, reagents and sterile consumables, including filter 
tips and sterile Eppendorf tubes were also used throughout preparation and 
experiments. 
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5.3 Results 
5.3.1 PCR optimisation  
PCR optimisation was performed to ensure assay conditions would achieve 
maximum amplification efficiency. Plasmid standards were used as the PCR 
template. Negative controls did not display amplification of the target sequence 
throughout optimisation (Figure 5.1). 
 
5.3.1.1 Temperature gradient 
A temperature gradient PCR was performed to optimise the primer annealing 
temperature (45-56 °C, Figure 5.1A; 55-65 °C, Figure 5.1B). The optimum 
amplification was detected at 55 °C (Lane 9; Figure 5.1B). Amplification did not 
occur above 63 °C. 
  
5.3.1.2 MgCl2 concentration 
The optimum MgCl2 concentration was selected as 4 mM per reaction due to high 
intensity clear banding and reduced product remaining within the wells (Lane 2; 
Figure 5.1C), compared to 3 or 5-7 mM. 
 
5.3.1.3 Formamide concentration 
Formamide increased amplification efficiency to a maximum concentration of 2%. 
The optimum percentage was selected as 1% due to improved banding, with no 
amplification detected at higher concentrations (5-10%; Figure.5.1D). 
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A        B 
  
 
C        D  
  
 
Figure 5.1 PCR optimisation. Agarose gel images of PCR optimisation including 
temperature gradients of 45-56 °C (A) and 55-65 °C (B), MgCl2 optimisation from 3-7 mM 
(C), and formamide optimisation from 0-10% (D). Lane one in each image is represented 
by 1Kb HyperLadder, target band present at 466 bp.  
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5.3.1.4 Tissue sample inhibition results 
Optimised PCR protocols were then applied to qPCR methodology and sample 
inhibition was investigated across a subset of samples prior to analysis (n=11). This 
included six HCA, three term and two negative controls. Samples were diluted 1 in 
2,1 in 10 and 1 in 20. An inverse relationship between increasing quantification cycle 
(CQ) values and decreasing SQ values proportional to concentration indicated no 
inhibition. An example from one inhibition experiment is presented in Table 5.1. 
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Sample Dilution CQ 
CQ 
mean 
Cq std. dev SQ SQ mean 
Within 
range? 
Inhibition? 
HCA21 Neat 24.819 24.472 0.351 1181.682 1383.289 Yes No 
  24.481   1258.379    
  24.117   1709.807    
 1 in 2 25.077 25.011 0.361 760.954 830.481 Yes No 
  25.334   612.543    
  24.621   1117.947    
 1 in 10 26.161 26.330 0.151 708.667 620.887 Yes No 
  26.379   593.910    
  26.451   560.085    
 1 in 20 27.842 28.103 0.385 196.663 168.558 Yes No 
  27.922   184.397    
  28.545   124.615    
 
Table 5.1 qPCR tissue sample inhibition analysis. An example of results to investigate potential inhibition in fetal membrane samples by analysing undiluted 
samples (neat), plus diluting 1 in 2, 1 in 10 and 1 in 20, amplified by BactQuant V3-V4 16S rRNA gene primers. Presented as quantification cycle (CQ) and 
starting quantity (SQ). 
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5.3.2 Standard curve results 
Standard curves were used as a reference to determine 16S rRNA gene copy 
number within samples (102-108). Standards were assayed in triplicate, with CQ and 
SQ calculated as the mean of the three values. Example standard curve qPCR 
results are presented, including amplification plot (Figure 5.2), standard curve copy 
number results (Table 5.2) and standard curve example (Figure 5.3). 
 
The accuracy of sample results from a qPCR assay is dependent on the accuracy 
of the standard curve (Thermo Fisher Scientific Inc, 2014). All standards included in 
analysis presented an acceptable R2 value, with an average of 0.984 (0.975-0.996). 
The slope of the standard curves ranged across experiments from -3.287 to -3.931, 
with an average of -3.474. The optimum slope would be -3.333 to display perfect 
doubling, with a range from -3.100 to -3.600 accepted (Thermo Fisher Scientific Inc, 
2014).  
 
The average amplification efficiency across experiments was 94.02%, with this 
ranging from 79.63-101.48%. Although two experiments presented below the 
optimum efficiency, the average was still within the optimum range. Low efficiency 
is not a criterion to reject an assay but can indicate less than optimum conditions 
(Thermo Fisher Scientific Inc, 2014). 
The LOD of each assay was assessed by monitoring standard curves. Standard 08 
was the lowest concentration standard for the assay, with a known concentration of 
101 and an average CQ of 30.97. However, the LOD was set at 102 for this method, 
as this was the sensitivity limit for the BactQuant primers and probe (Liu et al, 2012), 
with caution required for low biomass samples. The LOD was confirmed, as 
standard 08 presented with greater standard deviation and less consistency across 
experiments, compared to standard 07 (102; Figure 5.2). If samples fell below the 
LOD threshold, they were stated as OOR for this specific assay.  
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Figure 5.2 qPCR standards amplification plot. An example of the qPCR amplification plot of standard curves created on CFX Manager V3.1. Displayed as 
cycle number (cycles) compared to relative florescence units (RFU). 
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Content CQ CQ mean Cq std. dev SQ SQ (log10) 
Standard 01 5.420 5.741 0.354 3.0 x108 8.477 
 5.680     
 6.122     
Standard 02 11.742 11.473 0.362 3.0 x107 7.477 
 11.062     
 11.615     
Standard 03 13.174 13.146 0.158 3.0 x106 6.477 
 12.975     
 13.288     
Standard 04 17.767 17.857 0.126 3.0 x105 5.477 
 17.810     
 17.994     
Standard 05 21.523 21.586 0.136 3.0 x104 4.477 
 20.493     
 21.741     
Standard 06 25.172 25.188 0.124 3.0 x103 3.477 
 25.073     
 25.319     
Standard 07 28.151 27.924 0.397 3.0 x102 2.477 
 27.466     
 28.154     
Standard 08 30.293 30.737 0.385 3.0 x101 1.477 
 30.987     
 30.930     
 
Table 5.2 qPCR standard curve copy number results. An example of calculated copy 
numbers from an Escherichia coli plasmid standard curve (Standard 01-08) amplified by 
BactQuant V3-V4 16S rRNA gene primers, presented as quantification cycle (CQ), starting 
quantity (SQ) and SQ log10.
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Figure 5.3 qPCR standard curve example. An example qPCR standard curve used for 
reference, comparing log10 starting quantity (SQ) with mean quantification cycle (CQ). R2 
and slope displayed. Results correlate to Table 5.2.
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5.3.3 Low risk patient demographics 
For the low risk patient cohort, fetal membrane rolls were collected from 58 patients 
(Table 5.3). Gestational age was the only patient variable with a significant 
difference, as this was higher in vaginal delivery (39.966) compared to ELCS 
(39.235; p=0.005). 
 
 Patients  
(n=58) 
ELCS 
 (n=37) 
Vaginal 
(n=21) 
p.value 
Gestational age   
(mean (SD)) 
39.5 (0.9) 39.2 (0.6) 40.0 (1.1) 0.005* 
Maternal age (mean 
(SD)) 
31.4 (5.3) 31.9 (5.1) 30.5 (5.3) 0.353 
Maternal BMI (mean 
(SD)) 
25.5 (5.3) 24.7 (4.4) 27.3 (6.7) 0.276 
Smoker                     Yes 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 1.000 
                                  No 58.0 (100.0) 37.0 (100.0) 21.0 (100.0)  
Birthweight (mean (SD)) 3588.1 
(407.2) 
3586.8 
(420.2) 
3590.6 
(392.6) 
0.973 
 
Table 5.3 Low risk term fetal membrane patient demographics. Patient characteristic 
from all patients providing fetal membrane rolls, with data assessed from low risk term fetal 
membranes, including elective caesarean section (ELCS) and vaginal delivery (vaginal). 
Comparison between groups was performed via parametric two-sample independent T-test 
or nonparametric Wilcoxon Rank-Sum. Categorical data was assessed using 
nonparametric Fisher’s exact test. Significance threshold was p=≤0.05. Unless stated 
results are displayed as n (%). 
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5.3.4 Low risk patient sample qPCR results 
Pre-extracted DNA from low risk term fetal membrane rolls (n=58), plus DNA 
extraction kit negative controls (n=4), NTCs and plasmid standards were assayed 
in triplicate following identical processing and procedures.  
 
5.3.4.1 The majority of low risk fetal membranes were OOR for the assay.  
The majority of low risk term fetal membranes (79%; 46/58) fell below the LOD for 
this assay (<100 copies/µl). With, 78% of ELCS (29/37) and 81% of vaginal 
deliveries (17/21) having no detectable bacterial load on the fetal membranes. Thus 
bacterial load above the predetermined threshold was detected from 21% (12/58) 
of low risk term patients. 
To ensure reliability of results, samples with a copy number below the LOD for the 
assay were stated as OOR and removed from investigations (<100 copies/µl). This 
led to the analysis of 12 patients, with eight ELCS and four vaginal deliveries. The 
mean bacterial load from the new subset of low risk fetal membranes was 213.815 
copies/µl, 2.282 log10 (427.631 copies/mg, 2.584 log10) ranging from 110.471-
407.758 copies/µl. 
 
5.3.4.2 Mode of delivery does not impact bacterial load of low risk term fetal 
membranes.  
The ability to detect bacteria was not significantly different across mode of delivery, 
as 22% (8/37) of ELCS and 19% (4/21) of vaginal delivery samples displayed 
detectable bacterial loads (p=0.827). From the within range subset (n=12) ELCS 
samples had a greater average copy number of 216.156 copies/µl, 2.284 log10 
(432.312 copies/mg, 2.585 log10), compared to vaginally delivered fetal membranes 
at 209.134 copies/µl, 2.280 log10 (418.267 copies/mg, 2.581 log10), yet not 
significantly different across mode of delivery (p=0.808; Figure 5.4). No difference 
in bacterial load was present across other patient demographics including; 
gestational age (p=0.905), birthweight (p=0.443), or maternal age (p=0.430) and 
maternal BMI (p=0.416). 
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Figure 5.4 qPCR analysis of bacterial load in low risk term fetal membranes by mode 
of delivery. qPCR data from low risk term fetal membranes with elective caesarean section 
(ELCS) or vaginal delivery (vaginal) displayed as 16S rRNA gene copy number/µl (A) or 
16S rRNA gene copy number/mg (B). Extracted DNA was amplified using BactQuant V3-
V4 16S rRNA gene primers. 
 
 
5.3.4.3 Low risk fetal membrane bacterial load is comparable to negative 
controls.  
To investigate the bacterial signal from DNA extraction kit reagents, negative 
controls were compared to low risk fetal membranes.  
Negative controls yielded detectable bacterial load in 75% (3/4), with detection 
below the threshold in 25% (1/4). The mean detectable bacterial load from negative 
controls was 133.387 copies/µl (2.122 log10; Figure 5.5), ranging from 111.928-
150.626 copies/µl. The ability to detect bacteria above the threshold was 
significantly different between samples and negative controls (p=0.016), with 
greater ability to detect a bacterial load in negative controls (75%) compared to fetal 
membrane samples (21%). However, when a signal was detected there was no 
significant difference in copy number between fetal membranes (213.815 copies/µl) 
and negative controls (113.387 copies/µl, p=0.365; Figure 5.5). 
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Figure 5.5 qPCR analysis of bacterial loads from low risk term fetal membranes and 
negative controls. qPCR data of low risk fetal membranes (samples) and negative controls 
within the range of the assay. Extracted DNA was amplified using BactQuant V3-V4 16S 
rRNA gene primers and displayed as 16S rRNA copy number/µl. 
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5.3.5 HCA cohort sample demographics 
To investigate bacterial load in high risk or HCA fetal membranes, identical frozen 
samples to those used in chapter three for sequencing experiments were utilised for 
this qPCR protocol. 
Briefly, patient demographics displaying significant differences between HCA, PTB 
and term were gestational age and birthweight (p=0.001). This specifically between 
HCA and term (p=<0.001), or PTB and term (p=<0.001), but gestational age 
(p=0.799), or birthweight (p=0.291) were not different between HCA and PTB. 
Significant differences were also detected for fetal sex (p=0.013) and Apgar score 
(p=0.033). Characteristics monitored only in HCA and PTB patients with significant 
differences were; maternal inflammatory stage (p=<0.001) and grade (p=0.036), 
plus CRP level (p=0.006). Detailed patient demographic information can be found 
in chapter three. 
 
5.3.5.1 Tissue sample qPCR results 
Extracted DNA from frozen amnion and chorion (n=37), plus DNA extraction kit 
negative controls (n=10), NTCs and plasmid standards were assayed in triplicate 
following identical procedures. qPCR experiments were accepted based on 
efficiency of the standards, NTC amplification and standard deviation of triplicates, 
as discussed previously. Sample analysis included 24 patients, with 12 HCA, six 
PTB and six term. Tissue replicates led to the analysis of 37 samples (20 HCA, 11 
PTB and six term). All sample and control results from qPCR assays can be found 
in the appendix (Table A.4 and A.5).  
 
5.3.5.2 The majority of fetal membrane samples had detectable bacterial loads. 
Bacterial load above the predetermined threshold (100 copies/µl) was detected in 
68% of fetal membrane samples (25/37). Amnion samples displayed the greatest 
percentage of detectable bacterial load, in 100% (9/9) of HCA and 80% (4/5) of 
preterm patients, yet not significant (p=0.233). Within the chorion, 82% (9/11) of 
HCA patients, but 33.3% (2/6) preterm and 50% (3/6) term chorion tissues 
generated detectable bacterial loads, this not significant between HCA, PTB and 
term patients (p=0.132).  
Bacterial load levels out of the LOD for this assay (<100 copies/µl) were found in 
32% (12/37) samples. PTB chorion had the most OOR samples (4/6), yet, only 1/5 
PTB amnion were OOR. Term chorion had 3/6 samples OOR. Two HCA chorion 
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samples were OOR (2/11), but no OOR samples derived from HCA amnion (0/9). 
OOR copy numbers did not differ between HCA, PTB or term patients (p=0.632).  
 
Removal of all OOR replicates for this assay led to the analysis of 18 HCA samples 
(nine amnion, nine chorion), six PTB samples (four amnion, two chorion) and three 
term samples (three chorion). From these patients an average of 3421.218 copies/µl 
were detected, with the lowest bacterial load from a preterm amnion sample 
(115.221 copies/µl) and the highest from an HCA chorion sample (33,851.73 
copies/µl).  
 
5.3.5.3 Bacterial load is increased with histological inflammation of the 
amnion and chorion. 
Fetal membranes with HCA displayed a significantly greater mean bacterial load 
(5013.066 copies/µl, 10,026.132 copies/mg) compared to preterm (228.873 
copies/µl, 457.746 copies/mg) and term patients (254.819 copies/µl, 509 copies/mg; 
p=<0.001). The significance remained when comparing HCA and PTB only 
(p=<0.001), or HCA and term only (p=0.011), yet not significant when comparing 
PTB and term (p=0.548). Bacterial loads from HCA ranged from 172.075-
33,851.731 copies/µl, from PTB this was 115.222-405.954 copies/µl and 200.692-
304.220 copies/µl from term fetal membranes.  
No difference in mean bacterial loads were found between amnion and chorion 
results in HCA (4110.932 copies/µl vs 5915.199 copies/µl, p=0.436) or amnion and 
chorion from PTB (172.280 copies/µl vs 342.062 copies/µl, p=0.133). 
When focussing independently on the amnion, significantly greater bacterial loads 
were detected in HCA amnion compared to PTB amnion (4110.932 copies/µl (3.614 
log10) vs 172.280 copies/µl (2.236 log10); p=0.006; Figure 5.6A). When 
independently analysing chorion tissues, HCA bacterial loads were also greater than 
preterm and term, with a significance detected between HCA and PTB chorion 
(5915.199 copies/µl (3.772 log10) vs 342.062 copies/µl (2.534 log10); p=0.036), plus 
HCA and term chorion (254.819 copies/µl (2.406 log10); p=0.009). Bacterial loads 
did not differ between preterm and term chorion (p=0.400, Figure 5.6B).  
When presented as copy number/mg of tissue for clinical relevance, bacterial load 
levels for HCA amnion were 8221.864 copies/mg (3.915 log10), compared to 
344.556 copies/mg from PTB amnion (2.537 log10; Figure 5.6C). For HCA chorion 
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this was 11,830.401 copies/mg (4.073 log10), compared to PTB (684.123 copies/mg 
(2.835 log10)) and term chorion (509.638 copies/mg (2.707 log10); Figure 5.6D).  
 
The greatest bacterial load on both the amnion and chorion was detected from one 
patient in the HCA subset (HCA patient 17), with a bacterial load of 28,706.990 
copies/µl from the amnion, and 33,851.730 copies/µl from the chorion. For interest, 
when removed from analysis, the mean bacterial load in HCA reduced but remained 
significantly greater from amnion compared to preterm and term patients (1729.779 
copies/µl (3.238 log10) p=0.008), and chorion when compared to preterm patients 
(3459.588 copies/ µl (3.539 log10) p=0.012). 
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Figure 5.6 qPCR analysis of bacterial load by HCA status in the amnion and chorion. 
qPCR data displayed by log10 copy number/µl from amnion (A) and chorion samples (B) or 
log10 copy number/mg of tissue from amnion (C) and chorion samples (D). Patients were 
analysed in groups of histological chorioamnionitis (HCA), or preterm (PTB) and term birth 
without HCA (Term). Extracted DNA was amplified using BactQuant V3-V4 16S rRNA gene 
primers. Significance was analysed via nonparametric Kruskal-Wallis and nonparametric 
Pairwise Wilcoxon Rank-Sum to a threshold of p=≤0.05. 
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5.3.5.4 Non-HCA samples and negative controls have comparable bacterial 
loads. 
Bacterial loads above the threshold were detected in 71% (5/7) of negative controls, 
with an average of 193.601 copies/µl (147.326-248.612 copies/µl). As previously, 
OOR values were not included in analysis.  
Fetal membrane samples displayed significantly greater bacterial loads (3421.218 
copies/µl) compared to negative controls (193.601 copies/µl, p=<0.001; Figure 
5.7A). HCA samples were then removed from comparison and only preterm and 
term patients without HCA (non-HCA) were compared to negative controls to 
determine if the difference was due to inflammation. There was then no significant 
difference in bacterial load between non-HCA samples (237.521 copies/µl) and 
negative controls (193.601 copies/µl, p=0.387; Figure 5.7B).  
 
A       B 
   
 
Figure 5.7 qPCR analysis of bacterial load from fetal membranes and negative 
controls. qPCR data displayed by log10 copy number/µl of samples compared to DNA 
extraction kit negative controls. Samples include histological chorioamnionitis amnion and 
chorion (HCA Amnion, HCA Chorion) or preterm amnion and chorion (PTB Amnion, PTB 
Chorion), plus term chorion without HCA (Term Chorion). Samples were compared to 
negative controls (Neg Control; A). Only non-HCA samples were compared to negative 
controls (B). Extracted DNA was amplified using BactQuant V3-V4 16S rRNA gene primers. 
Significance was determined via nonparametric Kruskal-Wallis to a threshold of p=≤0.05.  
  
139 
 
5.3.6 Increased bacterial load is positively correlated to increased 
inflammatory stage and grade. 
Bacterial load levels were correlated to histologically confirmed inflammatory 
staging and grading to investigate the link between the amount of bacteria on the 
fetal membranes and the severity of maternal inflammation. 
There was a strong positive significant correlation between bacterial load and 
inflammatory staging (R2=0.782, p=0.002; Figure 5.8A) and grading in the amnion 
(R2=0.673, p=0.012, Figure 5.8B). In the chorion, a strong positive significant 
correlation between bacterial load and inflammatory staging (R2=0.841, p=<0.001; 
Figure 5.9A) and grading was also present (R2=0.730, p=0.003; Figure 5.9B).  
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A      B
 
 
Figure 5.8 Amnion inflammatory stage and grade correlated to bacterial load. Analysis 
between bacterial load log10 copy number/µl and histologically confirmed inflammatory 
staging (A) and grading score (B) within the amnion via nonparametric Spearman’s Rho 
correlation analysis to a threshold p=≤0.05.  
 
A       B 
 
 
Figure 5.9 Chorion inflammatory stage and grade correlated to bacterial load. Analysis 
between bacterial load log10 copy number/µl and histologically confirmed inflammatory 
staging (A) and grading score (B) in the chorion via nonparametric Spearman’s Rho 
correlation analysis to a threshold p=≤0.05.  
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5.3.6.1 Increased bacterial load is positively correlated with inflammatory 
gene expression. 
To further investigate the relationship between bacterial load and the inflammatory 
response, bacterial load levels detected in this research were compared to 
inflammatory gene expression levels determined by relative qPCR in a previous 
paper utilising identical samples (Waring et al, 2015). Previous research indicated 
than an increase in TLR1, TLR2, LY96, IL-8 and IRAK2 genes were linked to 
inflammation in the fetal membranes (Waring et al, 2015).  
 
Bacterial load from amnion and chorion were correlated to the expression of 
inflammatory mediator genes (Table 5.4). In the amnion, bacterial load was 
significantly positively correlated to TLR1 (Rs=0.599, p=0.034), TLR2 (Rs=0.626, 
p=0.025), and IL-8 (Rs=0.560, p=0.050). In the chorion, bacterial load was 
significantly positively correlated to TLR1 (Rs=0.604, p=0.025), TLR2 (Rs=0.776, 
p=0.002), LY96 (Rs=0.763, p=0.002), IL-8 (Rs=0.692, p=0.008) and IRAK2 
(Rs=0.732, p=0.004). The majority of the remaining inflammatory factors were also 
positively correlated to bacterial load across amnion and chorion fetal membranes, 
yet insignificant (Table 5.4). TIRAP, SARM1 and HMGB1 were negatively correlated 
in the amnion, with TLR6, HMGB1 and SIGIRR negatively correlated in the chorion. 
All negative findings were weak non-significant correlations (Table 5.4). 
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Table 5.4 Bacterial load correlated to inflammatory gene fold change in the amnion 
and chorion. Correlation was performed via nonparametric Spearman’s Rank Bonferroni 
adjustment (p=≤0.05, bold and italics) between absolute qPCR bacterial loads from amnion 
and chorion fetal membranes and inflammatory gene fold change results from relative 
qPCR from a previous publication (Waring et al, 2015) between matched paired samples. 
  
Amnion Chorion 
Inflammatory 
gene 
Spearman’s 
correlation 
p.value 
Inflammatory 
gene 
Spearman’s 
correlation 
p.value 
TLR1 0.599 0.034 TLR1 0.604 0.025 
TLR2 0.626 0.025 TLR2 0.776 0.002 
TLR4 0.489 0.093 TLR4 0.275 0.341 
TLR6 0.011 0.978 TLR6 -0.112 0.704 
SARM1 -0.214 0.482 SARM1 0.103 0.727 
MyD88 0.308 0.366 MyD88 0.125 0.671 
LY96 0.364 0.224 LY96 0.763 0.002 
IL-8 0.560 0.050 IL-8 0.692 0.008 
IRAK2 0.434 0.146 IRAK2 0.732 0.004 
HMGB1 -0.049 0.878 HMGB1 -0.178 0.542 
SIGIRR 0.083 0.843 SIGIRR -0.173 0.614 
TIRAP -0.044 0.892 TIRAP 0.169 0.563 
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5.4 Discussion 
The aim of chapter five was to initially determine if a bacterial signal can be detected 
in low risk term fetal membranes using 16S rRNA gene BactQuant primer and probe 
based qPCR. In addition, to then investigate the bacterial load in fetal membranes 
with the maternal inflammatory condition of HCA, to understand if the amount of 
bacteria on the fetal membranes impacts development of HCA. Also, the 
relationship between bacterial load and HCA inflammatory diagnosis criteria or 
inflammatory marker expression on fetal membranes were investigated.  
Overall, this chapter highlights that the majority of low risk term fetal membranes do 
not have detectable bacterial loads, with only 21% of fetal membranes above the 
LOD. Yet, bacterial loads were present in the majority of fetal membranes from HCA 
(90%), PTB (55%) and term patients (50%). The bacterial load of low risk and non-
HCA fetal membranes could not be distinguished from DNA extraction kit negative 
controls, with negative controls more likely to have a detectable signal (75%). HCA 
fetal membranes had significantly greater bacterial loads (5013.066 copies/µl) than 
non-HCA samples (237.521 copies/µl), with no impact of gestational age. Findings 
support that bacterial loads are distinct only when a maternal condition is present. 
Increased bacterial loads were positively correlated to increased maternal 
inflammation and five inflammatory factors. All of which confirm the relationship 
between bacterial infection and higher bacterial load related to inflammatory HCA. 
 
5.4.1 Bacterial load cannot always be detected in low risk term fetal 
membranes, but are increasingly detected in negative pregnancy outcomes. 
When analysed by qPCR the majority of low risk term fetal membranes (79%) did 
not have a detectable bacterial load above the LOD for the assay, yet were detected 
from 68% of fetal membranes from the second subset, including HCA (90%), 
preterm (55%) and term patients (50%). These findings suggest that the majority of 
low risk term fetal membranes do not have a genuine detectable bacterial load 
above the LOD for this assay, supporting the sterile placenta theory in low risk 
patients (de Goffau et al, 2019; Kuperman et al, 2020; Perez-Munoz et al, 2017; 
Theis et al, 2019). However, it is possible that there is a bacterial load below the 
LOD for this assay. Support for current findings have been observed in comparable 
qPCR assays, with bacterial loads from healthy term membrane rolls below the LOD 
of 102 copies/µl (Theis et al, 2019), with this confirmed by culture negative findings 
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from 28/29 samples (Theis et al, 2019). This is reflected by Doyle et al (2017), where 
68% of fetal membranes from preterm patients had detectable bacterial loads from 
16S rRNA qPCR (Doyle et al, 2017). Alternative research has observed bacteria at 
lower percentages, with only 14% of preterm fetal membranes with microbial 
invasion (Kim et al, 2009), and 11% of late PTB placental tissues presenting with 
detectable bacterial load (Sweeney et al, 2016), both by 16S rRNA PCR and 
sequencing. 
Bacterial loads were more likely to be detected from HCA (90%), with lower 
detection from PTB (55%) and term (50%), yet still greater than low risk term 
patients (21%). Findings suggest the potential role of bacteria in HCA, with a greater 
bacterial signal from HCA. This is supported by Musilova et al (2015), finding 
bacteria in 97% of HCA amnion samples by 16S rRNA PCR, plus from Sweeney et 
al (2016), detecting bacteria in 54% of HCA, compared to 19% in non-HCA 
membranes, irrespective of gestational age from 16S rRNA PCR and sequencing. 
Findings from the low risk term group in this research match those detected from 
non-HCA membranes in the Sweeney et al (2016) study. However, the high risk 
term subset displayed a greater percentage of samples with detectable levels. 
Patient demographics and inclusion/exclusion criteria differed, with more rigorous 
criteria applied to the low risk patient group, possibly explaining the difference 
across low risk term and non-HCA term patients. Multiplex qPCR has previously 
failed to detect Ureaplasma or Mycoplasma in term or preterm fetal membranes, yet 
were detected in 22% of HCA membranes (Kim et al, 2009). This suggesting the 
multifactorial characteristic of this condition where load of species may be important. 
Increased bacteria on fetal membranes in pregnancy related conditions is supported 
by Jones et al (2009), detecting bacteria in 70% of PPROM compared to 50% non-
PPROM term patients. Alternatively, Kuperman et al (2020) failed to amplify or 
detect the 16S rRNA gene in 27 placentas from healthy or pre-eclampsia patients, 
also using the BactQuant primer and probe. However, this was amplified by PCR 
and analysed by agarose gel, rather than the more sensitive qPCR method used 
here. But these findings were confirmed by negative culture and negative Gram 
stain results (Kuperman et al, 2020). 
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5.4.2 HCA fetal membranes have significantly greater bacterial load than PTB 
and term without HCA. Bacterial loads of up to 5.2 log10 copies/µl have been 
detected in HCA fetal membranes previously (Doyle et al, 2017), greater than 3.7 
log10 copies/µl detected here. Conversely, similar bacterial loads from 
chorioamnionitis, PTB and term have been detected from placental samples by 
qPCR amplification of the 16S rRNA gene (Leiby et al, 2018). However, this 
research included CCA, without the specificity to HCA as focused on in this project.  
Increased bacterial load in reproductive and pregnancy related conditions is 
supported by research into PPROM, with increased 16S rRNA gene copy number 
from PPROM (7700 copies/ml) compared to non-ruptured membranes (664 
copies/ml; Rehbinder et al, 2018). This utilised the BactQuant protocol with modified 
digital droplet PCR used to increase the sensitivity of the assay (Rehbinder et al, 
2018). The patient demographics in this research project had 75% of patients with 
PPROM compared to 25% with spontaneous PTB, thus further investigation into the 
clinical reason for PTB linked to bacterial load would be of interest. Although 
bacterial load was significantly different between HCA and non-HCA patients, no 
difference in the percentage of samples with detectable bacterial loads were 
evident, suggesting that bacterial load is of greater importance in HCA than bacterial 
presence.  
One HCA patient (patient 17) presented with exceptionally high levels of bacteria, 
but inclusion had minimal impact on research outcomes. The patient was diagnosed 
at inflammatory stage two, however was the only patient to also present with clinical 
signs of chorioamnionitis, including, high temperature indicating maternal fever and 
vaginal discharge. Not all CCA diagnostic criteria were met, as WBC and heartrate 
were not elevated, thus CCA was not diagnosed. No impact on results were seen 
following removal of this patient from analysis. Although the correlation between 
HCA and CCA is poor (Oh et al, 2017), and the findings are from one patient, this 
does suggest the importance of distinctive HCA and CCA investigation. 
 
5.4.3 Bacterial load is positively correlated to severity of inflammatory 
response in a dose dependent manner, with greater bacterial loads detected in 
higher inflammatory staging and grading in the fetal membranes. Increased 
inflammatory response in relation to increased bacterial load have previously been 
reported, specifically with higher bacterial loads in amniotic fluid linked to 
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inflammatory stage two and three in HCA (Kasper et al, 2010). This supports the 
requirement of assigning HCA according to standard criteria, including individual 
categorisation of stage one as subchorionitis and stage two and above as HCA, as 
followed in this research project. Previous research supports increased bacterial 
detection in higher inflammatory staging, as 87% of fetal membranes had detectable 
bacteria at stage three, compared to 33%, 40% and 60% at stage zero, one and two 
(Kim et al, 2009). However, the range of bacterial load overlapped, with 0-300,000 
16S rRNA gene copies/µl from stage three, 0-50,000, 0-200,000 and 0-400,000 
copies/µl from stage zero, one and two respectively (Kim et al, 2009). No definitive 
baseline or negative control threshold were stated, thus inclusion of results <10 
copies/µl may bias results. Increased bacterial load in higher staging has also been 
reported in amniotic fluid, with 106 16S rRNA gene copy numbers reported in stage 
three, compared to 103 in stage two (Urushiyama et al, 2017). However, 103 was 
also reported from stage one and zero (Urushiyama et al, 2017), suggesting a 
definitive threshold level for stage three, but not a linear relationship, as reported 
here. Although a linear relationship was observed in this research project only one 
HCA patient was diagnosed as stage three, with the majority of patients diagnosed 
at stage two inflammatory response. Recruitment of patients representing all staging 
conditions, plus inclusion of a term HCA subset could improve comparison and 
provide greater insight. 
Inflammatory staging is the main factor monitored for maternal inflammatory 
research due to a more informative descriptive criteria and greater clinical 
significance compared to inflammatory grading (Jessop and Sebire, 2011). Staging 
and grading are routinely combined when assessing HCA (Roberts et al, 2012). 
Findings here support combined analysis due to similar bacterial signal across stage 
and grade. Yet independent analysis of inflammatory grading may be important 
when investigating the location of bacteria, as grading reflects infiltration intensity 
across membranes (Redline et al, 2003). 
 
5.4.4 Bacterial load correlates with five inflammatory factors across the 
amnion and chorion. Increased 16S rRNA gene bacterial load was positively 
correlated to five inflammatory factors which varied across membranes. A positive 
correlation between TLR1, TLR2 and IL-8 to bacterial load was observed in both the 
amnion and chorion, with LY96 and IRAK2 positively correlated to bacterial load in 
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the chorion only. Findings provide multiple factors involved in the TLR pathway as 
potential targets for inflammatory detection. An increase of TLR1 and TLR2 in HCA 
has previously been observed in fetal membranes (Moco et al, 2013). Alternatively 
Rindsjo et al (2007) detected less TLR2 in HCA placental samples, compared to 
healthy patients, but this was related to gestational age, as TLR2 was increased in 
preterm compared to term patients.  
A previous project utilising the same samples also detected increased TLR1, TLR2 
and LY96 in the chorion, plus increased IL-8, IRAK2 and TLR4 in the amnion with 
HCA. TLR1, TLR2, LY96, IL-8 and IRAK2 gene expression was also correlated to 
increased inflammatory staging in HCA amnion and chorion (Waring et al, 2015), 
supporting the majority of findings here. TLR4 was significantly increased in the 
amnion with HCA previously, but not significantly correlated to bacterial load here. 
TLR4 expression and activation may be linked to HCA, but may not be influenced 
by the amount of bacteria.  
The inflammatory mediators significantly correlated to bacterial load here are all 
components of the NF-ĸβ pathway. LY96/MD2 is the extracellular gene linking 
component for lipopolysaccharides (LPS) and TLRs (Kawai and Akira, 2010). IRAK2 
and MyD88 are intracellular components of the NF-ĸβ pathway activated following 
TLR/IL binding (Kawai and Akira, 2010). IL-8 is a downstream product promoted by 
the NF-ĸβ pathway, and has been detected in greater concentrations from fetal 
membranes with chorioamnionitis via multiplex cytokine assays (Sweeney et al, 
2016). IL-8 has also been linked to inflammatory grading of the fetal membranes 
(Kasper et al, 2010), and has been investigated for predictive HCA staging in 
amniotic fluid (Kacerovsky et al, 2009). However, IL-8 detection has also been 
related to membrane weakening and rupture during active labour (Noda-Nicolau et 
al, 2016), thus may not be specific to HCA. 
TLR1 and TLR2 gene expression were positively correlated to bacterial loads in 
both amnion and chorion membranes. These receptors are ligand specific to 
lipopeptides from Gram-negative triacylated bacteria, for example Ureaplasma 
(Moco et al, 2013). This suggests that specific microbial components may activate 
the inflammatory response in HCA via the TLR1/2 hetero/homodimer to trigger the 
NF-ĸβ pathway (Kawai and Akira, 2010). Thus the abundance of Gram-negative 
bacteria on the fetal membranes may be important to the inflammatory response in 
HCA, with interest to specifically investigate this theory by species-specific qPCR. 
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It is possible that activation of the inflammatory response is due to cellular trauma 
tissue ischemia, hypoxic stress or danger signalling rather than bacterial load (Rock 
et al, 2010). Damage associated molecular patterns (DAMPs), including HMGB1 
may activate the MyD88 pathway in the sterile inflammatory response theory (Kawai 
and Akira, 2010; Romero et al, 2014b). However, our work suggests that bacterial 
load is the key driver to inflammation in the fetal membranes studied here.  
Further research investigating the threshold of overall bacterial load or specific 
bacteria required to generate an inflammatory response should be investigated. In 
vitro bacterial stimulation of primary fetal membrane cell culture with a variety of 
bacterial components in varying concentrations, over different time periods may aid 
to detect which bacterial ligand and at what threshold load are required to activate 
the inflammatory response. Plus, to monitor how the inflammatory response 
transcends downstream pathway activation and expression of inflammatory 
mediators in response to bacterial presence. This would also involve monitoring the 
inducible expression of inflammatory factors following stimulation, as inflammatory 
factors may be potential biomarkers for HCA. The sensitivity and specificity of one 
or a combination of inflammatory factors would be required prior to clinical 
application. 
 
5.4.5 Amnion and chorion display comparable bacterial loads irrespective of 
HCA. Similar bacterial loads from different fetal environments has been supported 
by healthy term placental research, with 2.6 x102 16S rRNA gene copies/µl detected 
across maternal and fetal placental surfaces (Lauder et al, 2016; Theis et al, 2019). 
Contrastingly, greater bacterial signals have been detected on the chorion than 
amnion with PPROM (Fortner et al, 2014). The reverse has been reported by Kim 
et al (2009), observing more bacteria on the amnion than chorion with microbial 
invasion of the amniotic cavity (Kim et al, 2009). Increased bacteria on the amnion 
is suggested to reflect increased inflammatory response, as bacteria originating 
from vaginal or lower female reproductive tract environments would have to 
transverse the chorion prior to the amnion (Park et al, 2009). Further imaging 
analysis would allow visualisation of bacteria on each membrane to confirm bacterial 
presence and load. This could be investigated by IHC or Raman microspectroscopy, 
with the later allowing label free, non-destructive bacterial location analysis with 
149 
 
minimal processing from confounding factors of DNA extraction kits or PCR 
reagents (Chen et al, 2014). 
 
5.4.6 There is no difference in bacterial load between non-HCA fetal 
membranes irrespective of gestational age or mode of delivery. This 
strengthens the specificity of linking bacterial load and inflammatory HCA. Similar 
detection levels across gestational age has also been reported by Sweeney et al 
(2016), as 10% of PTB and 14% of term placenta had detectable bacteria in 16S 
rRNA sequencing analysis. This was also seen with species-specific qPCR, as 59% 
and 50% of preterm and term fetal membranes were positive for U. parvum 
(Sweeney et al, 2016). Alternatively, Jones et al (2009) found differences across 
gestational age, with bacteria present in 90% PTB, but not within term tissues. 
However, for the study all PTB were spontaneous vaginal deliveries and all term 
were ELCS (Jones et al, 2009), thus variation in mode of delivery may bias results. 
Findings here suggest that mode of delivery does not impact bacterial load or 
bacterial presence in low risk term fetal membranes, with similar signals from ELCS 
and vaginal deliveries. This suggests minimal bacterial contribution to the fetal 
membranes during labour or delivery; thus mode of delivery may not be the origin 
of bacteria on the fetal membranes. However, bacteria were only detected in 21% 
of low risk term samples using these methods, leading to a small cohort of 12 
patients. For the low risk cohort sequencing was not conducted, and bacterial 
profiles were not analysed. Bacterial profiles could vary between mode of delivery, 
as previously found by Dominguez-Bello et al (2010), with vaginally originating 
bacteria, including Lactobacillus and Prevotella colonising the neonate from vaginal 
deliveries, and skin originating bacteria including Staphylococcus on caesarean 
section neonates. Conversely, a longitudinal study observed no impact on infant 
microbiota following vaginal or caesarean section delivery, from labour to ten weeks 
(Stewart et al, 2017). Variation in bacterial origin would be expected if mode of 
delivery contributed to bacterial communities, yet findings here question the 
confidence in detecting bacteria on low risk term fetal membranes.  
 
5.4.7 The bacterial load of non-HCA fetal membranes cannot be distinguished 
from negative controls, suggesting no distinct bacterial load levels in PTB and 
term fetal membranes in absence of a negative maternal condition. This supports 
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the sterile placenta theory discussed by the majority of research (de Goffau et al, 
2019; Kuperman et al, 2020; Perez-Munoz et al, 2017; Theis et al, 2019), due to 
concordance with negative control bacterial loads, plus greater ability to detect 
bacterial loads in negative controls than non-HCA fetal membranes. However, HCA 
did display a significantly higher bacterial load compared to negative controls. This 
supports the theory that the fetal membranes are sterile unless a maternal condition 
is present, and further indicates the infection related inflammatory response of HCA.  
Comparable bacterial loads between healthy placenta and negative controls of PCR 
grade water has been supported in contamination research studies (Leiby et al, 
2018; Theis et al, 2019), with 102 16S rRNA copies/µl detected from healthy 
placental membranes, plus comparable levels from negative controls of sterile 
water, extraction blanks and air swabs (Lauder et al, 2016). The low levels from 
samples and controls are similar to signals detected within this research project. 
Alternatively, negative controls of air swabbed theatre room have shown to have 
greater bacterial loads than healthy placenta (Theis et al, 2019). Bacterial load 
levels have also shown to be location specific, with a 20-fold increase from placental 
compared to fetal membrane samples (Parnell et al, 2017). In the Theis et al (2019) 
study all bacterial signals were <102, thus under the LOD and may not be accurate 
and reliable. Whereas in the Parnell et al (2017) study, placenta and fetal 
membranes had 400 copies/µl compared to 34 copies/µl from negative controls and 
sterile water (Parnell et al, 2017). The LOD was set at <102 in this research project, 
thus confidence in bacterial signals is only possible above this limit. Nevertheless, 
a signal below this LOD may be present but not accurately assessed in this assay. 
Inability to distinguish between the non-HCA patients and negative control signals 
here, indicates the low bacteria present on non-HCA fetal membranes. The low 
amounts of bacteria in non-HCA samples are likely due to external contribution 
rather than in utero origin; either from sample handling, processing, extraction and 
sequencing methodology or environmental contamination during labour or delivery 
(de Goffau et al, 2019; Kuperman et al, 2020; Perez-Munoz et al, 2017; Theis et al, 
2019). Negative controls in this research consisted of dH2O and DNA extraction kit 
negative controls. Further negative controls could have been included to understand 
the impact of environmental contamination, including air swab or open tubes, 
beneficial to understand bacterial contribution from theatre suites, hospital wards 
and qPCR processing locations (Lauder et al, 2016; Theis et al, 2019). Introducing 
a positive control of spiked samples or further body site analysis from high bacterial 
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load locations would increase comparison and ensure accountability of results 
(Kuperman et al, 2020). This including positive control vaginal samples, which 
display 106 16S rRNA gene copies/µl compared to 102 from placenta and fetal 
membranes (Lauder et al, 2016). 
 
5.5 Conclusion 
Overall findings suggest the involvement of bacterial infection to inflammatory HCA 
and highlights that greater bacterial load levels are linked to HCA inflammatory 
severity and specific inflammatory factors in the fetal membranes. No support for a 
distinct bacterial signal in non-HCA and low risk term fetal membranes was found. 
In combination, findings support the sterile inflammation theory, with low bacterial 
involvement unless an inflammatory related condition is confirmed. 
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Chapter Six: Raman spectroscopy for the detection and distinction of bacteria 
in mono and polymicrobial culture conditions. 
 
Abstract 
Aim 
The aim of chapter six was to determine if Raman spectroscopy could identify 
bacteria based on a spectral fingerprint or distinct spectral peaks. In addition, this 
chapter aims to investigate the ability to discriminate individual bacteria in 
polymicrobial cultures. It is hoped that understanding this technology allows for 
potential application to clinical tissues. 
Methods 
The spectral fingerprint of bacterial droplets from cultured Escherichia coli, 
Klebsiella pneumoniae and Staphylococcus aureus were measured using Raman 
spectroscopy (inVia, Renishaw) at conditions of 532 nm laser, 500-2000 cm-1 
spectral range, at 80 seconds for four accumulations before processing in WIRE 
(5.1; Renishaw, 2020b). Bacteria were investigated in multiple concentrations (10-1-
10-5), or in mono and polymicrobial combinations. 
Results 
The Raman spectral peak at 1003 cm-1 was consistent across all bacteria, 
combinations and concentrations but not present in controls, with intensity of this 
peak significantly correlated to E. coli and K. pneumoniae concentrations. E. coli 
and K. pneumoniae shared three spectral peaks. S. aureus had the most distinct 
Raman peaks (95%) these assigned to Gram-positive cell wall components.  
Conclusion 
Findings show that bacteria can be identified by one spectral peak, with 
characteristic Raman peaks relevant to specific bacterial characteristics including 
Gram status identified. Quantitative analysis and bacterial discrimination in 
polymicrobial cultures is inconclusive. Additional Raman spectra from a wider 
variety of bacteria in culture and clinical conditions is required for confidence in 
species level resolution. 
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6.1 Introduction 
In a clinical setting the requirement for timely bacterial identification is critical for 
diagnosis and treatment options. Current clinical detection methods include 
bacterial culture, PCR and sequencing (Lorenz et al, 2017; Pahlow et al, 2015). 
Identification is reliable and sensitive, but requires increasing time commitments, 
with contamination issues from culture media and sequencing reagents (Maquelin 
et al, 2002; Pahlow et al, 2015).  
A method requiring less time and processing would increase the efficiency, accuracy 
and confidence in detecting bacterial presence in low biomass clinical tissues. 
Previously, Fourier-transformed infrared spectroscopy (FTIR) and matrix-assisted 
laser desorption/ionization (MALDI) spectroscopy techniques have been applied to 
bacterial culture and clinical samples for timely detection of clinical conditions 
without excess processing (Bocklitz et al, 2015; Pielesz et al, 2019). These 
spectroscopy techniques allow biochemical and molecular profiling (Bocklitz et al, 
2015), rather than morphological characterisation and sequence detection as per 
previous culturing and sequencing technologies (Lorenz et al, 2017; Pahlow et al, 
2015). However, these spectroscopy methods are destructive and require high 
sample volumes, limiting clinical application (Hlaing et al, 2013; Maquelin et al, 
2002). 
A novel method for bacterial detection and pathological diagnosis has been applied 
to bacterial cultures (Almarashi et al, 2012; de Siqueira E Oliveria, Giana and 
Silveira, 2012; Kusters et al, 2015), and placental tissues (Chen et al, 2014). This 
method is Raman spectroscopy, which acts to identify the presence and location of 
specific bacteria or tissue differences based on biochemical information, molecular 
composition, functional groups and chemical structures displayed as a unique 
spectral fingerprint (Ashton et al, 2011; Mlynarikova et al, 2015). Raman 
spectroscopy is a non-destructive, non-invasive label free spectroscopy method, 
which is a beneficial choice for bacterial and tissue analysis due to decreased 
preparation and processing steps (Pahlow et al, 2015). This decreases analysis time 
and improves reliability of results, due to the removal of confounding culture or DNA 
extraction steps (Mlynarikova et al, 2015).  
In bacterial detection research, 23 identifying spectral peaks across multiple 
bacteria have been observed, with the ability to distinguish between Gram-positive 
and negative bacteria at the 857, 907 and 1382 cm-1 peaks with 87-100% specificity 
(de Siqueira E Oliveria, Giana and Silveira, 2012). Strain specific distinctive peaks 
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have also been suggested, with differentiation possible between pathogenic 
O157:H7 and non-pathogenic K-12 E. coli strains (Hamasha et al, 2013), or based 
on antibiotic properties (Kusters et al, 2015; Li et al, 2018). Although spectral 
fingerprints have been explored for bacterial identification, the current limit of 
detection (LOD) for microbiological identification using Raman spectroscopy has not 
yet been determined.  
 
6.1.1 Clinical relevance of Raman spectroscopy 
Non-destructive Raman spectroscopy could be beneficial in the clinical setting of 
pregnancy related conditions, including histological chorioamnionitis (HCA), to 
improve point of care diagnosis. Current diagnosis methods require fixative and 
embedding procedures, before applying staining protocols (Holzman et al, 2007; 
Stout et al, 2013). All of which require extended preparation steps, which modify the 
genuine tissue composition and interfere with the microbiota, as shown with the 
Formalin-Fixed Paraffin-Embedded samples used in chapter four of this thesis. 
Sequencing or culture methods are then applied for bacterial detection. A non-
destructive diagnostic method which would remove staining and labelling, plus 
combining microbiological analysis with visual detection may improve HCA 
diagnosis. Previous research has applied Raman spectroscopy to placental and 
fetal membrane samples (Chen et al, 2014; O’Brien et al, 2014; Pielesz et al, 2019). 
This includes the detection of spectral peaks distinctive to protein side chains from 
hypoxic placentas with pre-eclampsia (Chen et al, 2014), and decreased lipid 
content in preterm cervical cells (O’Brien et al, 2014). Thus, suggesting a sound 
rationale for application to HCA fetal membrane samples. 
 
This thesis has found that increased bacterial loads are present on the fetal 
membranes in the mostly asymptomatic condition of HCA (Chapter five). Bacterial 
load is therefore a suggested marker for HCA, yet due to the low biomass sample 
characteristics further confirmation of bacterial load and presence would be 
beneficial. Raman offers the potential opportunity to determine bacterial presence 
from biochemical characteristics measured by spectroscopy, as well as visualising 
the spatial location of bacteria on the fetal membranes by microspectroscopy. Prior 
to clinical application, confidence in the LOD from low bacterial concentrations is 
required. Plus, understanding the ability to identify bacteria to species level, and 
identifying individual microbes in a polymicrobial culture. Confidence is required to 
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ensure correct identification and assignment, allow targeted analysis, plus generate 
known reference spectra for comparison when applied to low concentration 
polymicrobial clinical tissues.  
 
The aim of chapter six was to determine if Raman spectroscopy could detect and 
differentiate between three bacteria (E. coli, K. pneumoniae and S. aureus) in a 
polymicrobial environment, based on a spectral fingerprint or distinct spectral peaks. 
In addition, to understand the LOD of the instrument for future application to low 
biomass fetal membrane tissues.  
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6.2 Theory and review of Raman spectroscopy 
6.2.1 Theory of Raman spectroscopy 
Raman spectroscopy is used for identifying unique functional groups, molecular 
composition and chemical structures within a sample. This is based on the vibration 
of chemical bonds caused by intense laser light scattering creating high resolution 
narrow bands (Ashton et al, 2011; Mlynarikova et al, 2015; Movasaghi, Rehman and 
Rehman, 2007)(Figure 6.1). 
 
 
Figure 6.1 Typical Raman biological spectra. Representation of a typical spectra from 
Raman spectroscopy reflective of relevant biological material peaks and bands, with 
identifying groups highlighted. Image provided by Renishaw (Renishaw, 2020a). 
 
 
6.2.2 Raman spectroscopy instrumentation 
The Raman instrument consists of a monochromatic light source which emits a laser 
light onto the sample causing molecule excitation (Lorenz et al, 2017; Pahlow et al, 
2015). The photon molecules are excited from the ground state to a virtual energy 
state, before returning to a lower vibrational state (Butler et al, 2016; Hlaing et al, 
2013; Larkin, 2011). It is this vibrational energy that is measured in Raman 
spectroscopy, and is unique to each molecule creating individual spectral 
fingerprints (Larkin, 2011).  
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In the specific instrument used here (inVia Raman, Renishaw), the initial laser light 
travels through a beam expander to direct the light source (Figure 6.2), before 
passing through a focus mirror via a holographic notch filter. The laser then focuses 
on the sample positioned on a microscope stage (Smith and Dent, 2005). Following 
reflection from the sample and microscope slide surface the scattered light travels 
away from the sample and passes back through the holographic notch filters, 
through a focus slit and into a diffraction grating device to split the scattered light 
into a spectrum of wavelengths (Smith and Dent, 2005). The spectra are then 
detected by a light sensitive device. The charge coupled device detection camera 
(CCD; Figure 6.3), is a multichannel detector with photosensitive elements, which 
detects, and stores charged molecular information converted to a numerical value 
(Hamasha et al, 2013; Larkin, 2011). Software then displays results by wave number 
Raman shifts from incident frequency (cm-1) for spectral intensity measurements 
(Movasaghi, Rehman and Rehman, 2007). 
 
 
 
Figure 6.2 Internal view of inVia Raman enclosure. A labelled photograph of the internal 
instrument of the inVia Raman enclosure used in this research. The laser light initially travels 
through the beam expander, to the laser mirror, through the holographic notch filter and into 
the focus slit to be directed onto the microscope slide surface. The light is reflected from the 
sample and microscope slide surface back through the focus slit and into the diffraction 
grating device to split the laser into a spectra and direct this to the charge coupled device 
detection camera to store the measured molecular information. 
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Figure 6.3 External view of inVia Raman enclosure. An external diagrammatic 
representation of the inVia Raman enclosure (Renishaw). Image provided by Renishaw 
(Renishaw, 2020a) with additional labelling. The class one laser enclosure contains the 
microscope and microscope stage. The main enclosure contains the structures depicted in 
figure 6.2. The charge coupled device detection camera can be viewed to the left of the 
enclosure. 
 
 
6.2.3 Raman spectral processing 
The output from Raman spectroscopy is a spectral graph comparing Raman shift 
(cm-1) and intensity (au), plus a numerical intensity information table. Output spectra 
require post-processing to ensure that only genuine molecular vibrations from laser 
excitation are processed, and confounding factors are not highlighted as relevant 
features. Estimated baseline correction can firstly be applied. This to remove sample 
and background fluorescence, plus thermal fluctuations from the CCD to give a flat 
baseline for the spectra (Butler et al, 2016; Guo, Bocklitz and Popp, 2016). Cosmic 
ray removal should then be performed to remove any sporadic random narrow band 
spikes which may be observed on the spectra. These occur when a high energy 
particle collides with the CCD leading to random disturbance (Butler et al, 2016; 
Hlaing et al, 2013). The Raman shift spectra can then be truncated to increase focus 
to a desired range, in biological research the relevant area is mainly 600-1600 cm-1 
(Butler et al, 2016; Hamasha et al, 2013; Smith and Dent, 2005). 
Spectral peak tables provide information for peaks to be classified and assigned to 
a product by supervised or unsupervised methodology (Butler et al, 2016). 
Unsupervised methodology requires no prior knowledge of the sample, with a 
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pattern recognition approach and comparison to a published reference database, 
indicating what product each peak represents (Rizkalla et al, 2012). Whilst 
supervised classification compares peak number to a predetermined reference 
database created on the identical instrument under identical parameters and sample 
processing (Butler et al, 2016). 
 
6.2.4 Sample processing for Raman spectroscopy 
Sample processing of biological material must be carefully considered prior to 
application. For bacterial analysis, the majority of protocols suggest washing and 
centrifuging the sample, aiming to remove background contribution from the media 
(Hlaing et al, 2013). When media is not removed following E. coli culture, peaks 
have been detected at 886, 1480 and 1620 cm-1 from Mueller Hinton media (de 
Siqueira E Oliveria, Giana and Silveira, 2012). Alternatively 1040, 1360 and 1600 
cm-1 in RPMI media (Mlynarikova et al, 2015), with variance due to different 
nutritional enrichment products (Mlynarikova et al, 2015).  
The choice of microscope slide impacts spectral output. Glass and calcium fluoride 
(CaF2) microscope slides show high background fluorescence (Butler et al, 2016), 
with a key identifiable peak at 321 cm-1 from CaF2 slides (Lewis et al, 2017). 
Stainless steel microscope slides show optimal results with low fluorescence and 
no specific spectral peaks detected (Lewis et al, 2017). With the additional benefit 
of decreased acquisition time and increased intensity due to the double passing of 
the laser when redirected from the reflective surface (Lewis et al, 2017).  
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6.3 Raman spectroscopy methods 
Three different bacterial species (Escherichia coli, Klebsiella pneumoniae and 
Staphylococcus aureus) were used to evaluate the ability of Raman spectroscopy 
to differentiate between bacteria at varying concentrations and combinations.  
 
6.3.1 Bacterial culture 
Under sterile techniques one colony of E coli, K. pneumoniae or S. aureus was 
inoculated from a Luria-Bertani (LB) agar plate into 100 ml LB media and incubated 
at 37 °C for 16 hours. Optical density (OD600) values were measured on a UV 
spectrophotometer (Jenway 7305), with values of >1.4 biomass processed (OD600 
x µl of culture). To quantify bacteria, stock solutions and dilutions were then plated 
on LB agar plates and colony forming units (CFUs) calculated following overnight 
incubation at 37 °C. 
 
6.3.2 Bacterial preparation for Raman spectroscopy 
After incubations, 1 ml of bacterial culture was collected into a microcentrifuge tube. 
Additional aliquots were collected for serial dilutions and polymicrobial analysis.  
To prepare dilutions, 1 ml of overnight culture and 9 ml of fresh LB media were 
combined, before performing serial dilutions to cover the desired range (10-1-10-5) 
and aliquoting 1 ml of each dilution into sterile microcentrifuge tubes.  
For polymicrobial analysis, 500 µl of two bacterial cultures were collected and 
combined into microcentrifuge tubes (E. coli and K. pneumoniae, E. coli and S. 
aureus or K. pneumoniae and S. aureus).  
All 1 ml cultures (mono, polymicrobial and dilutions) were then centrifuged at 15,000 
xg for four minutes, before discarding the supernatant and repeating the 
centrifugation step. Supernatants were discarded and pellets were resuspended in 
30 µl dH2O by gentle pipetting. To a stainless steel slide (Renishaw), 10 µl of each 
culture was added and air dried for two hours before Raman analysis. A control of 
10 µl fresh LB media was prepared under identical conditions. This was repeated in 
triplicate for each mono and polymicrobial culture, concentration and control. 
 
6.3.3 Raman spectroscopy experimental set up 
A Raman inVia Qontour system (Renishaw) was used to analyse samples, equipped 
with a Lecia microscope and Lecia EL600 compact light source. WIRE software (5.1; 
Renishaw, 2020b) was used to set parameters and analyse output results. 
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6.3.4 Instrument calibration 
Full machine calibration was performed upon installation (May 2019), with monthly 
calibration performed by technicians. Daily calibrations were performed prior to 
operation using the quick calibration function in WIRE (5.1; Renishaw, 2020b). This 
uses an internal silicon reference to monitor accuracy of peak detection, with an 
expected peak centre of 520.5 cm-1 at a constant intensity over time. 
 
6.3.5 Bacterial spectral acquisition 
Dried bacterial droplets on stainless steel microscope slides were added onto the 
Raman microscope stage within the class one enclosure and viewed under 50x 
magnification using the live video tool. Visible bacterial areas were selected for 
measurement. Single point scan measurements were performed using the spectral 
acquisition setup. A 532 nm laser (RL532-08) at 2400 lines/mm grating and 50% 
laser power (25 mW) was applied and all spectra were initially collected at 200-3200 
cm-1 at ten seconds exposure time and one accumulation. The spectral range was 
then reduced to 500-2000 cm-1 to increase the focus on biologically relevant 
material. Samples were measured at 80 seconds for four accumulations to an 
acquisition time of 320 seconds per spectra.  
Bacterial droplets were analysed at four points in the outer perimeter, with replicates 
merged using the batch measure function. Background spectra were collected from 
stainless steel slides and fresh LB media under identical parameters. 
 
6.3.6 Raman spectral processing method 
Baselines were subtracted from raw spectra using least squared polynomial fit to an 
order of four (Butler et al, 2016; Guo, Bocklitz and Popp, 2016). This removes 
sample and background fluorescence to an approximate closely related profile 
without loss of signature peaks (Hamasha et al, 2013). Cosmic rays were detected 
and removed using the nearest neighbour algorithm. Once again ensuring 
replacement of the cosmic ray to a similar spectral neighbour (Larkin, 2011). Pick 
peak function was used to automatically assign numerical values to peaks. 
Information on peak centre, height, width, area, absolute intensity, plus high and low 
edges were tabulated. 
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6.3.7 Raman data analysis 
Spectra and peak information were exported from WIRE (5.1, Renishaw 2020b). 
Initial analysis involved comparison of the overall spectral image, bacterial 
fingerprint and the presence/absence of peaks across mono and polymicrobial 
cultures. Peak shifts and intensity were also analysed across all concentrations and 
bacterial combinations. Correlation between peak intensity and bacterial 
concentration was performed via nonparametric Spearmans Rank Bonferroni 
adjustment in R (R Core Team, 2017).  
Assigning peaks to relevant biomolecular components was conducted by 
unsupervised methodology, by comparison to published reference databases (de 
Gelder et al, 2007; Maquelin et al, 2002; Movasaghi, Rehman and Rehman, 2007; 
Talari et al, 2015), plus from research using comparable systems and protocols 
(Cheong et al, 2016; de Siqueira E Oliveria, Giana and Silveira, 2012; Hamasha et 
al, 2013). 
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6.4 Results 
6.4.1 Calibration and background reference spectra 
Positive calibration was confirmed by detection of a high intensity narrow band 
visible at 520 cm-1 relating to the internal silicon chip (Figure 6.4). 
 
Background measurements were taken from stainless steel microscope slides and 
blank LB culture media. The spectra from the microscope slide returned 
undistinguishable peaks with counts <70 (Figure 6.5). No detectable spectral peaks 
and intensity counts <100 were observed from the culture media (Figure 6.6). 
 
 
 
 
Figure 6.4 Reference calibration spectra of the internal silicon chip. An example of the 
output spectra for the internal silicon chip within the Raman instrument used for calibration. 
Figure represents Raman shift cm-1 against intensity counts. A defined peak at 520.5 cm-1 
is expected. 
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Figure 6.5 Reference background spectra of a stainless steel microscope slide. An 
example of the reference calibration spectra for the stainless steel microscope slide of which 
bacterial droplets were mounted. Figure represents Raman shift cm-1 against intensity 
counts. 
 
 
 
Figure 6.6 Reference background spectra of culture media. An example of the 
reference calibration spectra for blank Luria-Bertani (LB) culture media of which all bacteria 
were cultured. Figure represents Raman shift cm-1 against intensity counts. 
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6.4.2 Example spectral processing results 
Unprocessed raw Raman spectra from a bacterial sample was collected from WIRE 
(5.1; Renishaw, 2020b)(Figure 6.7A). Baselines were detected (Figure 6.7B) and 
subtracted to a least squared polynomial fit (Figure 6.7C). Following cosmic ray 
analysis on this example, only one cosmic ray was detected and removed (601 cm-
1; Table 6.1). Automatic peak assignment was performed to create a final labelled 
Raman spectra and peak information table (Figure 6.8). Processing was identical 
across all samples. 
 
 
 
Figure 6.7 Raman baseline subtraction example. An example of a raw Raman bacterial 
spectra collected at 80 seconds for four accumulations on a 532nm laser, 2400 lines/mm 
grating, 50% laser power at 500-200cm-1 spectral range (A). The baseline detection method 
was then used to detect baseline levels (B) and subtract baseline signals to remove 
background and sample autofluorescence (C). Spectra measured and processed in WIRE 
(5.1; Renishaw, 2020b). 
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Table 6.1 Cosmic ray removal table. An example table for the detection and assignment 
of cosmic rays via WIRE (5.1; Renishaw, 2020b). 
 
 
 
Figure 6.8 Example of pick peak function and final processed spectra. Raman peak 
assignment was performed automatically following acceptance of cosmic ray removal at 
601 cm-1 (Table 6.1). Results are displayed as labelled spectral peaks and numerical 
spectral peak information tabulated in WIRE (5.1; Renishaw, 2020b). 
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6.4.3 Raman spectra from monomicrobial droplets 
Raman spectra in the range of 600-2000 cm-1 were collected from four points on 
each bacterial droplet, repeated in triplicate and merged to present averaged values. 
Figure 6.9 displays the individual Raman spectra from merged E. coli (A), K. 
pneumoniae (B) and S. aureus (C). 
 
All bacteria have spectral fingerprints containing defining properties representing 
biological material. Increased peak intensity, yet decreased resolution was detected 
between 1200-1700 cm-1 (Figure 6.9). Spectra from E. coli and K. pneumoniae were 
more similar, with S. aureus more different (Figure 6.9). 
One Raman peak was consistently detected across all bacteria, combinations and 
concentrations (Figure 6.9). The peak at 1003 cm-1 was assigned to the amino acid 
phenylalanine (Cheong et al, 2017; de Gelder et al, 2007; Lorenz et al, 2017; 
Movasaghi, Rehman and Rehman, 2007; Talari et al, 2015). 
 
Individual peaks within the 600-1700 cm-1 range were assigned to biologically 
relevant components by comparison to previously generated databases (de Gelder 
et al, 2007; Hlaing et al, 2013; Movasaghi, Rehman and Rehman, 2007; Talari et al, 
2015).  
Automatic assignment consistently detected 16 Raman peaks from merged E. coli 
spectra, 12 of which were distinct to E. coli (75%). These mainly represent DNA 
bases, amides, lipids and proteins, yet also specifically assigned to 
lipopolysaccharides (LPS) and phosphoenolpyruvate (Table 6.2). K. pneumoniae 
had 15 Raman peaks, 11 of which were distinct only to this bacterium (75%). The 
majority of those specific to K. pneumoniae represented universal DNA bases, 
amides and proteins (Table 6.3). S. aureus had the highest number of Raman peaks 
assigned (19), with 95% (18/19) distinct to S. aureus. These covered a greater 
spectral range and were assigned to a wider variety of categories including, amides, 
acids, DNA bases and proteins, plus collagen, teichoic acid and myristic acid (Table 
6.4). 
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Figure 6.9 Raman spectra from monomicrobial culture droplets. Processed Raman 
spectra for overnight cultures of bacterial droplets from Escherichia coli (A), Klebsiella 
pneumoniae (B) and Staphylococcus aureus (C) following background subtraction, cosmic 
ray removal and automatic peak assignment. Spectra were collected using a 532nm laser 
at 2400 lines/mm grating, 50% laser power at 80 seconds exposure for four accumulations 
over a spectral range of 500-2000cm-1. The 1003 cm-1 peak consistent across all bacteria 
is highlighted. 
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Table 6.2 Raman spectral peak assignment for Escherichia coli. Raman spectral peaks 
detected in E. coli, with band assignment from pre-established databases and research. 
Raman peaks highlighted in bold were detected in this bacterium only. Spectral peaks 
correlate to those detected in figure 6.9A. 
  
Raman 
shift (cm-1) 
Band assignment Reference 
532 Alanine de Gelder et al, 2007 
642 Proline de Gelder et al, 2007 
703 DNA/RNA bases de Gelder et al, 2007 
811 RNA, riboflavin de Gelder et al, 2007; Hlaing et al, 2013; 
Talari et al, 2015 
854 Lipopolysaccharides de Gelder et al, 2007 
877 Proline de Gelder et al, 2007; Movasaghi, Rehman 
and Rehman, 2007; Talari et al, 2015 
935 Proline, valine, glycogen, 
alpha helix protein backbone 
Movasaghi, Rehman and Rehman, 2007; 
Talari et al, 2015 
1003 Phenylalanine Cheong et al, 2017; de Gelder et al, 2007; 
Lorenz et al, 2017; Movasaghi, Rehman and 
Rehman, 2007; Talari et al, 2015 
1034 Phenylalanine, collagen, 
phosphoenolpyruvate 
de Gelder et al, 2007; Talari et al, 2015 
 
1046 Tryptophan de Gelder et al, 2007 
1127 Nucleic acid Li et al, 2018 
1240 RNA, amide III, proline de Gelder et al, 2007; Hlaing et al, 2013; 
Talari et al, 2015 
1338 Cytosine, amide III Ashton et al, 2011; Neugebauer et al, 2006 
1453 Structural proteins and lipids de Siqueira E Oliveria, Giana and Silveira, 
2012; Movasaghi, Rehman and Rehman, 
2007; Talari et al, 2015 
1578 Adenine, guanine de Siqueira E Oliveria, Giana and Silveira, 
2012; Talari et al, 2015 
1663 Amide I, DNA, protein Hlaing et al, 2013; Talari et al, 2015 
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Table 6.3 Raman spectral peak assignment for Klebsiella pneumoniae. Raman 
spectral peaks detected in K. pneumoniae, with band assignment from pre-established 
databases and research. Raman peaks highlighted in bold were detected in this bacterium 
only. Spectral peaks correlate to those detected in figure 6.9B. 
  
Raman shift 
(cm-1) 
Band assignment Reference 
529 Uracil, fructose  de Gelder et al, 2007 
578 Adenine, guanine de Gelder et al, 2007 
643 Tyrosine Movasaghi, Rehman and Rehman, 2007 
736 Adenine Talari et al, 2015 
747 Phenylalanine de Gelder et al, 2007 
781 Cytosine, uracil Hlaing et al, 2013; Talari et al, 2015 
829 Tyrosine de Siqueira E Oliveria, Giana and Silveira, 
2012; Maquelin et al, 2002 
936 Amylose de Gelder et al, 2007 
1003 Phenylalanine Cheong et al, 2017; de Gelder et al, 2007; 
Lorenz et al, 2017; Movasaghi, Rehman and 
Rehman, 2007; Talari et al, 2015 
1127 Nucleic acid de Gelder et al, 2007; Li et al, 2018 
1239 Amide III, mannose de Gelder et al, 2007; Hlaing et al, 2013; Talari 
et al, 2015 
1338 Cytosine, amide III Ashton et al, 2011; Neugebauer et al, 2006 
1452 Amide III, glycine, 
tryptophan 
de Gelder et al, 2007; Hlaing et al, 2013 
1578 Adenine, guanine, de Siqueira E Oliveria, Giana and Silveira, 
2012; Talari et al, 2015 
1664 Amide I Talari et al, 2015 
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Table 6.4 Raman spectral peak assignment for Staphylococcus aureus. Raman 
spectral peaks detected in S. aureus, with band assignment from pre-established databases 
and research. Raman peaks highlighted in bold were detected in this bacterium only. 
Spectral peaks correlate to those detected in figure 6.9C. 
Raman shift 
(cm-1) 
Band assignment Reference 
652 Glucose de Gelder et al, 2007 
743 DNA/RNA bases de Gelder et al, 2007 
746 DNA/RNA bases Movasaghi, Rehman and Rehman, 2007; Talari 
et al, 2015 
783 DNA/RNA bases Movasaghi, Rehman and Rehman, 2007; Talari 
et al, 2015 
824 Valine, histidine de Gelder et al, 2007 
856 Proline Movasaghi, Rehman and Rehman, 2007; Talari 
et al, 2015 
884 Collagen Movasaghi, Rehman and Rehman, 2007; Talari 
et al, 2015 
907 Teichoic acid de Siqueira E Oliveria, Giana and Silveira, 2012 
973 Pyruvate, phosphate de Gelder et al, 2007 
1003 Phenylalanine Cheong et al, 2017; de Gelder et al, 2007; 
Lorenz et al, 2017; Movasaghi, Rehman and 
Rehman, 2007; Talari et al, 2015 
1050 Fatty acids de Gelder et al, 2007 
1128 Myristic acid, proteins and 
carbohydrates 
de Gelder et al, 2007; Movasaghi, Rehman and 
Rehman, 2007; Talari et al, 2015 
1333 Proline, guanine de Gelder et al, 2007; Movasaghi, Rehman and 
Rehman, 2007; Talari et al, 2015 
1396 β-carotene Talari et al, 2015 
1447 Phenylalanine, proteins de Gelder et al, 2007; Movasaghi, Rehman and 
Rehman, 2007; Talari et al, 2015 
1451 Collagen Movasaghi, Rehman and Rehman, 2007; Talari 
et al, 2015 
1580 Phenylalanine Talari et al, 2015 
1623 Tryptophan Talari et al, 2015 
1665 Amide I, collagen Movasaghi, Rehman and Rehman, 2007; Talari 
et al, 2015 
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6.4.4 Raman spectra from polymicrobial droplets 
Spectra from combined polymicrobial bacterial droplets were analysed to determine 
if previously highlighted distinct peaks from individual bacteria could be detected in 
a polymicrobial environment.  
 
When monitored independently E. coli and K. pneumoniae shared similar spectral 
profiles and four spectral peaks (1003, 1127, 1338 and 1578 cm-1) representing 
nucleic acid bases and amides, plus the phenylalanine peak detected in all bacteria 
(Table 6.2 and 6.3). 
 
In combined droplets, the shared 1003 and 1127 cm-1 peaks were present, yet 1338 
and 1578 cm-1 showed a -2 cm-1 and +1 cm-1 Raman shift to 1336 and 1579 cm-1 
respectively (Figure 6.10A). The distinct peaks previously detected only in E. coli 
(642 and 1453 cm-1) or K. pneumoniae (936 and 1664 cm-1) were also detected in 
combined droplets (Figure 6.10A). However, 10/12 and 8/11 previously distinct 
peaks from E. coli and K. pneumoniae respectively were not detected in combined 
cultures. Although not detected exactly, slight Raman shifts of +2, -1, +1 and +1 cm-
1 for peaks of 811, 935, 1578 and 1663 cm-1 were detected from E. coli, or +2, -1, 
+1, -1 cm-1 for 578, 643, 1452 and 1579 cm-1 for K. pneumoniae. 
 
E. coli and S. aureus shared one specific peak for phenylalanine (1003 cm-1) when 
analysed independently (Table 6.2 and 6.4), this peak was also observed in the 
polymicrobial combination (Figure 6.10B). Distinct peaks at 746 and 1451 cm-1 
previously detected independently from S. aureus were present in combined 
cultures, as was the E. coli specific 1663 cm-1 peak (Figure 6.10B). Once again 
11/12 E. coli independent peaks were not detected in combined cultures, neither 
were 16/19 from S. aureus. Closely related peaks were detected in combined 
cultures with a -1, -2 and +1 cm-1 shift for 854, 1453 and 1578 cm-1 for E. coli and a 
-2 cm-1 shift at 783 cm-1 for S. aureus. 
 
When compared individually K. pneumoniae and S. aureus shared the 1003 cm-1 
spectral peak representing phenylalanine (Table 6.3 and 6.4), also detected in 
combined cultures (Figure 6.10C). In combined droplets, four peaks previously only 
detected in K. pneumoniae were present (747, 936, 1338 and 1664 cm-1), with two 
peaks specific to S. aureus (973 and 1580 cm-1; Figure 6.10C). Closely related 
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peaks were detected in combined cultures related to S. aureus including a +1, -2, 
+1 cm-1 and +1 cm-1 shift for 746, 783, 1447 and 1665 cm-1, or a +2 cm-1 shift at 
1578 cm-1 for K. pneumoniae.  
 
 
 
 
Figure 6.10 Raman spectra from polymicrobial culture droplets. Raman spectra from 
combined bacterial droplets of overnight washed cultures from Escherichia coli and 
Klebsiella pneumoniae (A), E. coli and Staphylococcus aureus (B), plus K. pneumoniae and 
S. aureus (C), following background subtraction, cosmic ray removal and automatic peak 
assignment in WIRE (5.1; Renishaw, 2020b). Spectra were collected using a 532nm laser 
at 2400 lines/mm grating, 50% laser power at 80 seconds exposure for four accumulations 
over a spectral range of 500-2000cm-1.  
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6.4.5 Raman spectral intensity results 
To determine if Raman spectroscopy could be used to quantify bacterial 
concentration, dilutions of bacterial cultures were analysed (10-1-10-5). Intensity of 
the 1003 cm-1 peak was selected for analysis due to consistent detection throughout 
all mono and polymicrobial combinations and concentrations.  
The intensity of the 1003 cm-1 peak varied across undiluted bacteria, with this 
observed at 27,447, 43,900 and 12,561 counts from E. coli, K. pneumoniae and S. 
aureus, respectively. Absolute intensity of the 1003 cm-1 peak across dilutions is 
displayed in Table 6.5 and Figure 6.11. Bacterial concentration was significantly 
negatively correlated to intensity of the 1003 cm-1 spectral peak in E. coli (R2=-0.943, 
p=0.017) and K. pneumoniae (R2=-1.000, p=0.003), but not for S. aureus (R2=-
0.771, p=0.103).  
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 Undiluted 10-1 10-2 10-3 10-4 10-5 
E. coli 27,447 18,451 17,510 13,987 15,973 10,274 
K. pneumoniae 43,900 34,336 23,300 18,825 7447 1270 
S. aureus 12,561 6231 10,382 11,579 5485 1424 
 
Table 6.5 Table of intensity for the 1003 cm-1 spectral peak from serial dilution curves. 
Intensity of the 1003 cm-1 Raman spectral peak from overnight washed cultures of 
Escherichia coli, Klebsiella pneumoniae and Staphylococcus aureus measured in undiluted 
bacterial cultures and over a dilution series (10-1-10-5) to determine the quantitative ability 
of inVia Raman spectroscopy. Spectra were collected using a 532nm laser at 2400 
lines/mm grating, 50% laser power at 80 seconds exposure for four accumulations over a 
spectral range of 500-2000cm-1.  
 
 
Figure 6.11 Intensity of the 1003 cm-1 spectral peak from serial dilution curve. Spectral 
peak intensity of the 1003 cm-1 peak in overnight washed and diluted cultures of Escherichia 
coli, Klebsiella pneumoniae and Staphylococcus aureus from undiluted bacterial cultures 
and over a dilution series. Represented as neat or dilutions of 10-1-10-5. Figure correlates to 
findings from Table 6.5.  
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6.5 Discussion 
Chapter six aimed to determine if Raman spectroscopy could identify bacteria based 
on a spectral fingerprint or distinct spectral peaks in mono and polymicrobial 
cultures. In addition, LOD analysis for application to low biomass clinical samples 
was performed. Overall, findings indicate that the three bacteria studied share one 
spectral peak (1003 cm-1), with Raman peaks relevant to specific bacterial 
characteristics including Gram status identified. Raman spectroscopy presents high 
sensitivity and resolution, yet the ability to confidently discriminate bacteria in 
polymicrobial cultures was inconclusive, as was the quantitative ability of the 
instrument. Thus, further optimisation of relevant species in low biomass samples 
would be required prior to application to clinical conditions. 
 
6.5.1 Bacteria can be detected by a Raman peak at 1003 cm-1. The detection of 
a sharp high intensity peak at 1003 cm-1 was observed across all bacteria regardless 
of concentration, mono and polymicrobial combination or bacterial status, thus may 
be a possible characteristic marker to identify bacterial presence in clinical samples. 
The 1003 cm-1 peak represents phenylalanine (de Gelder et al, 2007; Movasaghi, 
Rehman and Rehman, 2007; Talari et al, 2015). This essential amino acid has 
previously been detected in a wide range of bacterium, including confirmation in E. 
coli (Chong et al, 2016; Hamasha et al, 2013; Hlaing et al, 2013; Lorenz et al, 2017; 
Mlynarikova et al, 2015), K. pneumoniae (Cheong et al, 2017) and S. aureus 
(Hamasha et al, 2013; Lorenz et al, 2017; Mlynarikova et al, 2015). Alongside 
Staphylococcus epidermidis (Mlynarikova et al, 2015), Pseudomonas aeruginosa 
(Hlaing et al, 2013) and Bacillus subtilis (Strola et al, 2014). The 1003 cm-1 peak is 
ubiquitous across bacteria here, but as an essential amino acid this may also be 
present in other biological samples and human tissues (Paolini et al, 2001). To be 
confident that this peak is represented universally across bacteria, but specific only 
to bacteria would require further investigation in a greater range of bacteria, 
including Prevotella and Ureaplasma for clinical relevance. Alternatively, it may be 
intensity of the peak which is distinctive rather than presence. Alternate peaks may 
be more specific to bacterial detection including bacterial specific LPS detected in 
E. coli at 854 cm-1, or Gram-positive cell wall components detected in S. aureus, 
including teichoic acid at 907 cm-1. Alternatively, the 1453 cm-1 peak has been 
suggested as the spectral peak universal and specific to bacteria, linked to structural 
lipids and proteins (de Siqueira E Oliveria, Giana and Silveira, 2012). The 1453 cm-
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1 peak was detected in E. coli within this research project, with a slight shift observed 
in K. pneumoniae (-1 cm-1, 1452 cm-1) and S. aureus (-2 cm-1, 1451 cm-1).  
 
6.5.2 E. coli, K. pneumoniae and S. aureus have similar spectral fingerprints, 
with independent characteristic peaks relevant to each bacteria detected. 
Biologically relevant band assignments were detected across all bacterial spectra, 
mainly assigned to DNA bases and amino acids (de Gelder et al, 2007). All bacteria 
displayed similar spectral fingerprints, with increased intensity in the 1200-1700 cm-
1 range, representing proteins and amides (Butler et al, 2016; Talari et al, 2015). E. 
coli and K. pneumoniae were the only two bacteria to share any identical peaks, 
other than the universal phenylalanine peak (1003 cm-1), with three additional peaks 
shared (1127, 1338 and 1578 cm-1). More closely related bacteria may display more 
similar spectral peaks than distant, due to shared taxonomy to the family level, 
functional similarities and Gram status (Cheong et al, 2017). These peaks represent 
universal components including amino acids, DNA bases, amides and 
phenylalanine (de Siqueira E Oliveria, Giana and Silveira, 2012; Li et al, 2018), thus 
potentially non-specific to the investigated bacteria. 
Few identified peaks were specific to relevant bacterial properties, including an LPS 
specific peak observed in E. coli (854 cm-1) characteristic to Gram-negative outer 
membranes (Meredith et al, 2016) and phosphoenolpyruvate (1034 cm-1), the 
primary route for glucose uptake (Long et al, 2017). Alternatively, in K. pneumoniae 
the 1239 cm-1 peak represents mannose, which is required for glucose uptake in 
this bacteria (Kostina et al, 2005). A peak assigned to teichoic acid (907 cm-1) and 
peptidoglycan (857 cm-1) was detected in S. aureus only. These are main 
components of Gram-positive bacterial cell walls (Gross et al, 2001). The detection 
of collagen (1451 cm-1) may not be expected in S. aureus, but collagen-like proteins, 
with the same triple helix structure have been previously detected in Staphylococcus 
spp. (Yu et al, 2014). These findings support the beneficial use of characteristic 
bands as biomarkers for individual bacterial species detection or Gram status. The 
analysis of additional Gram-positive bacteria would be required to confirm findings 
and ensure detection across species. Previous research has suggested that Raman 
peaks at 1447 and 1663 cm-1 allow resolution between E. coli and S. aureus (Hlaing 
et al, 2013). This was confirmed here as the 1447 cm-1 peak was only detected from 
S. aureus, and 1663 cm-1 was only detected from E. coli in both mono and 
polymicrobial cultures. This suggests that specific discrimination between the two 
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bacteria is possible, however assignment was to generic DNA or proteins, thus may 
not be specific to each bacteria in a polymicrobial clinical environment. This has 
been reflected with the inability to resolve E. coli, K. pneumoniae, S. aureus and P. 
aeruginosa bacteria due to similarities in cell wall, cell membrane, nucleic acid 
content and metabolomic processes (Martinez et al, 2019). The ability to 
discriminate between the three species studied has previously been observed, with 
contrasting findings to this research project. de Siqueira E Oliveria, Giana and 
Silveira (2012) found peaks of 1382 cm-1 specific to S. aureus, 1130 cm-1 specific to 
E. coli and 1157 cm-1 for K. pneumoniae. 
 
6.5.3 Bacterial distinction in polymicrobial environments is inconclusive. Only 
few independent spectral peaks that were detected in monomicrobial cultures were 
also detected in polymicrobial cultures. This questions the consistency of detecting 
specific species across changing environments, including in a polymicrobial clinical 
sample. One E. coli, four K. pneumoniae and two S. aureus specific peaks were 
identified in polymicrobial cultures, with greater independent peaks detected from 
monomicrobial analysis. This constraint has been identified previously using surface 
enhanced Raman spectroscopy (SERS), with peak differences detected from 
independent culturing of E. coli, K. pneumoniae, S. aureus and P. aeruginosa 
compared to findings from polymicrobial communities of these species (Martinez et 
al, 2019). Low concordance between mono and polymicrobial spectral peaks could 
be explained by decreased peak resolution and a shift towards the most dominant 
bacteria (Martinez et al, 2019), or may be due to overlapping and accumulation of 
two closely related Raman peaks following the merging of spectral replicates, 
creating a non-specific peak to either independent bacteria (Larkin, 2011). 
 
6.5.4 Peak intensity was related to bacterial concentration in E. coli and K. 
pneumoniae, suggesting the possibility of bacterial load quantification using 
Raman spectroscopy. However, this was not linear along dilutions or consistent 
across all bacteria studied, as dilution and intensity were not significantly correlated 
in S. aureus. Therefore, quantification may not be possible for all bacteria. Peak 
intensity may be related to other factors rather than bacterial concentration. 
Bacterial growth phase has previously been shown to impact spectral intensity 
(Hlaing et al, 2013), with choice of location for analysis within the droplet also 
impacting results due to bacterial heterogeneity (Butler et al, 2016; Cheong et al, 
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2017). Such variables remained consistent across analysis, nevertheless, further 
investigations over a broad range of bacteria and greater dilutions may improve 
findings. The intensity of only one Raman peak was correlated to dilutions, with 
investigation of more peaks required, which may include bacterial independent 
spectral peak analysis. Nevertheless, the ability to detect bacterial concentrations 
of 10-5 is a beneficial application of Raman spectroscopy to low biomass samples. 
However, only small staggered steps are performed between each laser 
measurement point (300 nm), so as long as one bacterial cell is present for the laser 
to focus on the Raman bacterial spectra can be created (Strola et al, 2014), thus not 
producing uniquely quantifiable findings. 
 
6.5.5 Strengths and limitations of Raman spectroscopy 
Low background noise was detected from stainless steel slides and LB culture 
media, indicating minimal external contribution to spectral peaks and increasing 
confidence that only genuine bacterial signals were measured. Thus, the washing 
and centrifuging steps performed prior to analysis remain important as previously 
advised (Hlaing et al, 2013). Integration of washing steps will be increasingly 
important in future investigations when bacteria may require different experimental 
conditions, as media-specific peaks independent of bacteria have been detected 
(Chauvet et al, 2017; de Siqueira E Oliveria, Giana and Silveira, 2012; Mlynarikova 
et al, 2015). However, only one culture media was used and monitored in this 
research so conclusions cannot be derived.  
 
Three bacterial species were used in this research, thus universal application is 
limited. A greater spectral database is required prior to application on clinical 
samples. It would be beneficial to include multiple species from the same genus to 
determine species level resolution patterns. The use of Raman spectroscopy to 
resolve bacteria to strain level has successfully been observed in E. coli, yet 
heterogeneity across individual colonies were detected (Almarashi et al, 2012). 
Polymicrobial droplets contained equal volumes and ratios of each bacterium, which 
may not be representative of a clinical environment, where one species may be of 
higher abundance, as seen from sequencing analysis earlier in this thesis. Thus 
further research investigating different ratios within polymicrobial combinations 
would be useful. 
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A selection of databases and published research were used as references to 
determine peak assignment, as standard for the majority of Raman spectroscopy 
studies (Larkin, 2011; Movasaghi, Rehman and Rehman, 2007). Due to the current 
lack of SOPs and standardised protocols, different methodologies are conducted 
and may impact comparison between findings. 
The sensitivity and specificity of Raman results would need to be analysed further, 
as peak differences were sometimes only +/- one cm-1 shift different between 
individual bacteria or when moving from mono to polymicrobial cultures. A shift may 
not impact results if the peak is assigned to the same product, for example if a 
spectral range covers the same biological structure. Whereas an impact will be seen 
if the shift causes a change in band assignment product. This raises uncertainty of 
independent distinction between bacteria when using the unsupervised assignment 
method. It would have been optimum to compare peaks to a reference database 
specific to the instrument and protocol used in this research, which would contain 
all relevant compounds biologically assigned here, to improve accuracy of peak 
assignment. However, this would require analysis of an infinite number of bacteria, 
clinical samples and reagents to ensure that all aspects were covered. This exceeds 
the scope of this thesis, requiring multiple operators, increased cost and extensive 
application time. Thus only databases presenting protocols with similar 
instrumentation and processing steps were used for comparison. 
 
6.5.6 Future research and applications of Raman spectroscopy 
The rapid, non-destructive, label free mechanism of Raman spectroscopy could be 
utilised to detect and determine bacterial presence on clinical samples in a quicker 
and more efficient way than achieved by current methods, which require the 
application of multiple methodologies to generate comparable results. Clinical 
material may add additional challenges to Raman spectroscopy due to greater 
confounding variables impacting signal intensity. Multiple methods have been 
developed to enhance the Raman signal, including SERS which utilises a metallic 
nanoparticle covered surface for bacterial adhesion to increase detection, sensitivity 
and improve band resolution (Chauvet et al, 2017; Cheong et al, 2017; Li et al, 
2018). Application would require additional processing steps, resources, time and 
instrumentation, reducing comparison to current findings but enhancing clinical 
application. 
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Investigating the spectral fingerprint of bacteria in vitro is important, but culture 
methodologies offer limited application to the clinical setting due to differing 
conditions and without the further impact of the biological tissue on spectral output. 
Protocol optimisation on clinical samples would be required to investigate tissue 
autofluorescence, which may conceal genuine Raman signals (Butler et al, 2016). 
Before applying Raman spectroscopy to clinical samples, clinically relevant bacteria 
could be spiked into tissue samples to create a new database for clinical reference. 
Raman spectroscopy and sequencing technology could be combined to increase 
the understanding of clinically relevant microorganisms. Previous sequencing 
results could inform of the highly abundant or clinically relevant bacteria to be targets 
of interest within Raman protocols. This could include Prevotella, Ureaplasma or 
Escherichia in HCA research as detected in Chapter three. Combined application 
could decrease the time and increase the accuracy of bacterial identification and 
infection diagnosis.  
 
Application to medically relevant conditions including pre-eclampsia (Chen et al, 
2014), detection of preterm birth (O’Brien et al, 2014) and monitoring placental 
molecular structure throughout pregnancy (Pielesz et al, 2019) have previously 
been researched, presenting a sensible basis for future fetal membrane research. 
In relation to previous work explored in this thesis, the application of Raman 
spectroscopy to fetal membranes with HCA may be beneficial to improve point of 
care diagnosis. This research has detected an increase in bacterial load from 
patients with HCA (Chapter five), yet confirmation of bacterial presence and 
identification would be beneficial without the impact of processing contaminants. A 
database of clinically relevant HCA bacteria, including Prevotella and Ureaplasma 
would be required prior to application. A label free non-destructive method for HCA 
is increasingly important due to the low biomass characteristics of the fetal 
membranes. The benefit of decreased processing requirements and limited external 
bacterial contribution in Raman analysis would enhance genuine bacterial detection 
in fetal membranes.  
Raman microspectroscopy combines the use of spectroscopy and confocal 
microscopy to map bacterial spatial location on the tissue of interest. This novel 
application could be applied to samples used in this research to understand the 
spatial location of bacteria on the amnion and chorion in HCA, to increase 
understanding of the inflammatory response, plus initiation and progression of the 
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condition. However, findings here suggest extensive additional in vitro research is 
required prior to transferring into a clinical setting. 
 
6.6 Conclusion 
Bacterial presence can be detected by a prominent Raman spectral peak at 1003 
cm-1. Characteristic Raman peaks relevant to specific bacterial characteristics 
including Gram status were identified. Raman spectroscopy can identify 
concentrations of 10-5 bacteria. Application to low biomass clinical samples would 
require further research and optimisation of techniques, as quantitative analysis, 
and bacterial discrimination in polymicrobial cultures is inconclusive.  
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Chapter Seven: Discussion and concluding remarks. 
 
7.1 Research project aims  
Histological chorioamnionitis (HCA) impacts up to 30% of preterm births (Kim et al, 
2015), with links to early life complications of morbidity and mortality, including early 
onset sepsis and necrotising enterocolitis (Strunk et al, 2018; Taft et al, 2015). 
Although advances have been made in understanding the fetal membrane 
microbiota in chorioamnionitis (Prince et al, 2016; Sweeney et al, 2016), key 
redundant areas remain to be investigated. 
This research project aimed to increase current knowledge and understanding of 
the fetal membrane microbiota via multiple technologies. With specific aims;  
 
- To investigate the microbiota of the amnion and chorion from HCA patients 
and compare these to preterm and term birth without HCA, via Illumina 
amplicon sequencing (Chapter three).  
- To determine if bacteria can be detected from low risk term fetal membranes 
by probe based quantitative polymerase chain reaction (qPCR), plus to clarify 
and confirm bacterial signals on the fetal membranes with and without HCA 
(Chapter five).  
- To further understand bacterial load levels in an inflammatory condition by 
investigating the link between bacterial load and HCA severity or 
inflammatory markers via probe based qPCR (Chapter five).  
 
For clinical optimisation, research aimed; 
 
- To determine if Formalin-Fixed Paraffin-Embedded (FFPE) fetal membrane 
samples are comparable to frozen membranes in DNA quantity and 
microbiota. Plus, to determine if these readily available, collected and 
archived samples could be utilised in microbiota research for reduced cost, 
storage and processing impact (Chapter four).  
- To investigate if Raman spectroscopy can identify individual bacteria in low 
biomass mono and polymicrobial cultures. Plus, to understand the potential 
application of this method to clinical samples (Chapter six). 
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7.2 Summary of key findings 
This thesis indicates the involvement of bacterial infection and bacterial load in 
inflammatory HCA of the fetal membranes. 
Findings indicate that greater bacterial load is positively correlated to increased 
histological inflammation and inflammatory markers, with bacterial activation of the 
inflammatory pathway via a dose dependent response (Chapter five). Microbiota 
analysis suggests that HCA samples have a distinct bacterial profile, with a trend 
for increased Prevotella on the fetal membranes in higher grade HCA (Chapter 
three). Bacterial abundance and load increase on the fetal membranes with 
increasing HCA inflammation (Chapter three and chapter five). All indicating that 
HCA is a bacterial related inflammatory condition. 
Findings support the theory of low microbial presence in non-complicated fetal 
membranes due to no distinct bacterial load identified from low risk term or non-
HCA preterm or term patients (Chapter five). With increased likelihood of detecting 
a bacterial signal from negative controls (Chapter five). This supports the sterile 
placenta theory and suggests that bacteria are not acquired on healthy fetal 
membranes in utero or during labour and delivery, unless an inflammatory related 
condition is present. 
FFPE and frozen fetal membrane samples were not of comparable quality due to 
high contamination levels and decreased DNA quality and quantity from FFPE 
samples (Chapter four). FFPE and frozen samples also displayed distinctly different 
bacterial profiles across matched paired analysis (Chapter four). The high level of 
contamination, low DNA quality and minimal concordance with frozen tissues 
questions the genuine representation of the fetal membrane. Thus it is not 
recommended to replace frozen fetal membrane samples with FFPE samples for 
microbiota analysis. 
The novel Raman spectroscopy technique identified bacteria by one specific Raman 
peak, with functionally relevant peaks detected in respective bacteria (Chapter six). 
Further optimisation of bacterial discrimination in polymicrobial conditions and the 
quantitative ability of Raman spectroscopy is required prior to application on low 
biomass clinical samples. 
  
185 
 
7.3 Strengths and limitations 
All samples used in this research were collected from one hospital and one delivery 
unit, with HCA assessed by the same clinicians to reduce variation and increase 
consistency of sample handling. All samples from the HCA cohort study displayed 
progressive labour, limiting sample variation. However, external factors such as 
health status prior to and during pregnancy may impact findings but could not be 
analysed. 
A 24-patient sample set was utilised within this research project. A larger sample 
cohort would have strengthened findings and cover greater heterogeneity of the 
maternal and fetal response, though the low incidence of early preterm birth and 
HCA is a recognised problem in this field of research.  
 
HCA is asymptomatic in two thirds of cases (Redline et al, 2003), but clinical signs 
were variable between HCA and PTB patients here. This included increased white 
blood cell count (WBC), and C-reactive protein (CRP) levels, all independent of 
gestational age. These characteristics are linked to inflammation and potential 
markers for HCA diagnosis. Increased CRP has been detected from 
chorioamnionitis (Nair, Ramachandran and Joseph, 2018) and microbial invasion of 
the amniotic cavity (Musilova et al, 2015). However, the predictive value of CRP for 
HCA has been criticised due to low specificity and sensitivity to the condition 
(Erdemir et al, 2013). Spontaneous labour has also been related to an increase in 
these characteristics, due to active labour as an inflammatory process (Roberts et 
al, 2012). It remains of interest to continue monitoring clinical signs related to HCA, 
due to the possible link to inflammatory factor gene expression (Waring et al, 2015). 
 
Sample collection was established in 2013, yet optimised guidelines for placental 
sample collection were not published until after collection (Burton et al, 2014; 
Roberts et al, 2019). Future research would ensure implementation of suggested 
guidelines to improve reliability and reproducibility. This could include immediate 
snap freezing and processing of the samples, or quadrant biopsy sampling to 
represent multiple membrane locations (Roberts et al, 2019). This would avoid 
multiple freeze-thaw cycles of large tissue segments (Burton et al, 2014), which 
impacts the microbiota following four plus freeze-thaw cycles (Cuthbertson et al, 
2015). Additional parturition characteristics could also be recorded, including 
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duration of labour, as this impacts the opportunity for ascending bacteria (Burton et 
al, 2014). 
This research analysed bacterial presence within the amnion and chorion 
individually. The two fused membranes are independently functioning units with 
diverse cellular characteristics and properties (Park et al, 2009), plus demonstrate 
different inflammatory response patterns (Kallapur et al, 2001). Thus, microbiota 
characteristics and HCA development may differ. Independent membrane results 
are important to establish a timeline of bacterial location, inflammatory response 
progression, origin of bacteria and initiation of HCA. Research focusing on the fetal 
membranes as a combined entity will not capture the complexity of the individual 
membranes, thus individual study of the amnion and chorion is recommended. Due 
to clinical limitations this is not always possible, as noted in this research, as for a 
subset of patients only amnion or chorion were available, which could bias results 
and is a known limitation of human tissue collection. 
 
The absence of a known healthy fetal membrane microbiota complicates the ability 
to determine a microbiota linked to HCA, as no baseline is available for comparison. 
Fetal membranes without HCA from preterm and term labour are required for within 
study comparisons, as incorporated into this research. A positive control could have 
strengthened findings, for example comparable tissue samples spiked at known 
concentrations with a tissue specific microorganism. As the fetal membrane 
microbiota is not yet determined, it was not possible to confidently select and include 
a positive spiked control within this research.  
The histological threshold for HCA was set at stage two inflammatory response, due 
to the accepted reproducible diagnostic criteria (Redline et al, 2003). However, only 
one HCA patient was diagnosed at stage three, limiting conclusions at this level. 
Excluding stage one subchorionitis from the HCA subset ensures specificity to HCA. 
Other studies may have included stage one leading to different conclusions of 
infection and inflammation in HCA.  
 
Bacterial origin cannot be determined in this project as only fetal membrane samples 
were analysed. Bacteria found in the fetal membranes, including Ureaplasma and 
Prevotella have previously been detected in the vaginal microbiota (Doyle et al, 
2017). Ascending bacteria from the vaginal and lower female reproductive tract 
could be the possible route of transfer (Doyle et al, 2017). Also supported by Brown 
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et al (2018), detecting Prevotella in the vagina, prior to delivery, and the placenta 
postpartum when chorioamnionitis was present. An alternative route of 
haematogenous translocation from the oral cavity has been suggested (Fardini et 
al, 2010), due to simultaneous detection of Prevotella in the oral cavity and placental 
membranes (McCuaig et al, 2018). In contrast, bacterial contamination of low 
biomass placenta and fetal membrane samples is also a recognised theory (Leiby 
et al, 2018). The inclusion of vaginal, oral, skin and blood samples would allow 
greater understanding of the source of bacteria in this research and allow further 
investigation into the link between reproductive, placental and fetal membrane 
health.  
 
Longitudinal monitoring of the membranes prior to, during and after development of 
HCA is not possible. This would be beneficial to determine time of onset for the 
condition and bacterial pathway. However, the study of fetal membranes throughout 
gestation is invasive and unethical, with potential harm caused to both maternal and 
fetal health (Monastero and Pentyala, 2017). Amniotic fluid collected during 
amniocentesis may be the most representative sample (Jung et al, 2010), however 
the specificity and sensitivity to chorioamnionitis is limited (Lee et al, 2018; 
Monastero and Pentyala, 2017).  
Bacterial load and presence in the fetal membranes may be transient throughout 
gestation, as seen with the lower female reproductive tract (MacIntyre et al, 2015). 
When assessed postpartum, the causal microorganisms could have been 
eradicated or relocated, thus not detected, as the microbiota and health are not 
static variables (Stinson, Keelan and Payne, 2018a). This problem impacts a wide 
variety of pregnancy related conditions, including HCA, increasing the importance 
of rapid and accurate diagnosis postpartum. 
 
The combination of multiple methodologies, including Illumina sequencing and 
qPCR used in this research creates a broad view of HCA, increasing accuracy and 
reliability of findings. Complementary primers were applied across methods, with 
the V4 16S rRNA gene region used in qPCR matching the target for sequencing 
analysis. Sequencing provides reliable information to distinguish bacterial 
sequences to the genus level, with qPCR displaying increased accuracy for bacterial 
load measurements (Kim et al, 2017). Recent research has modified the BactQuant 
primer pair used in qPCR to increase sequence coverage (Rehbinder et al, 2018). 
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As the modified protocol was published after this research was conducted, the 
improved primers were not applied here but may be beneficial to investigate in future 
research.  
DADA2 post-processing used amplicon sequence variants (ASVs) rather than 
operational taxonomic units (OTUs; Callahan et al, 2016b). OTUs accumulate 
sequences into distinct groups, as sequences are mapped with 97% similarity to 
reference sequences (Kozich et al, 2013). In comparison, ASVs detect and cluster 
by one nucleotide variation, increasing sensitivity (Callahan, McMurdie and Holmes, 
2017).  
 
Fetal membrane research receives criticism due to low biomass samples and low 
bacterial abundance (Glassing et al, 2016). In low biomass samples external 
contamination can be increasingly mistaken for a true microbiota (Stinson, Keelan 
and Payne, 2018a). To minimise this, negative controls from DNA extraction kits, 
sequencing negatives and qPCR reagents, plus an independent subset of healthy 
controls were included and compared to samples to determine a baseline. 
Incorporating decontam into FFPE microbiota analysis was an additional beneficial 
method to identify contaminating bacterial sequences in fetal membranes relative to 
negative controls in this research. This allows detection at the data analysis stage, 
but integration of further pre-processing steps may minimise initial contamination, 
including PCR decontamination kits (Stinson, Keelan and Payne, 2018a). 
 
7.4 Future research 
Although conclusions have been presented and discussed, further research would 
be required to allow application and integration into clinical settings. Future research 
would include, but is not limited to the following suggestions.  
Further enhancements to research methodology may include combining species-
specific targeted primers with universal 16S rRNA gene qPCR (Brukner et al, 2015), 
to measure the bacterial load of target species of interest highlighted in sequencing 
analysis. The bacterial load threshold required to trigger an inflammatory response 
also warrants investigation. Cultured primary fetal membrane explants could be 
stimulated with bacteria across variable doses and time points to assess the 
inflammatory response. This could also investigate selected inflammatory factors as 
potential biomarkers for HCA, including Toll-like receptor (TLR) signalling mediators. 
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A limitation of qPCR is the inability to select for viable metabolically active bacteria, 
as both viable and non-viable bacteria are amplified. To overcome this limitation 
PMA qPCR can be performed (Richardson et al, 2017). Propidium monoazide 
(PMA) is an impermeable dye which intercalates and covalently binds genomic DNA 
to inhibit amplification of non-viable bacteria during PCR (Richardson et al, 2017). 
This only occurs within a compromised cell membrane, and will not penetrate intact 
cell membranes, thus distinguishing between viable, metabolically active and non-
viable, non-metabolically active bacteria (Richardson et al, 2017). This method has 
shown to improve diversity evenness for rare community members (Rogers et al, 
2013) and remove sequencing bias (Young et al, 2017). This would be informative 
for HCA analysis, but also for investigation between negative controls and non-HCA 
samples. The bacterial load levels did not differ between non-HCA tissues and 
negative controls, but the proportion of viable bacteria may differ and be an 
interesting and valuable insight.  
 
The collection and comparison of multiple body site samples to understand external 
bacterial contribution and enhance negative control comparison could include 
vaginal, oral, skin, amniotic fluid and neonatal samples analysed via sequencing to 
investigate bacterial origin correlating to fetal membranes. Plus, sequencing 
analysis of environmental samples and swabs taken from clinical locations within 
the hospital, and also from laboratories used for extraction and experimentation 
(Leiby et al, 2018).  Also, additional neonatal samples would allow investigation of 
the fetal response to HCA, including fetal inflammatory response syndrome (Park et 
al, 2009). This would also provide information of bacterial translocation across the 
fetal membranes and placenta to the fetus, exploring negative clinical outcomes 
relative to bacterial load and HCA inflammation.  
 
Potential application of Raman spectroscopy for bacterial detection in clinical tissues 
has been presented, however further investigation is required prior to integration 
into the clinical setting. Current questions including the ability to discriminate 
individual bacteria in a polymicrobial environment, plus the quantitative capability of 
Raman spectroscopy needs to be addressed. Currently, no standardised protocols 
or procedures are available for the inVia Raman instrument. Developing a 
universally applicable protocol for bacterial detection, preparation and processing 
parameters would be beneficial to ensure standardised use across research, but 
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also across the clinical setting. Expanding the initial spectroscopy reference dataset 
created here would be required to cover all clinically relevant bacteria, polymicrobial 
combinations, ratios and concentrations. This would be important prior to application 
on clinical samples to ensure relevance, confidence in detection and act as a 
reference point for diagnosis. 
Applying advanced spectral imaging and mapping for visual location of bacteria on 
the fetal membranes with HCA could further improve diagnosis in a non-destructive 
manner. Current tissue and placental based research applies pattern recognition 
and spectral fingerprint analysis (Pielesz et al, 2019; Schlabritz-Loutsevitch et al, 
2017). The future aim here would be to expand on this and investigate individual 
peaks of interest related to bacterial detection and visually map these onto the fetal 
membranes via Raman microspectroscopy. 
 
7.5 Research implications and clinical relevance 
Current research provides new insights into the contribution of bacterial load to HCA 
development and severity of maternal inflammation. Findings enhance existing 
knowledge of the relationship between infection and inflammation in HCA, aid in 
understanding the complexity of the fetal membrane response to immunological 
challenge, plus in the future aims to integrate novel diagnostic methods. 
 
Although a linear relationship between bacterial load and HCA was detected here, 
the clinical threshold required to trigger the inflammatory response warrants 
investigation. Highlighted inflammatory markers, including TLR signalling mediators 
have the potential to be used as diagnostic biomarkers for HCA inflammatory 
response, yet further investigations into the sensitivity and specificity to HCA 
diagnosis are required prior to clinical application.  
 
It has been historically assumed that the fetal membranes are sterile (Kovalovski et 
al, 1982), yet this research project shows that with an inflammatory condition, this is 
not the case. As bacterial loads were associated with inflammation levels in HCA, 
this could be transferred and investigated in other pregnancy related inflammatory 
conditions, including pre-eclampsia, preterm premature rupture of membranes 
(PPROM) or miscarriage. This research could also lead to questioning of other 
clinically relevant inflammatory conditions and locations otherwise assumed sterile, 
including acute pancreatitis (Hogue et al, 2012). 
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Beyond HCA, this findings suggests that bacteria may not be acquired on the fetal 
membranes in utero or during labour and delivery in low risk or non-HCA patients, 
indicating that bacteria are not the main initiator of non-inflammatory related 
parturition. Colonisation of low risk term neonates may be first acquired after labour 
from environmental sources, rather than in utero, unless an inflammatory related 
condition is present.  
 
The continued collection and storage of placental and fetal membrane samples is 
imperative for continual research into HCA, fetal membrane microbiota and the 
inflammatory response. The World Health Organisation (WHO) developmental 
goals at the outset of this project included increased research to improve maternal 
health, plus improve pregnancy outcomes and the health of the mother, baby and 
child throughout life (WHO, 2015). To achieve these goals, further funding and 
research is required for the biobanking of underrepresented reproductive material. 
It would be advised that fresh-frozen tissues are stored and analysed due to 
limitations from FFPE samples, as displayed in this thesis. Although application of 
FFPE tissues would benefit time, cost and resources, the extensive post-processing 
requirements, plus decreased quantity and quality of DNA make these samples 
unsuitable for microbiota research, but clinical investigations for HCA diagnosis 
should continue.  
 
7.6 Conclusion 
This thesis indicates that inflammation of the fetal membranes in HCA is associated 
with bacterial infection and increased bacterial load in a dose dependent manner. 
The severity of inflammation is positively correlated to bacterial load and activation 
of the TLR signalling pathway, but the threshold for activation is not yet known. 
Non-HCA preterm and term, plus low risk term fetal membranes have 
indistinguishable low bacterial loads, suggesting minimal bacterial presence on 
healthy fetal membranes without an inflammatory related condition.  
Frozen samples remain the current gold standard for microbiota research. Novel 
application of Raman spectroscopy to improve current detection and diagnosis of 
bacterial presence linked to HCA may be possible with further research and 
optimisation.  
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Appendices 
 
A.1. List of reagents, chemicals and commercial kits 
Agilent Technologies  
- Agilent high sensitivity DNA kit (5067-4626), including high sensitivity DNA chips, 
electrode cleaner, syringe kit, syringe, spin filters, plus reagents of high sensitivity 
DNA ladder, high sensitivity DNA marker (35/10380 bp), high sensitivity DNA dye 
concentrate, high sensitivity DNA gel matrix 
 
Applied Biosystems 
- ExoSap-IT PCR product clean up kit (78201.1) including ExoSap-IT reagent 
- 2X TaqMan Fast advanced master mix with UNG (4444554) 
 
Bioline 
- 5X DNA loading buffer blue (BIO-37045) 
- Agarose, molecular grade (BIO-41026) 
- HyperLadder 1 KB (BIO-33053) 
- SensiFAST SYBR No-Rox kit (BIO-98005) 
 
Fisher Scientific 
- HPLC grade methanol (M/4056/17) 
- LB broth Miller molecular media (BP1426-500) 
- LB agar Miller molecular powder (BP1425-500) 
- SequalPrep normalisation plate kit (A1051001) 
- Tris-acetate-EDTA (TAE) 25X powder (BP1331-1) 
- Tris-borate-EDTA (TBE buffer 10X)(B52) 
 
Gibco 
- Ampicillin, sodium salt irradiated (11593-027) 
 
Illumina  
- MiSeq reagent kit (MS-102-2002) including reagent cartridge and flow cell, plus 
hybridisation buffer (HT1) and incorporation buffer (PR2) 
- Nextera index kit i7 (N701-N712), i5 (S501-S508; FC-131-1002) 
- PhiX control kit V3 (FC-110-3001) 
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Invitrogen 
- AccuPrime Pfx SuperMix (10053322) 
- One shot TOP10 competent cell kit (C404003), including One Shot TOP10 
chemically competent E. coli, pUC19 DNA (10 pg/µl) and S.O.C. medium. 
- SYBR Safe DNA gel stain, 10,000X (S33102) 
- X-Gal (15520034) 
 
Kapa Biosystems 
- KAPA library quantification kit (KK4824) 
 
MoBio 
- BiOstic FFPE tissue DNA isolation kit (12250-50) containing FP1, FP2, FP3, FP4, 
FP5, FP6, FP7, FP8, 2ml collection tubes and spin filters. Lot numbers FP15D24, 
FP16B25, FP14E15. 
 
New England BioLabs 
- Bovine Serum Albumin (BSA) molecular biology grade 20 mg/ml (B9000S) 
- EcoRI kit (R0101L) including EcoRI enzyme (R0101S) and EcoRI reaction buffer 
10X (B0101S) 
 
Promega 
- 2X PCR mastermix (M750B), including Taq DNA polymerase and dNTPs 
- MgCl2 solution 25mM (A315H) 
- Nuclease free H2O (P119A) 
- PGEM-T easy vector system (A1360) including, PGEM-T easy vector (A137A; 50 
ng/ul), control insert DNA (A363A; 4 ng/µl) T4 DNA ligase (M180A), 2X rapid ligation 
buffer (C671A), nuclease free H2O (P119A). 
- PureYield plasmid miniprep system (A1223) containing, cell lysis buffer (A145D), 
neutralisation solution (A157D), endotoxin removal wash (A158D), column wash 
solution (A159D), elution buffer (A160D), mini columns (A166B) and collection tubes 
(A167B).  
 
Qiagen 
- QIAamp fast DNA tissue kit (51404) containing Buffer AVE, VXL, MVL, AW1, AW2, 
ATE, DX reagent, Proteinase K, RNAse A, mini spin columns, tissue disruption 
tubes and collection tubes. Lot numbers: 154025312, 154025313. 
- QIAprep spin miniprep containing, Buffer P1, P2, N3, PB, PE, EB, spin columns and 
collection tubes (27104). 
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Sigma Aldrich  
- KAPA SYBR FAST qPCR kit (KK4602) 
- LookOut DNA Erase (L8917) 
- N-N-Dimethylformamide (D4551-250) 
 
 
A.2. List of equipment 
Agarose gel tank, Edvotek Bio-Rad (HU13, 3638) 
Bioanalyzer system, Agilent Genomics, 2100 (5067.4628) 
Bio-Rad CFX connect real time system (CFX manager V3.1) 
Bio-Rad gel doc EZ gel imager (Image lab 3.0) 
Centrifuge, Christ RVC2-18 D-37520 
EDVOcycler PCR machine (V6.2) 
GBox SynGene Chemi-XX6 (DRXV2/2296) 
Illumina MiSeq, Northumbria University, Newcastle, UK 
Manual rotary microtome, Leica (RM2125)  
Microcentrifuge, Sigma D-37520 
Raman InVia Qontour (Renishaw) with WIRE 5.1  
Spectrophotometer, NanoDrop One, Thermo Fisher Scientific (V1.4 software) 
Spectrophotometer, NanoDrop 1000, Thermo Fisher Scientific (V3.8.1 software)  
Thermal cycler, Applied Biosystems (2720) 
Thermal cycler, C100 touch Bio-Rad 
ThermoMixer, Eppendorf 
UV spectrophotometer, Jenway (7305) 
Vacubrand diaphragm vacuum pump - 27373308-273525 
Vortex Genie 2, Jencons, Scientific Industries 
Vortex Chip IKA M51 orbital shaker  
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A.3. Table of primers 
 
Primer Use Sequence Reference 
V4F Illumina 
sequencing 
5’-GTGCCAGCMGCCGCGGTAA-3’ Biesbroek et al, 
2012 
V4R Illumina 
sequencing 
5’-GGACTACHVGGGTWTCTAAT-3’ Biesbroek et al, 
2012 
27F PCR 5’-AGAGTTTGATCMTGGCTCAG-3’ Salter et al, 2014 
1492R PCR 5’-TACGGYTACCTTGTTACGACTT-3’, Salter et al, 2014 
BactQuant 
Forward 
qPCR 5’-CCTACGGGDGGCWGCA-3’ Liu et al, 2012 
BactQuant 
Reverse 
qPCR 5’-GGACTACHVGGGTMTCTAATC-3’ Liu et al, 2012 
BactQuant 
probe 
qPCR (6FAM)5’-CAGCAGCCGCGGTA-3’ 
(MGBNFQ) 
Liu et al, 2012 
 
Table A.1 Primer sequences. Supporting information of primers and sequences used 
within Illumina sequencing, PCR optimisation and qPCR.  
 
A.4. Serial dilution calculations 
 
  C1 V1  V2 C2 
Dilution 
Source of 
V1 
Initial g/µl 
Vol of 
DNA 
Required 
(µl) 
Vol of 
Diluent 
(µl) 
Final 
Vol (µl) 
Final (g/µl) 
1 Stock 2.68 x 10-7 10 990 1000 2.68 x 10-9 
2 Dilution 1 2.68 x 10-9 10 90 100 2.68 x 10-10 
3 Dilution 2 2.68 x 10-10 10 90 100 2.68 x 10-11 
4 Dilution 3 2.68 x 10-11 5.48 94.52 100 1.468 x 10-12 
5 Dilution 4 1.468 x 10-12 10 90 100 1.468 x 10-13 
6 Dilution 5 1.468 x 10-13 10 90 100 1.468 x 10-14 
7 Dilution 6 1.468 x 10-14 10 90 100 1.468 x 10-15 
8 Dilution 7 1.468 x 10-15 10 90 100 1.468 x 10-16 
 
Table A.2 Serial dilution calculations for qPCR standard curves. Volume of DNA (µl) 
required calculated in relation to final concentration (g/ µl). 
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A.5. Formalin-Fixed Paraffin-Embedded tissue block images 
    
    
.       
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Figure A.1 Formalin-Fixed Paraffin-Embedded tissue block images. Images of 
wax block FFPE fetal membrane rolls prior to sectioning.
234 
 
A.6. Additional results 
 
A.6.1 NanoDrop spectrophotometer DNA extraction results example 
 
Sample ID ng/µl A260 A280 A260/280 A260/230 
A1 04-04 KIT -VE  0.69 0.01 0.01 0.96 0.03 
H1 04-04 HCA 19 CH1 532.71 10.65 5.77 1.85 2.36 
I1 04-04 HCA 19 CH2 468.31 9.37 5.03 1.86 2.28 
J1 04-04 HCA 19 CH3 65.21 1.30 0.70 1.88 1.81 
A1 23-02 KIT -VE 2.98 0.06 0.04 1.70 0.32 
B1 23-02 CA19 1B WAX -VE 18.99 0.42 0.22 1.83 2.24 
K1 23-02 CA19 1B TUBE 1 35.75 0.72 0.35 2.03 2.24 
L1 23-02 CA19 1B TUBE 2 46.22 0.92 0.51 1.81 1.38 
M1 23-02 CA19 1B TUBE 3 33.19 0.66 0.31 2.11 2.16 
 
Table A.3 Example of NanoDrop spectrophotometer sample results following DNA 
extractions. Example NanoDrop results from one patient sample in triplicate from the 
frozen chorion (H1-J1) and the respective FFPE fetal membrane roll (K1-M1). Respective 
kit negatives are included (A1), plus the wax negative control (B1). DNA concentration 
(ng/µl), plus purity ratio (A260/280, A260/230) displayed. 
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A.6.2 Bioanalyzer chip-based electrophoresis results 
 
Due to poor quality results from the agarose gel electrophoresis, chip-based electrophoresis 
was used on the same subset of Formalin-Fixed Paraffin-Embedded (FFPE) samples for 
improved detection with this methodology. 
 
Bioanalyzer gel results confirmed previous gel electrophoresis findings that FFPE fetal 
membranes contain highly fragmented DNA, indicated by multiple bands present, plus low 
quantity of DNA due to the pale intensity of banding. 
 
A transposed electropherogram is also produced per sample in reference to the gel image 
(Figure A.2). For the example presented the DNA molecular weight and size is comparable 
to that viewed on the gel image, with the mean peak at 397 bp and a smaller peak at 132 
bp, confirming the multiple and short fragmentation of FFPE samples. Upper and lower 
reference ladder markers are plotted at 35 bp and 10380 bp. An electropherogram of the 
whole reference ladder allows comparison to samples (Figure A.2). 
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A      
B      
C      
Figure A.2 Bioanalyzer chip-based gel electrophoresis example results Example of a 
gel electrophoresis image from a subset of Formalin-Fixed Paraffin-Embedded (FFPE) 
samples (A), plus sample electropherogram (B) and ladder electropherogram (C) from 
Bioanalyzer Agilent 2100. Ladder is included (L), with upper (purple) and lower (green) 
markers visible across samples (lane 1-11). Error in lane 7 is visible due to no marker 
detected (A). Example of an electropherogram from an FFPE sample (B) and gel reference 
ladder (C) plotted as marker time (s) against fluorescence (FU). Upper and lower marker 
included for reference (35 bp and 10380 bp). 
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A.6.3 Additional qPCR sample results 
 
 
 
Figure A.3 qPCR samples and standards amplification plot. An example of the qPCR 
standard curve (O), plus a subset of extracted DNA from frozen amnion and chorion (X) 
created on CFX Manager V3.1, comparing log10 starting quantity (SQ) with quantification 
cycle mean (CQ). R2, slope and efficiency are displayed. 
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Sample Tissue 
section 
Copy number/µl Copy number/mg Within 
range? 
HCA 09 CH 1 10.380 20.760 No 
 2 11.679 23.358 No 
 3 33.528 67.055 No 
HCA 14 CH 3 48.726 97.452 No 
HCA 15 AM 2 322.902 645.805 Yes 
 3 21.247 42.494 No 
HCA 15 CH 3 8633.842 17267.680 Yes 
HCA 16 AM 3 1130.511 2261.021 Yes 
HCA 17 AM 1 73441.670 146883.300 Yes 
 2 10568.180 21136.370 Yes 
 3 2111.117 4222.234 Yes 
HCA 17 CH 1 92987.310 185974.600 Yes 
 2 4754.246 9508.492 Yes 
 3 55484.050 110968.100 Yes 
HCA 19 AM 1 224.747 449.495 Yes 
 3 1201.345 2402.689 Yes 
HCA 19 CH 1 2573.476 5146.952 Yes 
 2 293.707 587.415 Yes 
 3 475.672 951.344 Yes 
HCA 21 AM 1 1484.093 2968.187 Yes 
 2 120.325 240.650 Yes 
HCA 21 CH 1 2148.411 4296.821 Yes 
 2 47.768 95.536 No 
HCA 22 AM 1 562.466 1124.933 Yes 
 2 422.715 845.430 Yes 
 3 720.395 1440.791 Yes 
HCA 22 CH 1 231.220 462.441 Yes 
 2 338.619 677.239 Yes 
 3 1004.616 2009.232 Yes 
HCA 24 AM 2 1119.270 2238.540 Yes 
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 3 1478.768 2957.537 Yes 
HCA 24 CH 1 9257.494 18514.990 Yes 
 2 148.551 297.102 Yes 
 3 490.508 981.015 Yes 
HCA 26 AM 1 1688.208 3376.415 Yes 
 2 1626.550 3253.100 Yes 
 3 769.581 1539.163 Yes 
HCA 26 CH 1 4884.652 9769.305 Yes 
 3 1208.249 2416.498 Yes 
HCA 29 AM 2 1312.972 2625.943 Yes 
HCA 29 CH 1 128.211 256.423 Yes 
 2 152.892 305.785 Yes 
HCA 31 CH 1 1090.911 2181.822 Yes 
PTB 05 CH 2 278.150 556.300 Yes 
PTB 18 AM 1 398.059 796.118 Yes 
 2 61.046 122.092 No 
 3 40.938 81.877 No 
PTB 18 CH 1 26.696 53.392 No 
 2 164.758 329.516 Yes 
 3 26.173 52.346 No 
PTB 20 AM 1 304.121 608.242 Yes 
 2 173.705 347.410 Yes 
 3 139.040 278.080 Yes 
PTB 20 CH 1 668.226 1336.452 Yes 
 2 143.723 287.447 Yes 
PTB 23 AM 1 57.537 115.073 No 
 2 64.515 129.030 No 
 3 41.426 82.852 No 
PTB 23 CH 2 90.375 180.750 No 
 3 33.927 67.854 No 
PTB 25 AM 1 88.432 176.864 No 
 3 243.309 486.617 Yes 
PTB 25 CH 1 146.773 293.545 Yes 
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Table A.4 qPCR fetal membrane sample copy number results. Calculated copy 
numbers for fetal membrane tissue samples. Values are displayed as starting quantity copy 
number/µl and copy number/mg and indicated if results were within range for the assay 
>100 copies/µl. Samples include histological chorioamnionitis (HCA), preterm (PTB) and 
term without chorioamnionitis (Term), plus kit negative controls (NEG), patient sample 
number and membrane origin (amnion=AM, chorion=CH). Tissue section represents 
sample segment utilised. 
 2 167.800 335.600 Yes 
 3 22.770 45.540 No 
PTB 27 AM 1 59.218 118.436 No 
 2 222.747 445.494 Yes 
 3 63.699 127.397 No 
PTB 27 CH 2 19.512 39.023 No 
 3 36.744 73.488 No 
TERM 02 CH 1 304.220 608.439 Yes 
TERM 03 CH 1 8.501 17.002 No 
TERM 06 CH 1 259.546 519.091 Yes 
TERM 07 CH 1 98.175 196.349 No 
 2 303.209 606.418 Yes 
TERM 08 CH 1 181.213 362.426 Yes 
 2 5.309 10.619 No 
TERM 28 CH 2 55.469 110.937 No 
NEG 01 - 173.358 - Yes 
NEG 02 - 106.293 - Yes 
NEG 03 - 102.989 - Yes 
NEG 04 - 86.741 - No 
NEG 05 - 99.888 - No 
NEG 06 - 252.556 - Yes 
NEG 07  - 105.079 - Yes 
NEG 08  - 134.129 - Yes 
NEG 09 - 83.004 - No 
NEG 10 - 130.437 - Yes 
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Sample Copy 
number/µl 
Copy 
number/mg 
Within range? 
1255 114.427 228.855 Yes 
1272 186.731 373.461 Yes 
1288 171.773 343.546 Yes 
1294 319.956 639.916 Yes 
1300 407.758 815.516 Yes 
1314 116.619 233.237 Yes 
1315 301.512 603.023 Yes 
1349 110.471 220.942 Yes 
1361 86.448 172.895 No 
1448 1.802 3.604 No 
1567 125.830 251.660 Yes 
1568 123.945 247.890 Yes 
1258 47.063 94.126 No 
1271 38.697 77.393 No 
1274 36.772 73.545 No 
1283 65.535 131.070 No 
1286 37.052 74.104 No 
1291 25.401 50.801 No 
1297 14.399 28.799 No 
1306 0.034 0.068 No 
1308 24.060 48.120 No 
1313 37.413 74.826 No 
1316 25.490 50.979 No 
1318 73.131 146.262 No 
1328 25.498 50.996 No 
1334 14.594 29.188 No 
1339 17.490 34.980 No 
1340 31.192 62.383 No 
1344 27.154 54.308 No 
1345 20.798 41.596 No 
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1362 37.997 75.993 No 
1364 66.424 132.847 No 
1435 21.777 43.554 No 
1437 61.569 123.139 No 
1439 80.494 160.989 No 
1447 89.888 179.776 No 
1449 5.558 11.116 No 
1450 50.753 101.505 No 
1453 42.043 84.086 No 
1354 331.563 663.126 Yes 
1383 10.321 20.641 No 
1385 74.112 148.223 No 
1386 53.612 107.224 No 
1408 255.196 510.393 Yes 
1426 30.920 61.841 No 
1456 39.410 78.820 No 
1457 17.075 34.149 No 
1463 37.328 74.656 No 
1464 13.487 26.974 No 
1470 20.510 41.020 No 
1471 67.297 134.593 No 
1483 20.385 40.771 No 
1488 25.710 51.421 No 
1495 72.145 144.290 No 
1506 38.284 76.567 No 
1513 78.455 156.909 No 
1523 0.679 1.358 No 
1529 1.929 3.858 No 
NEG 01 69.332 - No 
NEG 02 150.626 - Yes 
NEG 03 111.928 - Yes 
NEG 04 137.608 - Yes 
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Table A.5 qPCR low risk term fetal membrane sample copy number results. Calculated 
copy numbers for low risk term fetal membrane tissue samples. Values are displayed as 
starting quantity copy number/µl and copy number/mg and indicated if results were within 
range for the assay >100 copies/µl. Patient sample number and negative control replicates 
displayed. 
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